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CHAPTER I 
INTRODUCTION 
I n f e r t i l i t y i s no l o n g e r t h o u g h t a woman's f a u l t , as men alone account 
f o r a p p r o x i m a t e l y 30 p e r c e n t o f a l l cases o f i n f e r t i l i t y and play a c o n ­
t r i b u t i n g r o l e i n a n o t h e r 2 0 p e r c e n t ( 1 , 2 ) . Al though male i n f e r t i l i t y can 
be c a u s e d b y p s y c h o l o g i c a l o r p h y s i c a l e j a c u l a t o r y d y s f u n c t i o n , t h i s 
o c c u r s o n l y s p o r a d i c a l l y a n d i m p a i r m e n t of sperm q u a l i t y i s by f a r more 
t h e m o s t f r e g u e n t . The p e r c e n t a g e o f a l l e g e d l y f e r t i l e men w i t h sperm 
c o u n t s b e l o w 2 0 χ 1 0 ° / m l v a r i e s b e t w e e n 5 and 23 per cent ( t a b l e I ) ( 3 -
1 2 ) . The f e r t i l i t y o f t h e O l i g o s p e r m i e man's w i f e w i l l o f t e n compensate 
f o r h i s s u b f e r t i l i t y ( 1 3 , 1 4 ) . I n s u p p o r t o f t h i s assumption i s the e x p e r i ­
e n c e t h a t t h e w i f e o f a n a z o o s p e r m i c man conceives much e a s i e r w i t h donor 
i n s e m i n a t i o n t h a n t h e w i f e o f an O l i g o s p e r m i e man ( 1 5 ) . Due t o the 
f r e q u e n t c o m p e n s a t i o n b y t h e p a r t n e r ' s f e r t i l i t y only a p a r t of the male 
p o p u l a t i o n w i t h o l i g o s p e r m i a a s k s f o r m e d i c a l e v a l u a t i o n of i t s s u b f e r t i ­
l i t y . 
I n t h i s s t u d y o l i g o s p e r m i a i s d e f i n e d a c c o r d i n g t o MacLeod and Gold 
( 4 ) . T h e i r d e f i n i t i o n i s b a s e d on s i n g l e sperm counta of 1000 men whose 
w i v e s h a d r e g i s t e r e d a t a n i n f e r t i l i t y c l i n i c . F ive per cent of these men 
h a d a s p e r m c o u n t b e l o w 2 0 χ 1 0 6 / m l . A r b i t r a r i l y t h i s l e v e l was chosen t o 
d i f f e r e n t i a t e b e t w e e n f e r t i l e a n d i n f e r t i l e men. However, i n l a t e r p u b l i ­
c a t i o n s t h i s s p e r m s t a n d a r d was c h a l l e n g e d by s e v e r a l authors ( 5 , 8 , 9 , 1 2 ) . 
T h e i r s t u d i e s w e r e m o s t l y b a s e d on s i n g l e sperm counts of prevasectomy 
p a t i e n t s . The r e s u l t s o f d i f f e r e n t s t u d i e s are summarized i n t a b l e I . The 
s e l e c t i o n o f t h e p a t i e n t p o p u l a t i o n was d i f f e r e n t i n these s t u d i e s and 
p r o b a b l y c o n t r i b u t e d t o t h e w i d e r a n g e o f t h e r e s u l t s . Since the p r o o f o f 
f e r t i l i t y was t h e s t r o n g e s t i n t h e s t u d y of MacLeod and Gold ( 4 ) , t h e i r 
c o n c l u s i o n s seem t h e m o s t v a l i d and t h e r e f o r e have been accepted by most 
i n v e s t i g a t o r s . 
A l t h o u g h we a l s o u s e t h e c r i t e r i u m o f MacLeod and Gold ( 4 ) , the d iagno­
s i s o l i g o s p e r m i a i s o n l y made i f t h e sperm count i s p e r s i s t e n t l y lower 
t h a n 2 0 χ l O ^ / m l i n a t l e a s t t h r e e e j a c u l a t e s , each o b t a i n e d a f t e r sexual 
a b s t i n e n c e f o r 2 - 5 d a y s ( 1 6 ) . The minimum s t a n d a r d of t h r e e pretreatment 
s p e r m a n a l y s e s was c h o s e n o n t h e a n a l o g y o f the s t u d i e s of most i n v e s t i g a ­
t o r s a n d a l s o f o r p r a c t i c a l r e a s o n s . 
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Table I: Comparison of sperm density cohorts in different series of fertile men 
Authors year of number mode of 
publication of recruitment 
subjects 
Hotchkiss et al. 1938 
Macleod 4 Gold 4 1951 
Nelson 4 Bunge 5 1974 
Rehan et al. 1975 
7 
Sobrero 4 Rehan 1975 
8 Smith & Steinberger 1977 
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N3 prenatal = husbands of wives visiting the prenatal clinic 
However it has to be mentioned that in euspermic men there exists a 
circannual rhythm in sperm count which accounts for approximately 34?» of 
the variance during the year (17) and may in part explain the within 
subject variability. The within subject coefficient of variation for sperm 
count is in the order of 40% and although the period of abstinence is an 
important factor, the greater part of the within subject variability 
remains unexplained (IB). Therefore some authors advise a minimum of 5-6 
pretreatment semen analyses if the purpose of the study is to investigate 
the effect of treatment (19,20). 
Abnormalities in sperm density are mostly seen in combination with 
impairment of both sperm motility and morphology in infertile men (4,21). 
As sperm density is easy to determine in contrast to motility and morpho-
logy, most studies about oligospermia refer only to this parameter. How-
ever, sperm motility and morphology are considered the most crucial 
factors in determining the fertilizing capacity (22). Therefore, men with 
normal motility and morphology but with low sperm density are rarely seen 
at the andrologic clinic. Experience from in vitro fertilization programs 
shows that the incubation medium has to contain at least 0.2 million 
sperms/ml with good motility (23). This finding relativates at least the 
phrase "only one spermatozoon is necessary for conception" and supports 
the relevance of sperm density for fertilization. Besides during the 
migration of sperm through the female genital tract an impressive reduc-
tion in sperm density and selection of sperm morphology takes place. The 
final number of spermatozoa in the ampulla of the oviduct is estimated to 
be less than 200. The contrast between this number and the minimum number 
necessary for in vitro fertilization can be explained by the supposition 
that spermatozoa reaching the site of fertilization, represent a highly 
selective sample of extreme fertllizable gametes (24). 
All men investigated in this study showed besides oligospermia also 
impairment of sperm motility and morphology. Since motility is the most 
crucial parameter for the assessment of the potential fertility of sperm, 
its determination needs special attention. The sperm motility determina-
tions in this study were performed as soon as liquifaction was completed. 
This was generally the case within 30 minutes after sperm collection. The 
motility was determined mostly by the same experienced investigator. Since 
the vesicular secretions have an adverse effect on sperm motility (25) it 
is important especially in case of oligospermia, that motility determina-
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t i o n takes place immediately a f t e r l i q u i f a c t i o n . 
Although not mentioned in t h i s s tudy, p r o o f o f d e f i c i e n t m o t i l i t y was 
a l s o obtained by evaluation of the i n v i v o and i n v i t r o a b i l i t y t o 
p e n e t r a t e c e r v i c a l mucus. The f i r s t was done w i t h p o s t c o i t a l t e s t i n g and 
the l a s t by means of the sperm m i g r a t i o n t e s t o f Kremer ( 2 6 ) . I n t h i s t e s t 
the a b i l i t y of sperm to migrate from a sperm p o o l i n a g l a s s r o d f i l l e d 
w i t h c e r v i c a l mucus is studied. The r e s u l t s o f b o t h t e s t s were p o o r o r 
negat ive f o r a l l the patients i n the p r e t r e a t m e n t p e r i o d . 
E t i o l o g y of oligospermia 
Oligospermia has mult iple causes. The s u b d i v i s i o n i n p r e t e s t i c u l a r , 
t e s t i c u l a r and post-teat icular causes, most ly used i n case o f a z o o s p e r m i a 
i s only of l i m i t e d value for o l igospermia. Table I I summarizes t h e m a j o r 
causes of oligospermia. Depending on the s e v e r e n e s s o f t h e u n d e r l y i n g 
disease the same cause can r e s u l t i n azoospermia, d i f f e r e n t d e g r e e s o f 
o l igospermia or be compatible w i t h euspermia. I n t h e v a s t m a j o r i t y o f 
moderately Oligospermie men - t h i s i m p l i e s sperm d e n s i t y i n t h e r a n g e o f 
5-20 χ 106/ml - no d e f i n i t e cause can be d e t e c t e d ( 2 7 , 2 8 ) and t h e f i n a l 
d i a g n o s i s i s " id iopathic ol igospermia". General agreement e x i s t s as t o 
most of the c r i t e r i a necessary f o r t h i s d i a g n o s i s . These c r i t e r i a a r e 
summarized i n table I I I . 
The necessity to perform a t e s t i c u l a r b iopsy a n d / o r chromosomal a n a l y ­
s i s before making the diagnosis of i d i o p a t h i c o l i g o s p e r m i a i s c o n t r o v e r ­
s i a l . Since both diagnostic procedures w i t h r e g a r d t o t h e p a t i e n t s were 
o m i t t e d i n t h i s study, t h i s requires a j u s t i f i c a t i o n . B e f o r e t h e i n t r o d u c ­
t i o n of q u a n t i t a t i v e scoring techniques of t e s t i c u l a r b i o p s i e s , t h e h i s t o ­
l o g i c d e s c r i p t i o n s correlated poorly w i t h sperm a n a l y s i s and were o f v e r y 
l i m i t e d va lue. After the i n t r o d u c t i o n of ( s e m i ) q u a n t i t a t i v e s t u d i e s on t h e 
morphology of t e s t i c u l a r biopsies, severa l a u t h o r s ( 2 9 - 3 3 , 7 2 ) r e p o r t e d on 
the remarkable corre lat ion between semen a n a l y s i s and t h e h i s t o l o g i c a l 
p i c t u r e . From these studies i t became c l e a r t h a t i r r e v e r s i b l e d i s o r d e r s 
l i k e maturat ion arrest and h y a l i n i z a t i o n of t h e t u b u l a r w a l l were i n f a c t 
only found i n pat ients with severe o l i g o s p e r m i a (< 5 χ l O ^ / m l ) . However, i n 
p a t i e n t s w i t h mild oligospermia (5-20 χ l O ^ / m l ) and FSH l e v e l s i n t h e 
normal range, the most common f i n d i n g , sperm m a t u r a t i o n was d e c r e a s e d and 
p a r t i c u l a r l y disorganization of the s e m i n i f e r o u s e p i t h e l i u m was p r o n o u n c ­
e d . 
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Tab le I I : Causes of o l igospermia 
- Chromosomal d i s o r d e r s 
- H y p o t h a l a m i c - p i t u i t a r y d isorders 
- Hypo- and h y p e r t h y r o i d i s m 
- C o n g e n i t a l a d r e n a l hyperp las ia 
- P o l y g l a n d u l a r f a i l u r e 
- M e t a b o l i c d i s o r d e r s ; chron ic l i v e r disease; uremia 
- Gross o b e s i t y 
- P a r a p l e g i a 
- M y o t o n i c dys t r ophy 
- I n t o x i c a t i o n s 
- Drugs ( a l k y l a t i n g agents-salazopyr ine-cimet id ine-ant iandrogens-
e s t r o g e n s - s p i r o n o lac tone-pest ic ides) 
- I r r a d i a t i o n 
- D i s t u r b e d t e s t i c u l a r descent 
- V a r i c o c e l e 
- P o s t - t e s t i c u l a r p a r t i a l obs t ruc t ion 
- Male i n f e r t i l i t y syndrome (androgen receptor def ic iency) 
- I n f e c t i o n s : o r c h i t i s , ep id i dym i t i s , p ros ta t i t i s 
- Immuno log ic d i s o r d e r s 
- I d i o p a t h i c oligospermia 
Because o f t h e c l ose c o r r e l a t i o n reported by d i f f e r e n t authors us ing 
s o p h i s t i c a t e d techn iques one can question whether t e s t i c u l a r biopsy i n 
case o f moderate o l igospermia has addi t ional value. However, one se r ious 
argument i s i n favour of t h i s that the oligospermia may be caused by an 
o b s t r u c t i o n i n t he d u c t a l system. A study in several hundred Ol igospermie 
men demons t ra ted such a obs t ruc t ion in only 20% of the severe Ol igospermie 
cases ( 3 4 ) . Hence, i t was concluded that i n a populat ion of moderately 
O l i g o s p e r m i e men w i t h serum FSH levels in the normal range, the value of 
t e s t i c u l a r b i o p s y i s l i m i t e d to j u s t i f y th is as a rou t ine procedure. More-
o v e r , t e s t i c u l a r b iopsy ca r r i es the r isk of temporary damage of the 
s e m i n i f e r o u s e p i t h e l i u m (35) and induction of sperm an t ibod ies (36 ) . 
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Table H I : C r i t e r i a for the diagnosis of i d i o p a t h i c o l i g o s p e r m i a 
- Persistent sperm concentration of < 20 χ lO^/ml or t o t a l sperm count <40 
χ l o V m l in at least 3 semen analyses 
- No history or evidence on phys ica l examinat ion of c r y p t o r c h i d i s m , 
o r c h i t i s , epididymit is or p r o s t a t i t i s 
- No systemic disease and no i n t o x i c a t i o n s 
- Normal l i b i d o and potency 
- Testis volume Sl7 ml (40) 
- Varicocele ruled out by c l i n i c a l i n v e s t i g a t i o n 
- Serum FSH, -LH, -testosterone and - p r o l a c t i n i n the range o f 
euspermic men 
* Chromosomal anomalies ruled out by chromosomal a n a l y s i s 
* I n t r a t e s t i c u l a r gross pathology and/or p o s t - t e s t i c u l a r p a r t i a l 
obstruction ruled out by t e s t i c u l a r biopsy 
* f a c u l t a t i v e c r i t e r i a 
Comparable arguments have favoured the r e j e c t i o n of chromosomal a n a l y ­
sis i n the patients invest igated i n t h i s s t u d y . I n s e v e r a l s t u d i e s (37-39) 
i t was shown that among azoospermic men 13-15% were chromosomally a b n o r ­
mal, the vast majority (80%) being 47,XXY chromat in p o s i t i v e males. How­
ever, in Oligospermie men the incidence of chromosomal anomalies was not 
higher than 38, half of which was caused by anomalies of sex chromosomes 
and the other half by anomalies of autosomes. Since anomalies of sex 
chromosomes are almost always seen i n combinat ion w i t h hypogonadism, 
severe oligospermia and elevated serum FSH l e v e l s , and s i n c e none of t h e 
patients i n t h i s study have shown the above f e a t u r e s , t h i s p o s s i b i l i t y was 
disregarded. The chance of 1.5%, t h a t the o l i g o s p e r m i a c o u l d be caused by 
an autosomal anomaly and therefore should not be c o n s i d e r e d аз i d i o p a t h i c , 
was considered too low to j u s t i f y chromosomal a n a l y s i s i n a l l p a t i e n t s . 
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Endocr ine aspects of i d i o p a t h i c oligospermia 
High i n t r a t e s t i c u l a r testosterone levels are considered to be a requi­
s i t e t o the complet ion of spermatogenesis (41). For many years the current 
dogma has been t h a t i n p a t i e n t s w i t h disrupted spermatogenesis Leydig c e l l 
f u n c t i o n i s normal ( 4 2 ) . However, in many of the patients with severe 
t e s t i c u l a r damage, such as germ c e l l a r r e s t , S e r t o l i c e l l only syndrome 
and s e m i n i f e r o u s t u b u l e h y a l i n i z a t i o n , elevated LH and low testosterone 
l e v e l s are present ( 4 3 - 5 6 ) . 
F u r t h e r evidence of abnormal i t ies in Leydig c e l l function in men with 
s e m i n i f e r o u s t u b u l a r damage has been adduced from the subnormal response 
of t e s t o s t e r o n e t o s t i m u l a t i o n w i t h human chorion gonadotropin or LH-RH 
( 4 2 , 4 4 , 5 0 , 5 7 - 6 0 ) . I n some instances LH levels are high normal or elevated 
d e s p i t e normal l e v e l s of t e s t o s t e r o n e , which led to the postulate that a 
s t a t e of compensated Leydig c e l l f a i l u r e exists in these men. Elevation of 
t h e LH response t o LH-RH i n men wi th S e r t o l i c e l l only syndrome or 
K l i n e f e l t e r ' s syndrome f u r t h e r substantiates these abnormalities in Leydig 
c e l l f u n c t i o n ( 4 2 , 4 4 , 6 0 , 6 1 ) . This supports the concept of decreased feed­
back from Leydig c e l l s i n t h i s d isorder. In idiopathic oligospermia there 
i s a l s o growing ev idence, t h a t the t e s t i c u l a r abnormality is not l imi ted 
t o the s e m i n i f e r o u s t u b u l e but involves the Leydig c e l l as w e l l . Reduced 
plasma t e s t o s t e r o n e l e v e l s have been found in patients with low sperm 
counts (42,44,51,52,56,61-68) i n the presence of high normal or elevated 
serum LH l e v e l s (51,52,56) and increased responses to LH-RH in more than 
40% of these p a t i e n t s (15,64,65,68-71). Furthermore, reverse correlat ions 
between b a s a l serum LH and sperm counts have been reported by some inves­
t i g a t o r s ( 4 2 , 4 6 , 5 6 , 7 2 ) . 
I n a d d i t i o n t o these abnormal i t ies in c i r c u l a t i n g LH and testosterone 
l e v e l s i n i d i o p a t h i c o l i g o s p e r m i a , preliminary reports from in vivo and in 
v i t r o s t u d i e s p o i n t t o an accumulation of 17-OHP over testosterone under 
b a s a l c o n d i t i o n (54,73-76) and a f t e r HCG st imulat ion (57,59,73,77,78). 
T h i s f a v o u r s the concept of the presence of an enzymatic defect at the 
1 7 , 2 0 - І у а з е s t e p . Furthermore, i n pat ients with idiopathic oligospermia 
abnormal estrogen h a n d l i n g has been postulated in the pathogenesis of 
L e y d i g c e l l d y s f u n c t i o n . I n normal men the testes secrete estrogens which 
p r o b a b l y p lay a r o l e i n the l o c a l c o n t r o l of Leydig c e l l function (53,79, 
8 0 ) . I n men w i t h s e c r e t o r y azoospermia and in K l i n e f e l t e r ' s syndrome (53, 
7 
5 9 , 7 5 , 8 1 , 8 2 ) elevated serum e s t r a d i o l l e v e l s have b e e n f o u n d . I n men w i t h 
i d i o p a t h i c ol igospermia a l s o an i n c r e a s e i n t e s t i c u l a r i n t r a t u b u l a r 
c o n c e n t r a t i o n and/or an i n o r d i n a t e s e n s i t i v i t y t o i t s i n h i b i t o r y e f f e c t 
have been p o s t u l a t e d ( 7 5 , 7 9 , 8 1 , 8 3 ) p r o v i d i n g a r a t i o n a l e f o r t h e t r e a t m e n t 
o f t h e s e p a t i e n t s w i t h a n t i e s t r o g e n s a n d / o r a r o m a t a s e i n h i b i t o r s . A p a r t 
f r o m d e f e c t s i n t e s t o s t e r o n e a n d / o r e s t r a d i o l h a n d l i n g , a b n o r m a l i t i e s i n 
t e s t i c u l a r FSH receptors (84) and a n d r o g e n r e c e p t o r s (Θ5-Θ6) h a v e b e e n 
r e p o r t e d i n i n f e r t i l e men. Some a u t h o r s have c l a i m e d i n d i r e c t a n d d i r e c t 
e v i d e n c e f o r androgen r e s i s t a n c e i n 10 t o 40% o f p a t i e n t s w i t h a z o o s p e r m i a 
and s e v e r e ol igospermia ( 8 5 , 8 6 ) , b u t t h i s f i n d i n g h a s b e e n c h a l l e n g e d by 
o t h e r s ( 8 7 ) . 
Decreased pulse frequency of LH-RH and by i n f e r e n c e o f LH v e r y r e c e n t l y 
h a s been adduced as the cause o f s e l e c t i v e e l e v a t i o n o f FSH i n some 
p a t i e n t s w i t h i d i o p a t h i c o l i g o s p e r m i a ( " s l o w p u l s i n g o l i g o s p e r m i a " ) ( 8 8 -
9 1 ) , l o c a l i z i n g the cause of the s p e r r n a t o g e n i c d e r a n g e m e n t a t t h e h y p o t h a ­
l a m i c p i t u i t a r y l e v e l . I n c r e a s i n g t h i s p u l s e f r e q u e n c y t o a n o r m a l r a t e by 
p u l s a t i l e LH-RH a d m i n i s t r a t i o n , r e s u l t e d i n a f a l l o f s e r u m FSH l e v e l s and 
an i n c r e a s e i n sperm d e n s i t y ( 9 0 ) . 
From a l l these data i t i s e v i d e n t t h a t i d i o p a t h i c o l i g o s p e r m i a i s n o t a 
d i s t i n c t n o s o l o g i c a l e n t i t y but r a t h e r a m i x t u r e o f h y p o t h a l a m i c , p i t u i t a ­
r y and gonadal a b n o r m a l i t i e s l e a d i n g t o s p e r r n a t o g e n i c damage, d e c r e a s e d 
sperm d e n s i t y and impairment i n b o t h t h e m o r p h o l o g y a n d m o t i l i t y . 
T h e r a p y i n i d i o p a t h i c o l i g o s p e r m i a 
Ample t h e r a p e u t i c m o d a l i t i e s have been u s e d i n i d i o p a t h i c o l i g o s p e r m i a , 
most o f them based on wrong a s s u m p t i o n s o r e m p i r i c i s m . E x a m p l e s o f s u c h 
t h e r a p e u t i c regimens are v i t a m i n e E ( 9 2 , 9 3 ) , c o r t i c o s t e r o i d s ( 9 4 — 9 6 ) , 
t h y r o i d hormone therapy ( 9 7 ) , a r g i n i n e ( 9 8 - 1 0 0 ) , k a l l i k r e i n ( 1 0 1 ) , b r o m o ­
c r i p t i n e (102-104), gonadotrop ins ( 1 0 5 - 1 0 8 ) , m e s t e r o l o n ( 1 0 9 , 1 1 0 ) , t e s t o ­
s t e r o n e rebound therapy (111-113) and LH-RH ( 1 1 4 - 1 1 6 ) . F o r r e v i e w s e e 
S c h i l l and Michalopoulos ( 1 1 7 ) . I n most o f t h e s e o l d e r s t u d i e s c o n c e p t i o n 
r a t e s and sperm analyses were t h e o n l y m e n t i o n e d p a r a m e t e r s a n d no h o r m o ­
n a l d a t a were g iven. This changed w i t h t h e i n t r o d u c t i o n o f c l o m i p h e n e 
c i t r a t e as a mode of t r e a t m e n t . T h i s t r i p h e n y l e t h y l e n e d e r i v a t e ( f i g . 1 ) , 
a r a c e m i c mixture of two components w i t h b o t h e s t r o g e n i c a n d a n t i e s t r o g e ­
n i c p r o p e r t i e s s t i m u l a t e s the s e c r e t i o n o f p i t u i t a r y g o n a d o t r o p i n s and 
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thereby gonadal steroid secretion (118-124). 
C l o m i p h e n e Tnpheny le thy lene Tamoxifen 
Figure 1 
A l t h o u g h t h e mode of a c t i o n a t the hypotha lamic-p i tu i ta ry l e v e l i s no t 
c o m p l e t e l y u n d e r s t o o d , most of t he data avai lable suggest an a n t i e s t r o g e -
n i c a c t i o n a t t h e l e v e l of t h e hypothalamus and an e s t r o g e n i c a c t i o n a t 
t h e p i t u i t a r y l e v e l ( 1 2 5 ) . 
3ungck e t a l . (126) was t h e f i r s t to report on the e f f e c t of c lomiphene 
c i t r a t e on t h e s p e r m a t o g e n e s i s in normal volunteers as w e l l a s in O l i g o -
s p e r m i e men. T h i s p a p e r was fol lowed by numerous r e p o r t s of many a u t h o r s 
u s i n g d i f f e r e n t d o s e s of c lomiphene and regimens. After t h e r e p o r t of 
H e l l e r e t a l . ( 127 ) i n 1969, demons t ra t ing the toxic e f f e c t of h i g h d o s e s 
(400 mg d a i l y ) on s p e r m a t o g e n e s i s of clomiphene c i t r a t e , t h e impe t u s a s t o 
t h e u s e of c l o m i p h e n e i n men was accelera ted by the p u b l i c a t i o n s of 
P a u l s o n e t a l . ( 128-131) which s t r e s s e d the importance of t h e u s e of low 
d o s a g e and r e l i a n c e on FSH d e t e r m i n a t i o n s . Table IV summarizes t h e r e s u l t s 
of t h e most i m p o r t a n t s t u d i e s . I n t e r p r e t a t i o n of the d i f f e r e n t r e s u l t s i s 
hampered by l a c k of u n i v e r s a l agreement as to what c o n s t i t u t e s a p o s i t i v e 
r e s p o n s e t o t h e r a p y . For example no c l e a r - c u t standard has been deve loped 
f o r wha t means a ' s i g n i f i c a n t ' improvement in semen a n a l y s i s . F u r t h e r m o r e , 
t h e s e l e c t i o n c r i t e r i a of p a t i e n t s were incons i s t en t . One of t h e s c a r c e 
d o u b l e b l i n d c r o s s - o v e r s t u d i e s with clomiphene c i t r a t e showed a s i g n i f i -
c a n t i n c r e a s e i n sperm d e n s i t y dur ing the treatment p e r i o d w h e r e a s t h e r e 
was no c h a n g e d u r i n g t h e p l a c e b o per iod (139). The e r r a t i c r e s u l t s of t h e 
t r e a t m e n t of O l i g o s p e r m i e men wi th clomiphene c i t r a t e and t h e a s s u m p t i o n 
of a d i r e c t n e g a t i v e e f f e c t of the es t rogenic component of c lomiphene 
c i t r a t e on s p e r m a t o g e n e s i s l e d t o t reatment with c i s - c lomiphene c i t r a t e , 
wh ich i s d e v o i d of e s t r o g e n a c t i o n . However, even wi th c i s - c l o m i p h e n e 
r e s u l t s were e r r a t i c and u n p r e d i c t a b l e (142-144). 
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Table IV: Literature data on the effect of clomiphene citrate treatment in oligospermia 
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100 mg/day for 10 days 
periods every months 
during 3 months 
25 mg/day in 
25 days cycles with 
5 day rest period 
100 mg 3 times a week 
controlled trial 
100 mg 3 times a week 
controlled 
trial 
I n 1976 Comhaire (145) was the F i r s t to report on the Favourable 
r e s u l t s oF a n o t h e r t r i p h e n y l e t h y l e n e de r i va t i ve , tamoxiFen, i n the t r e a t -
ment oF i d i o p a t h i c o l i g o s p e r m i a (see Fig. 1). Admin i s t ra t i on oF t h i s 
c o m p e t i t i v e e s t r o g e n a n t a g o n i s t t o Oligospermie men resu l ted i n a moderate 
i nc rease oF serum LH and FSH l e v e l s and doubling oF serum tes tos te rone 
l e v e l s . Sperm d e n s i t y doub led i n h i s group oF pa t ien ts w i t h moderate 
o l i g o s p e r m i a . I n t e r e s t i n g l y t h i s drug had already been tes ted e x t e n s i v e l y 
i n the p a l l i a t i v e t r e a t m e n t oF breas t cancer (146). Whereas i n the human 
tamoxiFen has n e a r l y pu re a n t i e s t r o g e n i c propert ies (147) , the reverse 
ho lds t r u e For r o d e n t s . I n r a t s tamoxiFen causes a severe reg ress ion oF 
bo th the s e m i n a l v e s i c l e s and p r o s t a t e and also t e s t i c u l a r atrophy (148 ) . 
Th is o b s e r v a t i o n may e x p l a i n the long delay between r e g i s t r a t i o n oF 
tamoxiFen For p a l l i a t i v e t r e a t m e n t i n breast cancer p a t i e n t s and Fur ther 
research t o t e s t i t s useFu lness as a po ten t i a l therapeut ica l agent i n the 
t r ea tmen t oF i d i o p a t h i c o l i g o s p e r m i a . The argument to consider tamoxiFen 
more a p p r o p r i a t e For t h e t r e a t m e n t oF id iopath ic o l igospermia , came From 
the h y p o t h e s i s t h a t c l om iphene by means oF i t s estrogenic a c t i o n cou ld 
e x e r t a d i r e c t n e g a t i v e eFFect on the seminiFerous e p i t h e l i u m coun te r -
a c t i n g t h e s t i m u l a t i n g eFFect oF FSH and testosterone. AFter the F i r s t 
r e p o r t oF Comhaire s e v e r a l papers have been publ ished s t r e s s i n g the 
b e n e F i c i a l eFFect oF tamox iFen i n doses varying From 20-30 mg d a i l y (145, 
149 -154 ) . D o u b l i n g oF t h e sperm dens i t y and a 20-70% concept ion r a t e was 
r e p o r t e d by some a u t h o r s a F t e r a t reatment period oF 3 t o 12 months. Table 
V summarizes the da ta oF t hese s t u d i e s . W i l l i s (149) however us ing a much 
lower dose oF o n l y 10 mg c o u l d not observe any eFFect at a l l on sperm 
parameters d e s p i t e c l e a r - c u t changes i n serum gonadotropin, t es tos te rone 
and e s t r a d i o l l e v e l s . These d a t a suggested that the eFFect oF tamoxiFen on 
spermatogenes is i s dose dependen t . Otherwise, the seve r i t y oF the o l i g o -
spermia i n most oF t he p a t i e n t s i n the study oF W i l l i s could a lso a t l e a s t 
i n p a r t e x p l a i n t h e l a c k oF sperm improvement. The disadvantage oF tamox i -
Fen and a l s o c i s - c l o m i p h e n e t rea tmen t i n id iopathic o l igospermia may be 
due t o t h e Fac t t h a t b o t h agen t s b r i n g about an increase i n serum e s t r a -
d i o l l e v e l s comparab le o r even g r e a t e r than that oF tes tos te rone (145,149, 
1 5 0 ) . ThereFore b o t h agen t s produced e i t he r no change or even a decrease 
i n the t e s t o s t e r o n e / e s t r a d i o l r a t i o . 
As a l r e a d y m e n t i o n e d , e s t r a d i o l probably plays a r o l e i n the r e g u l a t i o n 
oF s p e r m a t o g e n e s i s , F i r s t by d i r e c t act ion on the seminiFerous tubu les 
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Table V: Literature data on the effect of tamoxifen treatment in idiopathic oligospermia 














Comhairel45 1976 2 χ 10 6 - 1 1 15 13 
Willis et al.1 4 9 1977 1 χ 10 
Vermeulen 4 
Comhaire150 197B 2 χ 10 9 - 1 2 21 15 not reported 
Schill 4 
Landthaler151 1980 2 χ 10 6 - 1 1 33 17 not reported 
Traub 4 
Thompson152 1981 2 χ 10 32 16 
Buvat et al.1 5 4 1983 2 χ 10 4 - 1 2 25 25 10 
and secondly by preventing the Leydig cell from maximally producing testo-
sterone in response to LH (91,155-163). Vigersky and Glass (79) postulated 
that if estradiol formation was decreased by an aromábase inhibitor like 
Al-testolactone (see fig. 2) than an improvement may occur in both sperm 





Earlier Marynick et al. (164) reported that Δΐ-testolactone indeed produc­
ed a fall in serum estradiol levels in normal men with a concomitant rise 
in testosterone levels. From the paper of Vigersky and Glass (79) it 
became clear that A^-testolactone administration for 6-12 months in a dose 
of 1 gr/day in 3 divided doses to 10 patients with idiopathic oligosper­
mia, lowered serum estradiol level by 34%, increased testosterone, and 
androstenedione levels by 47 and 70% respectively and produced an increase 
in the T/E2 ratio of 1265S. Basal and LH-RH stimulated gonadotropin levels 
were uneffected by these changes. Nevertheless, sperm density almost 
doubled after 6-12 months of therapy and 3 men impregnated their wives. 
After this encouraging study only 2 further preliminary studies have 
appeared on the effect of Δ l-testolactone on spermatogenesis, one by the 
same group using both Δΐ-testolactone and tamoxifen concomitantly and one 
study of Clark and Sherins (165,166). The later authors did not find any 
improvement at all after ù\-testolactone therapy in their patients with 
idiopathic oligospermia. 
Aim of the study 
In the section endocrine aspects of idiopathic oligospermia it was 
already stressed that in patients with idiopathic oligospermia Leydig cell 
function may also be impaired. A state of compensated Leydig cell function 
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function has been suggested i n these p a t i e n t s , the reason of which i s 
unknown so f a r . 
Seminiferous tubular damage per se may lead to the s e c r e t i o n of some 
factor(s) blocking Leydig c e l l testosterone b i o s y n t h e s i s . I n t h i s c o n t e x t 
recent f indings of Sharpe and other authors are of i n t e r e s t demonstrat ing 
the presence of an LH-RH-like peptide i n r a t t e s t e s (167170) and probably 
also in human testes (171-172). This peptide may modulate Leydig c e l l 
funct ion. On the other hand, seminiferous t u b u l a r i n j u r y may lead t o a 
secondary increase of LH (and/or LH-RH-like pept ides) w i t h subsequent 
desensitization of the Leydig c e l l and suppression of enzyme systems 
operative la te in the д^ pathway of t e s t i c u l a r s t e r o i d b i o s y n t h e s i s , i . e . , 
at the 17a-hydroxyla3e and 17,20-lyase step between progesterone and 17a-
hydroxyprogesterune, and between 17ot-hydroxyprogesterone and androstene-
dione respectively ( f i g . 3 ) . 
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Figure 3: Steroidogenesis through the d e l t a - 4 and the d e l t a - 5 pathways i n 
the t e s t i s 
We, therefore hypothesized t h a t i f chronic Leydig c e l l d e s e n s i t i z a t i o n 
were indeed present, s t i m u l a t i o n by LH-RH should reveal an anomalous 
response of testosterone and i t s major precursor 17a-hydroxyprogesterone 
in patients with id iopathic ol igospermia as compared w i t h euspermic men. 
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In chapter II this hypothesis is tested. 
As mentioned earlier, tamoxifen administration in doses varying from 20 
to 30 mg daily has a beneficial effect on sperm density, total sperm 
counts and conception rates (145, 150-154). Preliminary data, however, 
suggested that this defect is dose dependent as Willis et al. (149) failed 
to demonstrate systemic changes in sperm parameters in Oligospermie 
patients treated with the lower dosis 10 mg tamoxifen daily, despite 
clear-cut changes in serum gonadotropins and steroid levels reminiscent to 
those found after administration of the higher doses. These data prompted 
us to compare the effect of lower (5 and 10 mg once daily) and higher 
doses of tamoxifen (10 mg twice daily) on circulating horinone levels and 
sperm parameters in patients with moderate idiopathic oligospermia. The 
study was further designed to assess the predictary value of basal and 
LH-RH stimulated gonadotropin and steroid levels one month after starting 
therapy on the final outcome of spermatogenesis. Buvat et al. (153) 
provided preliminary evidence of a discriminating effect of tamoxifen 
induced hormonal changes soon after starting therapy on the eventual 
improvement of sperm parameters. In the case of amelioration of sperm, 
plasma testosterone vigorously increased whereas in the opposite case FSH 
levels overtly rose. Chapter III deals with the dose dependency and the 
value of hormonal data induced by tamoxifen administration in predicting 
the effect on sperm parameters. 
Our finding of the presence of an intrinsic difference in the acute 
Leydig cell response to LH-RH between euspermic and Oligospermie men, as 
reflected by the lack of an initial plasma testosterone rise and accumula­
tion of 17-OHP over testosterone suggesting a 17,20-lyase block (160,163, 
173-1Э4) prompted us to search for a, mechanism which could account for 
these differences. In rats and also in normal men ample evidence for a 
permissive role of estrogens has been adduced in the genesis of a 17,20-
lyase block, which could be abolished by concomitant administration of an 
antiestrogen (185-186). In patients with idiopathic oligospermia an alter­
ed estrogen handling has been suggested (53,59,75,79,81,82). We therefore 
wondered whether sustained lowering of endogenous estrogen levels by 
chronic administration of the aromatase inhibitor ¿l-testolactone may 
correct the anomalous Leydig cell response to LH-RH in these patients. 
(chapter IV). 
Increased intratest icular estrogen concentrations or an inordinate 
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s e n s i t i v i t y of the germinal e p i t h e l i u m t o t h e i r i n h i b i t i n g e f f e c t have 
been postulated as the cause of the d e f e c t i v e spermatogenesis i n p a t i e n t s 
with idiopathic oligospermia ( 7 9 ) . Evidence f o r a p i v o t a l r o l e o f e s t r o ­
gens in the suppression of spermatogenesis was f u r t h e r adduced by V i g e r s k y 
and Glass (79) who demonstrated t h a t l o w e r i n g e s t r a d i o l l e v e l s by a d m i n i s ­
t r a t i o n of the aromatase i n h i b i t o r A ^ - t e s t o l a c t o n e (TL) f o r 6-12 m o n t h s ) 
indeed improves sperm density and f e r t i l i t y i n p a t i e n t s w i t h i d i o p a t h i c 
oligospermia thus by a mechanism q u i t e d i f f e r e n t f rom t h a t o f t a m o x i f e n , 
which acts by competitive e s t r a d i o l r e c e p t o r b l o c k a d e . I n a n o t h e r p r e l i m i ­
nary study, Clark and Sherins ( 1 6 5 ) , however, f a i l e d t o d e m o n s t r a t e any 
ef fect at a l l of ЛІ- testo lactone t r e a t m e n t on sperm parameters i n t h e i r 
patients with idiopathic o l i g o s p e r m i a . These c o n f l i c t i n g d a t a p r o m p t e d u s 
to monitor careful ly the e f f e c t of s u s t a i n e d l o w e r i n g o f endogenous e s t r o ­
gen levels by ¿ l - testo lactone a d m i n i s t r a t i o n f o r s i x months on p i t u i t a r y -
Leydig c e l l function and sperm parameters i n p a t i e n t s w i t h i d i o p a t h i c 
oligospermia. 
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CHAPTER I I 
DIFFERENTIAL LI-FECf OF LUTEINIZING HORMONE-RELEASING HORMONE I N F U S I O N ON 
TESTICULAR STEROIDS IN NORMAL MEN AND PATIENTS WITH I D I O P A T H I C O L I G O S P E R -
MIA 
J .M.J . Dony, A .G.H. Smals , R. R o l l a n d , B . C . 3 . M . F a u s e r , C . M . G . T h o m a s 
(Pub l i shed i n F é r t i l . S t e r i l . 4 2 : 2 7 4 - 2 8 0 , 1 9 8 4 ) 
ABSTRACT 
Basal serum gonadotcop in l e v e l s i n 11 o l i g o s p e r m i o men w e r e s i g n i f i -
can t l y h igher than i n 9 e u s p e r m i c c o n t r o l s u b j e c t s , a l t h o u g h m o s t w e r e 
s t i l l i n the normal range . B a s a l s e r u m t e s t o s t e r o n e ( T ) , 1 7 - h y d r o x y p r o g e -
sterone (17-OHP) and e s t r a d i o l (E2 ) l e v e l s a n d t h e i r r a t i o s d i d n o t d i f f e r 
s i g n i f i c a n t l y . 
Continuous l u t e i n i z i n g h o r m o n e - r e l e a s i n g h o r m o n e ( L H - R H ) i n f u s i o n 
(1 yg/minute For 1Θ0 m i n u t e s ) d u r i n g i n t e g r a t e d b l o o d s a m p l i n g e v o k e d 
s i m i l a r g o n a d o t r o p i n r e s p o n s e s i n b o t h g r o u p s b u t h a d a d i f f e r e n t i a l 
e f f e c t on T: i n the c o n t r o l s u b j e c t s Τ i n c r e a s e d (P < 0 . 0 1 ) w i t h i n 1 5 
minutes t o 1.5 t i m e s b a s e l i n e , w h e r e a s i n t h e O l i g o s p e r m i e men Τ d e c r e a s e d 
(P < 0 . 0 1 ) . From 60 m i n u t e s o n , h o w e v e r , Τ a l s o s i g n i f i c a n t l y r o s e i n t h e 
Ol igospermie men, b u t t h e maximum i n c r e m e n t w a s a b o u t h a l f l o w e r (P < 
0.01) than i n t h e e u s p e r m i c m e n , d e s p i t e v i r t u a l l y s i m i l a r r i s e s i n 
17-OHP. Only i n the O l i g o s p e r m i e men d i d t h e 1 7 - 0 H P / T r a t i o i n c r e a s e (P < 
0.02) d u r i n g LH-RH, w h i c h i s c o m p a t i b l e w i t h t h e o c c u r r e n c e o f a 1 7 , 2 0 -
lyase b l o c k . Serum e s t r a d i o l ( E 2 ) d i d n o t i n c r e a s e i n e i t h e r g r o u p . 
I n c o n c l u s i o n , c o n t i n u o u s LH-RH i n f u s i o n u n c o v e r s a n i n t r i n s i c d i f f e r ­




L e y d i g c e l l f u n c t i o n and r e s e r v e i n id iopath ic oligospermia have 
c o n f i i c t i n g l y been r e p o r t e d t o be normal or impaired (1-4). On the 
s t r e n g t h o f d e c r e a s e d plasma t e s t o s t e r o n e (T) levels associated with 
h i g h n o r m a l o r s u p r a n o r m a l l u t e i n i z i n g hormone (LH) levels by some 
a u t h o r s ( 1 ) , a s t a t e o f compensated Leydig-cel l dysfunction has been 
s u g g e s t e d i n t h e s e p a t i e n t s . The reason for t h i s Leydig c e l l f a i l u r e is 
n o t k n o w n . S e m i n i f e r o u s t u b u l e damage per se may lead to the secretion 
o f some f a c t o r ( s ) b l o c k i n g L e y d i g c e l l Τ biosynthesis. In t h i s context, 
t h e r e c e n t f i n d i n g o f Sharpe ( 5 , 6 ) i s of i n t e r e s t , demonstrating the 
p r e s e n c e o f an L H - r e l e a s i n g hormone (LH-RH)-like peptide in rat testes, 
p r o b a b l y s e c r e t e d by t h e S e r t o l i c e l l and modulating Leydig c e l l Τ 
s e c r e t i o n . I n man, a l s o , LH-RH-l ike m a t e r i a l immunologically d i f f e r i n g 
f r o m n a t i v e h y p o t h a l a m i c LH-RH has been demonstrated i n seminal plasma 
o f h e a l t h y s u b j e c t s as w e l l as i n p a t i e n t s wi th idiopathic oligospermia 
( 7 , 8 ) . A n o t h e r e x p l a n a t i o n f o r the Leydig c e l l dysfunction in o l i g o ­
s p e r m i a m i g h t be t h a t s e m i n i f e r o u s tubule damage per se leads to a 
s e c o n d a r y i n c r e a s e o f LH a n d / o r an LH-RH-like peptide with subsequent 
d e s e n s i t i z a t i o n o f t h e L e y d i g c e l l , suppression of enzyme systems 
o p e r a t i n g l a t e i n t e s t i c u l a r s t e r o i d b iosynthesis, i . e . , at the 17,20-
l y a s e and 17 α - h y d r o x y l a s e s t e p , and hence reduced androgen secretion. 
S t e i n b e r g e r e t a l . ( 9 ) and Rodriguez-Rigau et a l . (10) recently provid­
e d i n v i t r o e v i d e n c e o f d e c r e a s e d 17,20-lyase a c t i v i t y in Leydig c e l l s 
o f a t l e a s t some p a t i e n t s w i t h i d i o p a t h i c oligospermia and high normal 
s e r u m g o n a d o t r o p i n l e v e l s . I f c h r o n i c Leydig c e l l desensit ization (11) 
w e r e i n d e e d p r e s e n t , l o w - d o s e LH-RH i n f u s i o n should reveal an anomalous 
s t e r o i d r e s p o n s e i n p a t i e n t s w i t h ol igospermia, as compared with 
e u g o n a d a l e u s p e r m i c men. The p r e s e n t study provides indirect evidence 
f o r an a l t e r e d L e y d i g c e l l f u n c t i o n i n these pat ients. 
MATERIALS AND METHODS 
N i n e h e a l t h y , p o t e n t i a l l y f e r t i l e volunteers [age, 30.3 + 4.6 years 
s t a n d a r d d e v i a t i o n (SD)] ; mean sperm count, 41.5 + θ χ lOfyml; abnormal 
f o r m s < 40%; mean sperm m o t i l i t y graded 5 for rapidly and 1 for slug­
g i s h l y p r o g r e s s i v e s p e r m a t o z o a ) ( 4 - 5 ) , and 11 i n f e r t i l e patients with 
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idiopathic oligospermia (age, 3 1 . θ + 4.5 y e a r s [ S D ] ; t e s t i c u l a r v o l u m e , 
19 + 2 ml SD ; sperm count ^ 20 χ 1 0 6 / m l ; mean, 1 2 . 1 + 2 . 4 χ 1 0 6 / m l ; 
abnormal forms, 67 +_ 4%; mean sperm m o t i l i t y , 3) p a r t i c i p a t e d i n t h i s 
study af ter informed consent was o b t a i n e d . 
LH-RH (Relefact , Hoechst H o l l a n d , Amsterdam, The N e t h e r l a n d s ) , 1 
pg/minute, was administered by c o n s t a n t i n t r a v e n o u s i n f u s i o n ( H a r v a r d 
pump; Harvard apparatus; South N a t i c k , MA) f o r 180 m i n u t e s t o a l l 
part ic ipants. 
Blood for LH, f o l l i c l e - s t i m u l a t i n g hormone (FSH), Τ, and e s t r a d i o l 
(E2) measurement was c o l l e c t e d a t 15-minute i n t e r v a l s by i n t e g r a t e d 
blood sampling through a h e p a r i n - c o a t e d c a t h e t e r ( K o w a r s k i c a t h e t e r ; 
Cormed, Middleport, N.Y.) u s i n g a c o n s t a n t w i t h d r a w a l pump. The 
procedure started at t=-45 minutes a t 4:00 P.M. ( 1 2 ) . Serum LH and FSH 
levels were measured i n a l l 15-minute samples, Τ and E2 a t t = 0 , 1 5 , 3 0 , 
60, 120 and 180 minutes. U n f o r t u n a t e l y , i n o n l y e i g h t f e r t i l e and e i g h t 
Oligospermie men s u f f i c i e n t b l o o d f o r a d d i t i o n a l 1 7 - h y d r o x y p r o g e s t e r o n e 
(17-OHP) measurement was a v a i l a b l e . Serum 17-0HP c o u l d o n l y be measured 
in blood samples obtained at t i m e i n t e r v a l s t = 0 , 30 and 120 m i n u t e s . 
Serum LH and FSH l e v e l s were measured by a s p e c i f i c h o m o l o g o u s 
double-antibody sol id-phase radioimmunoassays (13) u s i n g a n t i s e r a 
against highly p u r i f i e d human c h o r i o n i c g o n a d o t r o p i n (hCG) and FSH 
without any s i g n i f i c a n t mutual c r o s s - r e a c t i o n . The i n t r a a s s a y v a r i a b i ­
l i t y for duplicate measurements was 8.6% f o r LH and 8.15» f o r FSH. 
Normal ranges i n euspermic men a r e , r e s p e c t i v e l y , 4 t o 15 mIL)/ml and 
0.9 to 4.5 mIU/ml. Serum E2 l e v e l s were measured by s p e c i f i c r a d i o ­
immunoassay using an ant iserum r a i s e d a g a i n s t E 2 - 6 - ( O - c a c b o x y m e t h y 1 ) 
oxime bovine serum albumin ( i n t r a a s s a y c o e f f i c i e n t o f v a r i a t i o n , 6.2%) 
(14). Serum concentrations of Τ (normal range a t 8.00 A . M . , 314 t o 1337 
ng/100 ml, mean + SD: 568 + 19Θ ng/100 ml) and L7-0HP ( n o r m a l r a n g e a t 
8.00 A.M., 91 to 192 ng/100 m l , mean + SD: 136 + 39 ng/100 m l ) w e r e 
measured by radioimmunoassay a f t e r a paper c h r o m a t o g r a p h i c p u r i f i c a t i o n 
step using antisera ra ised i n r a b b i t s a g a i n s t 1 1 - h y d r o x y - t e s t o s t e r o n e -
11-hemisuccinate conjugated t o a lbumin and i n sheep a g a i n s t 1 1 - d e s o x y -
cortisol-21-hemisuccinate ( 1 6 , 1 7 ) . The i n t r a a s s a y c o e f f i c i e n t s o f 
var iat ion are 6.1S> and 4£, r e s p e c t i v e l y . To a v o i d i n t e r a s s a y v a r i a ­
t i o n , a l l samples from one i n d i v i d u a l were measured i n t h e same a s s a y . 
S t a t i s t i c a l analysis was performed u s i n g W i l c o x o n ' s p a i r e d r a n k t e s t 
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(Ρ v a l u e s d e n o t e d by Ρ ) , W i l c o x o n ' s two-sample test (P*), Friedman's 
n o n p a r a m e t r i c a n a l y s i s o f v a r i a n c e (P**) and Spearman's rank corre la­
t i o n t e s t ( P * * * ) . Unless o t h e r w i s e s t a t e d , the mean values + 1 standard 
e r r o r o f t h e mean (SEM) are g i v e n . 
RESULTS 
B a s a l serum g o n a d o t r o p i n and s t e r o i d levels 
The mean b a s a l serum LH l e v e l i n the Oligospermie men (13.7 + 0.9 
mlU/ml) was s i g n i f i c a n t l y h i g h e r (P* < 0.0001) than in the eugonadal 
c o n t r o l s u b j e c t s ( 7 . 0 + 0.Θ mlU/ml), although the indiv idual levels 
were i n t h e normal range i n a l l but one pat ient (20 mlU/ml). The mean 
serum FSH l e v e l i n the p a t i e n t s (3.3 +^  0.3 mlU/ml) also was s i g n i f i ­
c a n t l y h i g h e r t h a n i n the h e a l t h y men (2.0 + 0.2 IU/1, P* < 0.02), but 
i n n i n e o f them t h e l e v e l s were s t i l l i n the normal range. In the two 
r e m a i n i n g p a t i e n t s serum FSH l e v e l s were only s l i g h t l y elevated, 4.7 
and 5.3 m l U / m l , r e s p e c t i v e l y . No s t a t i s t i c a l l y s i g n i f i c a n t correlat ions 
were f o u n d between b a s a l LH and FSH levels in e i ther group (Oligo­
s p e r m i e men, г = - 0 . 0 3 ; c o n t r o l s u b j e c t s , г = +0.30; ρ*** < 0.10), or 
between FSH and t h e sperm count i n the Oligospermie patients (r = 0.04, 
P * * * < 0 . 1 0 ) . 
The mean e v e n i n g b a s a l plasma Τ and 17-0HP levels in the Oligosper­
mie men (360 +_ 33 ng/100 ml and 81 + 11 ng/100 ml) were s imi lar to 
t h o s e i n t h e eugonadal men (321 + 30 ng/100 ml and 82 + 6 ng/100 ml, P* 
< 0 . 1 0 ) . The 17-OHP/T r a t i o i n both groups also did not d i f f e r s i g n i f i ­
c a n t l y ( 0 . 2 4 + 0.03 versus 0.29 + 0 . 0 2 ) . The mean serum E2 levels were 
s i m i l a r i n b o t h groups of Ol igospermie and eugonadal men (41.9 + 2.2 
p g / m l v e r s u s 3 5 . 3 + 2.7 p g / m l ) , and the E2/T r a t i o s also did not d i f f e r 
s i g n i f i c a n t l y f r o m each o t h e r (0.012 + 0.003 versus 0.013 + 0.005). 
Response t o LH-RH i n f u s i o n ( f i g s . 1 t o 3) 
Serum LH l e v e l s s i g n i f i c a n t l y (P < 0.01) increased wi th in 15 minutes 
a f t e r s t a r t i n g LH-RH i n f u s i o n i n both the eugonadal and Oligospermie 
men, t h e i n c r e m e n t s not d i f f e r i n g s i g n i f i c a n t l y between the two groups 
( A L H a t t=15 m i n u t e s , 4.5 + 1.6 mlU/ml versus 7.7 + 2.6 mlU/ml). 
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After achieving peak l e v e l s a t 45 m i n u t e s , LH l e v e l s p l a t e a u e d . I n 
contrast to l i t e r a t u r e data ( 1 7 ) , i n n e i t h e r group was a b i p h a s i c LH 
response observed. 
Serum FSH levels s i g n i f i c a n t l y i n c r e a s e d (P < 0 . 0 1 ) w i t h i n 15 
minutes after s t a r t i n g the i n f u s i o n i n t h e h e a l t h y men ( A F S H a t t = 1 5 
minutes, 0.5 + 0.2 mlU/ml) and w i t h i n 30 m i n u t e s i n t h e O l i g o s p e r m i e 
patients (AFSH at t=30 minutes, 1.1 + 0 . 4 m l U / m l ) . A l t h o u g h t h e 
increases of both LH and FSH were s l i g h t l y b e t t e r i n t h e O l i g o s p e r m i e 
group as compared w i t h the c o n t r o l g r o u p , t h e d i f f e r e n c e i n t h e mean 
areas under the LH (2077 + 2Θ3 versus 1548 + 233 a r e a u n i t s ) and FSH 
curves (205 + 48 versus 124 + 27 area u n i t s ) l a c k e d s t a t i s t i c a l s i g n i ­
ficance. 
In the control group, serum Τ l e v e l s i n c r e a s e d w i t h o u t e x c e p t i o n 
with in 15 minutes to a mean l e v e l 1.5 +_ 0 . 1 t i m e s b a s e l i n e b o t h a t t = 1 5 
minutes (458 + 33 ng/100 m l , Ρ < 0 . 0 1 v e r s u s t = 3 0 m i n u t e s (466 + 29 
ng/100 ml, ρ < 0.01 versus t = 0 ) . T h e r e a f t e r , t h e mean l e v e l f e l l t o a 
value not s t a t i s t i c a l l y d i f f e r e n t from t h e p r e t r e a t m e n t v a l u e (385 ± 51 
ng/100 ml) at t=60 minutes. A second r i s e t o 458 + 35 ng/100 ml ( 1 . 5 + 
0.2 times baseline, Ρ < 0.05 versus t = 0 ) was observed a t 120 m i n u t e s 
af ter the s t a r t of the LH-RH i n f u s i o n . 
In contrast to the healthy c o n t r o l s u b j e c t s , i n t h e p a t i e n t s w i t h 
idiopathic oligospermia serum Τ l e v e l s d i d n o t show an e a r l y i n c r e a s e 
despite s imi lar LH increases, but decreased t o a n a d i r l e v e l 329 +_ 35 
ng/100 ml (0.9 + 0.05 times b a s e l i n e ) a t t=15 m i n u t e s (P < 0 . 0 1 v e r s u s 
t=0) ( f i g . 1 ) . 
At t=30 minutes i n e ight out of t e n p a t i e n t s t e s t e d , serum Τ l e v e l s 
were s t i l l equal to or below the b a s e l i n e v a l u e . 
The f i r s t s t a t i s t i c a l l y s i g n i f i c a n t serum Τ i n c r e a s e was n o t o b s e r v ­
ed u n t i l 60 minutes a f t e r s t a r t i n g t h e LH-RH i n f u s i o n (398 +_ 35 ng/100 
ml, 1.1 + 0.1 times basel ine, Ρ < 0.02 v e r s u s t = 0 ) . T h e r e a f t e r , l e v e l s 
further increased to 1.3 + 0 . 1 t i m e s b a s e l i n e b o t h a t 120 and 180 
minutes (P < 0.01 versus t = 0 ) . Comparing t h e i n c r e a s e s i n b o t h g r o u p s , 
the mean maximum r e l a t i v e (76 +_ 9% v e r s u s 37 +_ 6%, P* < 0 . 0 1 ) and a b s o ­
lute Τ increments (223 + 14 ng/100 ml v e r s u s 119 + 15 ng/100 m l , P* < 
0.001) were s i g n i f i c a n t l y h i g h e r i n t h e c o n t r o l s u b j e c t s t h a n i n t h e 
Oligospermie men ( f i g . 2) d e s p i t e s i m i l a r mean maximum a b s o l u t e 
increases in LH and FSH. 
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F i g u r e 1: Mean {+_ SEM) serum LH, FSH, Τ and E2 responses to constant 
LH-RH i n f u s i o n (1 pg/minute for 180 minutes) in 9 ( · — · ) 
eugonadal men and 11 (o—o) pat ients with idiopathic oligo­
s p e r m i a . The a s t e r i s k s indicate s t a t i s t i c a l l y significant 
changes as compared with the basal value. *P < 0.05. **P < 
0 . 0 1 . 
In c o n t r a s t t o serum T, in the control group serum 17-OHP levels 
remained unchanged d u r i n g t h e 30 minutes after s tart ing LH-RH infusion 
(88 + 6 ng/100 m l ) . T h e r e a f t e r , the levels increased to 1.8 ¿ 0 . 2 times 
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Figure 2: Mean maximum a b s o l u t e serum L H , FSH and Τ i n c r e m e n t s (+_ SEM) 
i n response t o c o n s t a n t LH-RH i n f u s i o n ( 1 y g / m i n u t e f o r 1 8 0 
minutes) i n 9 e u g o n a d a l men and 1 1 p a t i e n t s w i t h i d i o p a t h i c 
o l igospermia. The a s t e r i s k s i n d i c a t e a s t a t i s t i c a l l y s i g n i f i ­
cant d i f f e r e n c e (P < 0 . 0 0 1 ) b e t w e e n b o t h g r o u p s . 
In the Oligospermie p a t i e n t s , 17-OHP l e v e l s a t 30 m i n u t e s a l s o d i d 
not d i f f e r s i g n i f i c a n t l y f r o m t h e p r e t r e a t m e n t l e v e l ( 7 5 +_ 8 n g / 1 0 0 
ml), but t h e r e a f t e r , l e v e l s s i g n i f i c a n t l y i n c r e a s e d t o 138 ^ 1 3 n g / 1 0 0 
ml, 2.0 + 0.3 times b a s e l i n e a t t = 1 2 0 m i n u t e s (P < 0 . 0 1 v e r s u s t = 0 ) . 
serum Τ levels s i g n i f i c a n t l y r o s e i n t h e f i r s t 30 m i n u t e s a n d 17—OHP 
levels remained v i r t u a l l y unchanged ( F i g . 3 ) , t h e 17-OHP/T r a t i o i n t h e 
healthy c o n t r o l s u b j e c t s f e l l ( - 0 . 0 9 + 0 . 0 3 ) and 0 . 7 +_ 0 . 1 t i m e s b a s e ­
l ine (P < 0.05 versus t = 0) and t h e r e a f t e r r o s e t o p r e t r e a t m e n t l e v e l s 
at t=120 minutes ( 1 . 0 + 0 . 1 t i m e s b a s e l i n e , Ρ < 0 . 1 0 v e r s u s t = 0 ) . I n 
the Oligospermie groups the 17-OHP/T r a t i o v i r t u a l l y r e m a i n e d u n c h a n g e d 
(-0.01 + 0.03, P* < 0.10 v e r s u s h e a l t h y men) u n t i l 30 m i n u t e s a n d t h e n 
s i g n i f i c a n t l y increased t o 1.5 +_ 0 . 2 t i m e s b a s e l i n e (P < 0 . 0 2 v e r s u s 
t=0) at t=120 minutes. As t h e mean r i s e s o f s e r u m 17—OHP a t 1 2 0 m i n u t e s 
were i d e n t i c a l i n both groups o f h e a l t h y men a n d O l i g o s p e r m i e p a t i e n t s 
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( 5 7 +_ 14 n g / 1 0 0 ml v e r s u s 57 +_ 13 ng/100 m l ) , but the Τ increments were 
s i g n i f i c a n t l y l o w e r i n t h e l a t t e r (91 + 19 ng/100 ml versus 189 + 33 
n g / 1 0 0 m l ) , t h e mean i n c r e a s e i n t h e 17-OHP/T r a t i o i n the Oligospermie 
men was s i g n i f i c a n t l y h i g h e r t h a n i n the c o n t r o l subjects (0.090 + 0.03 
v e r s u s 0 . 0 0 2 + 0 . 0 4 , P* < 0 . 0 2 ) ( f i g . 3 ) . 
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F i g u r e 3 : M e a n s e r u m 1 7 - O H P , Τ , a n d 17-OHP/T r a t i o increments (+ SEM) 
i n r e s p o n s e t o c o n s t a n t LH-RH i n f u s i o n ( 1 ug/minute f o r 180 
m i n u t e s ) a t 3 0 a n d 1 2 0 m i n u t e s i n 8 eugonadal men О and 8 
p a t i e n t s w i t h i d i o p a t h i c o l i g o s p e r m i a ^ . The a s t e r i s k s 
i n d i c a t e s t a t i s t i c a l l y s i g n i f i c a n t d i f f e r e n c e s between the 
t w o g r o u p s . ( * ) P < 0 . 1 0 . *P < 0 . 0 5 . **P < 0 . 0 2 . ***P < 0.002. 
I n c o n t r a s t t o T , i n t h e c o n t r o l g r o u p serum E2 l e v e l s d i d not 
c h a n g e s i g n i f i c a n t l y b e t w e e n 0 a n d 15 m i n u t e s , b u t t h e r e a f t e r the 
l e v e l s s i g n i f i c a n t l y ( P * * < 0 . 0 0 2 5 ) d e c r e a s e d t o l o w e s t values 29 + 2 
p g / m l , a t 1 8 0 m i n u t e s (P < 0 . 0 1 v e r s u s t = 0 ) . I n t h e Ol igospermie men, 
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E2 levels at t=15 were a l s o s i m i l a r t o t h e b a s e l i n e v a l u e . T h e r e a f t e r , 
the levels showed a downward t r e n d t o l o w e s t v a l u e s , 3 4 +_ 1 p g / m l , a t 
t=180 minutes (P** < 0 . 1 0 ) . At t = 1 8 0 m i n u t e s , t h e mean E2 l e v e l s i n t h e 
Oligospermie men were s i g n i f i c a n t l y h i g h e r t h a n i n t h e h e a l t h y c o n t r o l 
subjects (P < 0.05). 
DISCUSSION 
The mean basal gonadotropin l e v e l s i n t h e p a t i e n t s w i t h s e v e r e t o 
moderate oligospermia from the p r e s e n t s t u d y w e r e s i g n i f i c a n t l y h i g h e r 
than in the control subjects d e s p i t e n o r m o g o n a d o t r o p i s m i n m o s t o f t h e 
pat ients. Basal sex s t e r o i d l e v e l s ( T , 17-OHP a n d Е г ) » h o w e v e r , w e r e 
s imi lar to those in the h e a l t h y c o n t r o l s u b j e c t s , s u g g e s t i n g t h e 
presence of compensated Leydig c e l l f a i l u r e i n t h e s e O l i g o s p e r m i e men 
( 1 ) . Low-dose continuous LH-RH i n f u s i o n and i n t e g r a t e d b l o o d s a m p l i n g , 
however, disclosed d i f f e r e n t i a l r e s p o n s e p a t t e r n s o f s e r u m Τ a s w e l l a s 
17-OHP between the c o n t r o l s u b j e c t s and t h e O l i g o s p e r m i e p a t i e n t s . 
The absolute and r e l a t i v e maximum i n c r e m e n t s o f s e r u m Τ i n r e s p o n s e t o 
the LH-RH infusion in the O l i g o s p e r m i e men w e r e o n l y h a l f t h e i n c r e a s e 
observed in the eugonadal c o n t r o l s u b j e c t s d e s p i t e c o m p a r a b l e o r e v e n 
higher r ises in serum g o n a d o t r o p i n l e v e l s i n t h e f o r m e r . S c h w a r z s t e i n 
et a l . (3) came to the same c o n c l u s i o n c o m p a r i n g t h e e f f e c t o f a r a p i d 
bolus in ject ion of 50 ug LH-RH i n h e a l t h y men a n d n o r m o g o n a d o t r o p i c 
patients with oligospermia. These i v e s t i g a t o r s a l s o f o u n d s i g n i f i c a n t l y 
lower r ises of serum Τ i n t h e l a t t e r , 30 m i n u t e s a f t e r LH-RH l o a d i n g . 
In contrast, Massaia et a l . (4) d i d n o t o b s e r v e any d i f f e r e n c e i n t h e 
response of Τ or E2 a f t e r a s i m i l a r h i g h - d o s e b o l u s i n j e c t i o n . The 
present data and Schwarzstein's d a t a on a d i f f e r e n t i a l Τ r e s p o n s e a f t e r 
short-term LH-RH i n f u s i o n or a b o l u s i n j e c t i o n c o n f i r m d a t a o n l o n g -
term Leydig c e l l s t i m u l a t i o n by hCG i n O l i g o s p e r m i e men ( 1 ) . A s u b ­
normal r i s e of serum Τ was o b s e r v e d a f t e r 4 t o 5 d a y s o f hCG s t i m u l a ­
t i o n i n patients with s e m i n i f e r o u s t u b u l e p a t h o l o g y , s u g g e s t i n g t h a t 
the pathologic process a lso i n v o l v e s t h e i n t e r t u b u l a r c o m p a r t m e n t o f 
the t e s t i s (1). 
In t h i s context i t i s o f p a r t i c u l a r i n t e r e s t t h a t d e s p i t e s i g n i f i ­
cantly lower Τ increases i n r e s p o n s e t o LH-RH i n f u s i o n i n t h e O l i g o ­
spermie men, the increments of i t s m a j o r p r e c u r s o r 17-OHP a t 1 2 0 m i n -
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u t e s a f t e r s t a r t i n g t h e i n f u s i o n were almost i d e n t i c a l . Therefore, in 
c o n t r a s t t o t h e f i n d i n g s i n h e a l t h y c o n t r o l subjects, in whom 17-OHP 
a n d Τ r a n a p a r a l l e l c o u r s e , l e a v i n g the 17-OHP/T r a t i o unchanged, in 
t h e O l i g o s p e r m i e p a t i e n t s t h e r e was a dissociated course, the 17-OHP/T 
r a t i o i n c r e a s i n g by a b o u t 50%. Al though i t is precarious to translate 
c h a n g e s i n c i r c u l a t i n g s t e r o i d l e v e l s i n t o i n t r a t e s t i c u l a r changes, the 
r e l a t i v e a c c u m u l a t i o n o f 17-OHP over Τ during LH-RH stimulat ion in the 
O l i g o s p e r m i e men t e n t a t i v e l y might be interpreted to mean the occur­
r e n c e o f a n e n z y m a t i c i m p a i m e n t l o c a l i z e d at the 17,20-lyase step 
( 1 8 ) , a s s u m i n g t h a t no a l t e r n a t e pathway for the precursor i s available 
a n d o t h e r enzymes o r f a c t o r s p e r t a i n i n g to hormone secretion remain 
u n a l t e r e d . 
I t h a s t o be n o t e d , h o w e v e r , t h a t i n the unstimulated basal condi­
t i o n t h e r e was no r e l a t i v e a c c u m u l a t i o n of the Τ precursor and there­
f o r e n o e v i d e n c e o f an enzyme d e f e c t . These data are reminiscent of 
s i m i l a r f i n d i n g s i n K l i n e f e l t e r ' s syndrome (16), and i n patients with 
v a r i c o c e l e i n whom o n l y g o n a d o t r o p i n st imulat ion uncovered the presence 
o f a p u t a t i v e e n z y m a t i c i m p a i r m e n t (19). In contrast, Steinberger et 
a l . ( 9 ) a n d R o d r i g u e z — R i g a u e t a l . ( 1 0 ) found in v i t r o evidence of 
a c c u m u l a t i o n o f 17-OHP o v e r Τ i n the testes of some patients with i d i o ­
p a t h i c o l i g o s p e r m i a b o t h u n d e r b a s a l and stimulated condit ions. 
C o n t i n u o u s LH-RH i n f u s i o n i n a d d i t i o n to the differences i n Τ and 
17—OHP r e s p o n s e s r e v e a l e d a n o t h e r h i t h e r t o unreported dissociat ion, 
n a m e l y , i n t h e a c u t e r e s p o n s e o f Τ soon a f t e r s t a r t i n g the infus ion. In 
t h e h e a l t h y c o n t r o l s u b j e c t s , serum Τ levels showed a biphasic response 
w i t h a n e a r l y peak a t 15 and 30 minutes a f t e r s t a r t i n g the infusion. In 
c o n t r a s t , i n t h e O l i g o s p e r m i e men, serum Τ levels did not show the 
e a r l y p e a k b u t r a t h e r a f a l l a t 15 minutes in a l l but one pat ient. A 
s t a t i s t i c a l l y s i g n i f i c a n t r i s e i n serum Τ levels was not observed u n t i l 
6 0 m i n u t e s a f t e r s t a r t i n g t h e LH-RH i n f u s i o n , but the increases remain­
e d l o w e r t h a n i n t h e c o n t r o l s u b j e c t s . I t has to be noted that in the 
h e a l t h y c o n t r o l s u b j e c t s serum Τ l e v e l s showed the early increase w i t h ­
o u t c o n c o m i t a n t c h a n g e i n 17-OHP l e v e l s , suggesting the presence of a 
r e a d i l y r e l e a s a b l e Τ p o o l w h i c h was apparently absent i n the Oligosper­
m i e m e n . The e a r l y Τ r i s e o c c u r r i n g a f t e r infusion of only 15 ug of 
LH—RH c o n f i r m s d a t a o f S c h w a r z s t e i n et a l . (20,21), who found maximum Τ 
l e v e l s 16 m i n u t e s a f t e r a 50 pg intravenous bolus in ject ion of LH-RH in 
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normal men. As in our s e r i e s , some s u b j e c t s showed a c l e a r e a r l y Τ 
response with vir tual ly unchanged LH l e v e l s . These d a t a c o n t r a s t , 
however, with the data of Nankin e t a l . , who f a i l e d t o d e m o n s t r a t e an 
early Τ rise not only af ter a subcutaneous i n j e c t i o n of 100 uQ LH-RH 
but also after an intravenous bolus i n j e c t i o n (22) or i n f u s i o n of LH 
(23) leading to three- to ninefold i n c r e a s e s of c i r c u l a t i n g LH l e v e l s 
within 5 to 30 minutes. The slower route of LH-RH a d m i n i s t r a t i o n might 
account for the divergent f inding in Nankin's s t u d y . The lack of an 
early Τ r ise in the Oligospermie p a t i e n t s from t h e p r e s e n t s t u d y 
contrasts with the findings in the heal thy men and could not be p r e s a g ­
ed from the basal sex s t e r o i d l e v e l s , which were s i m i l a r i n b o t h 
groups. The only difference between the hea l thy and O l i g o s p e r m i e men 
was the twice higher basal LH l e v e l in the l a t t e r . This c h r o n i c hyper— 
gonadotropism could have led to d e p l e t i o n of the r a p i d l y r e l e a s a b l e Τ 
store, thereby preventing the e a r l y Τ response induced by LH-RH i t s e l f 
or the LH-RH-mediated LH i n c r e a s e . An a l t e r n a t i v e e x p l a n a t i o n f o r t h e 
lack of an acute LH-RH-induced Τ response may be t h a t in i d i o p a t h i c 
oligospermia seminiferous tubule damage leads t o i n c r e a s e d g o n a d o t r o p i n 
levels and local secretion of LH-RH-like p e p t i d e s which e v e n t u a l l y 
inhibit Leydig cel l s te ro idogenes i s . 
Schwarzstein et a l . ( 3 ) , however, a d m i n i s t e r i n g 50 y g LH-RH a s an 
intravenous bolus injection a t 8.00 A.M., a l s o in p a t i e n t s w i t h i d i o p a ­
thic oligospermia, found an a l b e i t subnormal, but s t i l l s t a t i s t i c a l l y 
significant, early Τ increase 30 and 45 minutes a f t e r t h e i n j e c t i o n . 
Although diurnal variat ions in t h e Τ response t o LH-RH should be t a k e n 
into consideration - the LH-RH infus ion t e s t s in t h e p r e s e n t s t u d y were 
performed in the evening - they cannot exp la in the lack of an i n i t i a l Τ 
increase in the Oligospermie men, because such an i n c r e a s e d i d o c c u r i n 
our healthy subjects and Schwarzs te in ' s ( 3 ) . D i f f e r e n c e s in t h e method 
of LH-RH administration could account for the a b e r r a n t Τ r e s p o n s e , 
which may only become overt a f t e r slow low-dose LH-RH i n f u s i o n and may 
be obscured by massive LH-RH bolus i n j e c t i o n s . 
Nevertheless, the data in t h i s study i l l u s t r a t e t h a t i n i d i o p a t h i c 
oligospermia Leydig ce l l function i s anomalous. Chronic d e s e n s i t i z a t i o n 
by elevated gonadotropins and/or l o c a l l y s e c r e t e d LH-RH-like p e p t i d e s 
due to seminiferous tubule damage, leading t o enzymatic impai rment , may 
be one of the numerous causes of the Leydig c e l l d y s f u n c t i o n . F u r t h e r -
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more, low-dose LH-RH i n f u s i o n uncovers an i n t r i n s i c difference in acute 
L e y d i g c e l l s t i m u l a t i o n between healthy men and patients with 
i d i o p a t h i c o l i g o s p e r m i a w i t h an e a r l y serum Τ r ise in the former but a 
f a l l i n t h e l a t t e r . 
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CHAPTER I I I 
EFFECT OF LOWER VERSUS HIGHER DOSES OF TAMOXIFEN ON PITUITARY-GONADAL 
FUNCTION AND SPERM INDICES [N OLIGOZOOSPERMIC MEN 
J . M . 3 . D o n y , A . G . H . S m a l s , R. R o l l a n d , Ч.С.З.М. Fauser, С.M.G. Thomas 
( a c c e p t e d f o r p u b l i c a t i o n i n A n d r o l o g i e , 19B5) 
SUMMARY 
A d m i n i s t r a t i o n o f t h e a n t i e s t r o g e n t a m o x i f e n f o r one month t o 12 
p a t i e n t s w i t h i d i o p a t h i c o l i g o z o o s p e r m i a s i g n i f i c a n t l y increased the 
mean b a s a l t e s t o s t e r o n e ( T ) l e v e l and t h e responses of l u t e i n i z i n g 
h o r m o n e ( L H ) a n d f o l l i c l e s t i m u l a t i n g hormone (FSH) t o constant 
l u t e i n i z i n g h o r m o n e - r e l e a s i n g hormone (LH-RH) i n f u s i o n but d i d not 
s i g n i f i c a n t l y i n f l u e n c e t h e mean e s t r a d i o l (E2) l e v e l s or the E2 over 
t e s t o s t e r o n e r a t i o . Mean s p e r m c o n c e n t r a t i o n and t o t a l sperm output 
i n c r e a s e d b y a b o u t 70% a f t e r a mean t r e a t m e n t p e r i o d of 5.5 + 0.4 
m o n t h s . No s t a t i s t i c a l l y s i g n i f i c a n t d i f f e r e n c e was found between the 
t w o s u b g r o u p s o f p a t i e n t s t r e a t e d w i t h e i t h e r t h e lower (5 or 10 mg 
o n c e d a i l y ) o r h i g h e r d o s e o f t a m o x i f e n (10 mg t w i c e d a i l y ) w i t h 
r e s p e c t t o b a s a l o r LH-RH s t i m u l a t e d g o n a d o t r o p i n and t e s t o s t e r o n e 
r e s p o n s e o r t h e E 2 / T r a t i o a n d t h e e f f e c t on sperm d e n s i t y and t o t a l 
s p e r m o u t p u t . I n b o t h s u b g r o u p s t h e sperm m o t i l i t y and morphology 
r e m a i n e d u n c h a n g e d . 
I n c o n c l u s i o n h i g h e r d o s e s o f t a m o x i f e n i n t h i s study prove not t o 
b e s u p e r i o r t o l o w e r d o s e s i n i m p r o v i n g mean sperm d e n s i t y and t o t a l 
s p e r m o u t p u t . The r e l a t i v e s m a l l p e r c e n t a g e of p a t i e n t s a c h i e v i n g 
n o r m a l i z a t i o n o f o n l y t h e s e s p e r m p a r a m e t e r s pleads f o r f u r t h e r search 
f o r m o r e e f f e c t i v e s e l e c t i o n o f p a t i e n t s and o t h e r more e f f e c t i v e 
t r e a t m e n t m o d a l i t i e s i n p a t i e n t s w i t h i d i o p a t h i c o l igozoospermia. 
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INTRODUCTION 
Since Comhaire (1976) f i r s t r e p o r t e d o n t h e u s e o f t h e c o m p e t i t i v e 
n o n - s t e r o i d a l a n t i - e s t r o g e n t a m o x i f e n i n p a t i e n t s w i t h i d i o p a t h i c 
o l i g o z o o s p e r m i a , ample r e p o r t s ( W i l l i s , e t a l . 1 9 7 7 ; V e r m e u l e n a n d 
Comhaire 197Θ; S c h i l l and L a n d t h a l e r 1 9 8 0 ; T r a u b a n d T h o m p s o n 1 9 8 1 ; 
Bartsch and S c h r e i b e r 1 9 8 1 ; B u v a t , e t a l . 1 9 8 2 ; F r a j e s e , e t a l . 1 9 8 3 ) 
have appeared d e a l i n g w i t h i t s b e n e f i c i a l e f f e c t o n s p e r m d e n s i t y a n d 
t o t a l sperm c o u n t s . P r e l i m i n a r y d a t a s u g g e s t e d t h a t t h i s e f f e c t i s d o s e 
dependent as W i l l i s , e t a l . ( 1 9 7 7 ) f a i l e d t o d e m o n s t r a t e s y s t e m a t i c 
changes i n sperm p a r a m e t e r s i n O l i g o z o o s p e r m i e p a t i e n t s t r e a t e d w i t h 1 0 
mg tamoxi fen d a i l y i n s t e a d o f t h e 2 0 mg u s e d b y C o m h a i r e ( 1 9 7 6 ) . 
However, s c r u t i n i z i n g t h e s c a r c e l i t e r a t u r e d a t a o n h o r m o n a l e f f e c t s 
of h igher and lower doses o f t a m o x i f e n , n o o v e r t d i f f e r e n c e w a s f o u n d 
i n hormonal p a r a m e t e r s b e t w e e n t h e s e s t u d i e s ( C o m h a i r e 1 9 7 6 ; W i l l i s , e t 
a l . 1977; Vermeulen and C o m h a i r e 1 9 7 8 ) . T h e s e d a t a p r o m p t e d u s t o 
compare the e f f e c t o f l o w e r ( 5 a n d 1 0 mg o n c e d a i l y ) a n d h i g h e r d o s e s 
(10 mg t w i c e d a i l y ) o f t a m o x i f e n o n c i r c u l a t i n g h o r m o n e l e v e l s a n d 
sperm parameters i n p a t i e n t s w i t h i d i o p a t h i c o l i g o z o o s p e r m i a . The s t u d y 
was f u r t h e r d e s i g n e d t o a s s e s s t h e p r e d i c t a r y v a l u e - i f a n y - o f b a s a l 
and LH-RH s t i m u l a t e d g o n a d o t r o p i n a n d s t e r o i d l e v e l s o n s p e r m a t o g e n e s i s 
one month a f t e r s t a r t i n g t a m o x i f e n t h e r a p y . F a b i a n , e t a l . ( 1 9 8 0 ) n a m e ­
l y showed t h a t s t e a d y s t a t e l e v e l s o f t a m o x i f e n a r e a c h i e v e d a f t e r 4· 
weeks of t h e r a p y t h e l e v e l s r e m a i n i n g c o n s t a n t f o r p e r i o d s u p t o 6 
months t h e r e a f t e r . 
MATERIALS AND METHODS 
F i f t e e n n o r m o g o n a d o t r o p i c p a t i e n t s w i t h i d i o p a t h i c o l i g o z o o s p e r m i a 
and l o n g s t a n d i n g i n f e r t i l i t y i n i t i a l l y e n t e r e d t h e s t u d y a f t e r g i v i n g 
informed consent and a f t e r a p p r o v a l o f t h e p r o t o c o l b y t h e h o s p i t a l 
e t h i c a l c o m m i t t e e . Only 12 o f t h e m c o m p l e t e d t h e s t u d y ( a g e , 3 2 . 9 + 5 . 1 
SD y e a r s ) . A l l o f t h e s e p a t i e n t s h a d a n o r m a l t e s t i c u l a r v o l u m e a s s e s s ­
ed w i t h a Prader o r c h i d o m e t e r ( v o l u m e : 2 0 + 1 . 7 m l S D ) . T h e r e w a s n o 
h i s t o r y of i n f l a m m a t o r y t e s t i c u l a r d i s e a s e a n d n o n e o f t h e p a t i e n t s h a d 
p r e v i o u s l y r e c e i v e d any f o r m o f h o r m o n a l t r e a t m e n t . T h e p r e s e n c e o f 
v a r i c o c e l e was e x c l u d e d i n a l l o f t h e m . T h e i r w i v e s s h o w e d n o r m a l o v u -
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l a t o r y c y c l e s and p a t e n t t u b e s on hysterosalpingography, but despite 
good mucus q u a l i t y n e g a t i v e post c o i t a l t e s t s . The sperm density deter­
mined a t 1 month i n t e r v a l s i n a t least 2 specimens oF semen freshly 
o b t a i n e d by m a s t u r b a t i o n a f t e r sexual abstinence For 4 to 5 days was 
9 . 2 + 1.9 SE χ 1 0 6 / m l . The mean t o t a l sperm output per ejaculate was 
3 8 . 3 _+ 8.3 χ 1 0 6 / m l ( t a b l e I I ) . Mean sperm m o t i l i t y (graded 5 For 
r a p i d l y p r o g r e s s i v e and 1 f o r s l u g g i s h l y progressive spermatozoa) was 3 
and t h e mean p e r c e n t a g e abnormal forms 66 +_ 3.5 SE %. 
Of t h e t w e l v e p a t i e n t s c o m p l e t i n g the study - f i v e i n i t i a l l y entered 
i n each dose g r o u p - seven r e c e i v e d the lower dosis of 5 mq (n=3) or 10 
mg ( n = 4 ) o f t a m o x i f e n (Nolvadex®, ICI L td) once dai ly - these patients 
were f u r t h e r d e n o t e d as t h e " l o w e r dose group" - and f i v e received the 
h i g h e r dose o f 10 mg t w i c e d a i l y ("higher dose group"). 
The d u r a t i o n o f t r e a t m e n t was s i x months. Before and after one month 
o f t a m o x i f e n t h e r a p y r e s p o n s i v e n e s s of LH, FSH, Τ and E2 to LH-RH 
( R e l e f a c t , H o e c h s t H o l l a n d , Amsterdam, The Netherlands) 1 ug/minute 
a d m i n i s t e r e d by c o n s t a n t i n t r a v e n o u s i n f u s i o n (Harvard pump; Harvard 
a p p a r a t u s ; S o u t h N a t r i c k , MA) f o r 180 minutes was assessed (Fauser et 
a l . 1 9 8 3 ; Dony e t a l . 1 9 8 4 ) . B lood f o r LH, FSH, Τ and Ε2 measurement 
was c o l l e c t e d a t 15 m i n u t e i n t e r v a l s by integrated blood sampling 
t h r o u g h a h e p a r i n c o a t e d c a t h e t e r (Kowarski-catheter, Cormed, Middle-
p o r t , N.Y.) u s i n g a c o n s t a n t w i t h d r a w a l pump. 
The p r o c e d u r e s t a r t e d a t t = - 4 5 minutes at 4.00 P.M. Serum LH and FSH 
were measured i n a l l 15 m i n u t e samples, Τ and E2 in the samples obtain­
ed a t t = 0 , 1 5 , 3 0 , 4 5 , 6 0 , 9 0 , 1 2 0 , 1 5 0 and 180 minutes. Serum LH and FSH 
l e v e l s were measured by two s p e c i f i c homologous double-antibody s o l i d -
phase r a d i o i m m u n o a s s a y s (DASP) (van Geelen, et a l . 1981), using a n t i -
s e r a a g a i n s t h i g h l y p u r i f i e d human chorion gonadotropin (hCG) and FSH 
w i t h o u t any s i g n i f i c a n t m u t u a l c r o s s r e a c t i o n . 
The i n t r a a s s a y v a r i a b i l i t y f o r d u p l i c a t e measurements was 8.63> for 
LH and 8 . 1 % f o r FSH. Normal ranges i n euspermic men are 4 - 1 5 and 0.9 
- 4 . 5 mID/ml r e s p e c t i v e l y (Dony, et a l . 1984). 
Serum E2 l e v e l s were measured by a s p e c i f i c radioimmunoassay (RIA) 
u s i n g an a n t i s e r u m r a i s e d a g a i n s t E2-6-(0-carboxymethyl) oxime bovine 
serum a l b u m i n ( i n t r a a s s a y c o e f f i c i e n t of v a r i a t i o n 6.2%) (Thomas, et 
a l . 1 9 7 7 ) . Serum c o n c e n t r a t i o n of Τ was measured by RIA after a paper 
c h r o m a t o g r a p h i c p u r i f i c a t i o n s t e p using an antiserum raised in rabbits 
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against I L - h y d r o x y - t e s t o s t e r o n e - l l - h e m l s u c c i n a t e c o n j u g a t e d t o a l b u m i n 
( i n t r a a s s a y c o e f f i c i e n t o f v a r i a t i o n 6.1%) ( S m a i s , e t a l . 1 9 7 6 ) . T o 
avoid i n t e r a s s a y v a r i a t i o n s a m p l e s f r o m o n e i n d i v i d u a l w e r e m e a s u r e d i n 
the same assay as much as p o s s i b l e . 
S t a t i s t i c a l a n a l y s i s was p e r f o r m e d u s i n g W i l c o x o n ' s p a i r e d r a n k t e s t 
(P values denoted by P) and W i l c o x o n ' s t w o s a m p l e t e s t ( P * ) . U n l e s s 
otherwise s t a t e d t h e mean v a l u e s +_ 1 SEM a r e g i v e n . 
RESULTS 
E f f e c t of LH-RH i n f u s i o n on s e r u m g o n a d o t r o p i n a n d s t e r o i d l e v e l s 
before tamoxi fen a d m i n i s t r a t i o n ( f i g . 1 ) . 
The mean b a s a l LH and FSH l e v e l s i n t h e t w e l v e O l i g o z o o s p e r m i e m e n 
13.4 + 0.θ mIU/ml and 3.0 + 0 . 4 m l U / m l , r e s p e c t i v e l y ( t a b l e I ) w e r e i n 
the normal range t h o u g h s i g n i f i c a n t l y h i g h e r t h a n t h e v a l u e s r e p o r t e d 
e a r l i e r f o r eugonadal c o n t r o l s u b j e c t s ( L H , 7 . 0 +_ 0.8 m I U / m l , P* < 0 . 0 1 
versus Ol igozoospermie men, FSH, 2 . 0 + 0 . 2 m I U / m l , P* < 0 . 0 2 ) ( D o n y e t 
a l . 1984). I n o n l y t h r e e o f t h e p a t i e n t s s e r u m LH l e v e l s ( 1 6 , 1 6 a n d 2 0 
mIU/ml) and i n two serum FSH l e v e l s ( 4 . 7 a n d 5 . 3 m I U / m l ) w e r e s l i g h t l y 
e l e v a t e d . Serum Τ was i n t h e n o r m a l r a n g e i n a l l p a t i e n t s , w h e r e a s 
serum E2 l e v e l s and t h e E2/T r a t i o w e r e o f t h e same o r d e r o f m a g n i t u d e 
as r e p o r t e d e a r l i e r f o r n o r m a l men ( 3 5 . 3 +_ 2 . 7 p g / m l a n d 0 . 0 1 3 +_ 0 . 0 0 5 , 
r e s p e c t i v e l y ) (Dony, e t a l . 1 9 8 4 ) . No s t a t i s t i c a l l y s i g n i f i c a n t d i f f e r ­
ences were found between t h e t w o g r o u p s o f p a t i e n t s t o b e t r e a t e d w i t h 
the lower or h i g h e r doses o f t a m o x i f e n i n a n y o f t h e b a s a l o r s t i m u l a t ­
ed p i t u i t a r y - g o n a d a l f u n c t i o n s o r s p e r m i n d i c e s ( t a b l e I a n d I T ) . 
Consider ing t h e group o f t w e l v e O l i g o z o o s p e r m i e p a t i e n t s a s a w h o l e , 
b e f o r e tamoxi fen t h e r a p y s e r u m Τ l e v e l s s i g n i f i c a n t l y (P «. 0 . 0 5 ) f e l l 
w i t h i n 15 minutes a f t e r s t a r t i n g LH-RH i n f u s i o n . T h e f i r s t s t a t i s t i c a l ­
l y s i g n i f i c a n t Τ i n c r e a s e was o b s e r v e d a f t e r 6 0 m i n u t e s (P ·- 0 . 0 5 
versus t=0) and peak l e v e l s w e r e a c h i e v e d a f t e r 9 0 m i n u t e s ( 1 . 3 +_ 0 . 1 
t imes b a s e l i n e , Ρ < 0 . 0 1 v e r s u s t = 0 ) . T h e r e a f t e r , t h e m e a n Τ l e v e l s 
p lateaued and remained s i g n i f i c a n t l y e l e v a t e d u n t i l t h e e n d o f t h e 
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F i g u r e 1 : Mean (+_ SEM) serum LH, FSH, Τ and E2 increments in response 
t o c o n s t a n t LH-RH i n f u s i o n (1 vg/minute for 180 minutes) in 
12 p a t i e n t s w i t h i d i o p a t h i c Oligozoospermie before ( · — · ) and 
a f t e r ( o — o ) 1 month of tamoxifen treatment. The asterisks 
i n d i c a t e s t a t i s t i c a l l y s i g n i f i c a n t differences between both 
g r o u p s ( * ) 0 . 0 5 < Ρ < 0 . 1 0 . *P < 0.05. **P < 0.01. 
C o m p a r i n g t h e two g r o u p s t o be t r e a t e d with the lower and higher 
d o s e o f t a m o x i f e n no s t a t i s t i c a l s i g n i f i c a n t differences were found at 
any p o i n t o f t h e c u r v e s between the absolute Τ levels (data not shown) 
o r t h e maximal Τ i n c r e m e n t s ( t a b l e I ) . 
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Table I: Basal and LH-RH (1 yg/minute for 180 minutes) stimulated serum LH, FSH, Τ and E2 levels and the ratio E2 
over Τ (mean + SEM) in 12 patients with idiopathic Oligozoospermie before and after treatment with lower 
(5 or 10 mg Nolvadex daily, n=7) or higher (10 mg twice daily, n=5) doses of tamoxifen (ТАМ) for one 
month 
all patients (n = 12) low dose group (n = 7) high dose group (n = 5) 
basal LH (mIU/ml) 
max LH (mIU/ml) 
area LH (area units) 
basal FSH (mIU/ml) 
max FSH (mIU/ml) 
area F5H (area units) 
basal Τ (ng/100 ml) 
max Τ (ng/100 ml) 
basal Í2 (pg/ml) 
basal E2/T (ratio) 
before 
ТАМ 
13.4 ± 0.8 
27.2 ± 3.7 
201 ± 26 
3.0 ± 0.4 
2.5 * 0.5 
9.3 ± 3.2 
406 ± 47 
126 * 27 
41 ± 3 
0.012 ± 0.002 
after 1 month 
of ТАМ 
15.2 ± 1.2 
38 ± 5** 
312 * 43** 
3.5 ± 0.5 
3.5 ¿ 0.7** 
11.8 * 3.4 
517 ± 43* 
127 * 27 
48 ± 4 
0.010 ± 0.001 
before 
ТАМ 
13.4 ± 1.3 
27.6 ± 5.8 
202 ± 32 
3.2 t 0.4 
2.9 ± 0.8 
11.0 ± 4.9 
383 ¿ 80 
145 ± 18 
44 i 3 
0.014 ± 0.002 
after 1 month 
of ТАМ 
13.2 ± 1.0 
34.3 ± 5.1* 
298 ± 54* 
3.4 ± 0.6 
4.2 ± 0.9(*) 
13.9 ± 5.3 
501 ± 45 
132 ± 41 
43 ± 3 
0.009 ± 0.001 
before 
ТАМ 
13.6 ± 1.0a 
26.8 * 4.3a 
200 ± 45 a 
2.7 * 0.6a 
1.8 ± 0.5a 
7.0 ± 3.1a 
437 ± 57 a 
114 ± 16a 
38 ± 5 a 
after 1 month 
of ТАМ 
17.8 ± 1.9b 
43.0 ± 9.9b(*) 
332 ± ПЬ{*) 
3.6 ± 0.8b 
2.6 ± 0.9b 
9.0 ± 3.7b 
540 ± 82 b 
120 * 31 b 
56 ± 8 b 
0.010 ± 0.001a 0.011 ± 0.001b 
(*) 0.05< Ρ < 0.10 V3 before tamoxifen 
* Ρ < 0.05 уз before tamoxifen 
** Ρ < 0.01 vs before tamoxifen 
a Ρ > 0.10 vs before low dose tamoxifen 
b Ρ > 0.10 vs after low dose tamoxifen 
I n c o n t r a s t t o T , s e r u m E2 l e v e l s v i r t u a l l y remained unchanged 
t h r o u g h o u t t h e LH-RH t e s t b o t h when c o n s i d e r i n g the group аз a whole 
( f i g . 1 ) a n d t h e two s u b g r o u p s ( d a t a not shown). 
E f f e c t o f t a m o x i f e n a d m i n i s t r a t i o n i r r e s p e c t i v e of the dose on LH-RH 
s t i m u l a t e d g o n a d o t r o p i n and s t e r o i d l e v e l s and serum output in the 
O l i g o z o o s p e r m i e p a t i e n t s ( f i g . 1 ) . 
C o n s i d e r i n g t h e g r o u p o f t w e l v e Oligozoospermie pat ients as a whole, 
one m o n t h o f t a m o x i f e n a d m i n i s t r a t i o n d i d not s i g n i f i c a n t l y increase 
t h e mean b a s a l s e r u m LH o r FSH l e v e l s ( f i g . 1 , table I ) . The mean serum 
Τ v a l u e s , h o w e v e r , s i g n i f i c a n t l y i n c r e a s e d (P < 0.05). In contrast, 
s e r u m E2 l e v e l s v i r t u a l l y r e m a i n e d unchanged. 
One m o n t h o f t a m o x i f e n t r e a t m e n t w i t h o u t exception enhanced the LH 
r e s p o n s e t o LH-RH i n f u s i o n , t h e maximum LH increments and the area 
u n d e r t h e LH c u r v e ( f i g 1 , t a b l e I ) . At almost a l l time intervals from 
60 m i n u t e s o n t h e LH i n c r e m e n t s were s i g n i f i c a n t l y higher (P < 0.05 t o 
Ρ
 <
 0 . 0 1 ) d u r i n g t a m o x i f e n t h e r a p y . Tamoxifen also enhanced the maximum 
FSH r e s p o n s e t o LH-RH b u t d i d n o t i n f l u e n c e the area under the curves 
( t a b l e I ) . The Τ i n c r e m e n t s i n response t o LH-RH during tamoxifen 
t h e r a p y w e r e s i m i l a r t o t h o s e o b s e r v e d w i t h o u t tamoxifen at a l l time 
i n t e r v a l s ( f i g . 2 ) . The mean serum E2 l e v e l s v i r t u a l l y remained 
u n c h a n g e d d u r i n g LH-RH i n f u s i o n b o t h before and during tamoxifen 
a d m i n i s t r a t i o n . A l t h o u g h t h e a b s o l u t e l e v e l s were somewhat higher i n 
t h e l a t t e r c o n d i t i o n , t h e E2 changes d i d not d i f f e r s i g n i f i c a n t l y 
( f i g . 1 ) . 
The mean s p e r m d e n s i t y a n d t o t a l sperm counts s i g n i f i c a n t l y increas­
e d (P < 0 . 0 5 ) d u r i n g t a m o x i f e n t h e r a p y from 9.2 + 1.9 before to 16.3 + 
3 . 7 χ 1 0 6 / m l and 3 8 . 3 + Θ.3 t o 6 4 . 1 + 10.8 χ 1θ6, respectively, 5.5 + 
0 . 4 m o n t h s a f t e r s t a r t i n g t r e a t m e n t ( t a b l e I I ) . Sperm m o t i l i t y and the 
p e r c e n t a g e a b n o r m a l f o r m s , h o w e v e r , d i d not improve s i g n i f i c a n t l y . I t 
h a s t o b e n o t e d t h a t no s t a t i s t i c a l l y s i g n i f i c a n t changes were observed 
d u r i n g t h e f i r s t t w o m o n t h s o f t r e a t m e n t . Only one pregnancy occurred 
d u r i n g t h e t r e a t m e n t p e r i o d , i . e . i n t h e 2 χ 10 mg tamoxifen group. 
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Table II: semen parameters (mean * SEM) in 12 patients with idiopathic oligozoospermia before and during treatment 
with tamoxifen, 5 or 10 mg nolvadex , daily (low-dose, η = 7) or 20 mg (high-dose, η = 5) for a mean 







-1 mean (-2/-1) 
during tamoxifen 
(months) 
+2 >3 (5.5*0.4) 
Sperm density 
(lOfyml) 
low 9.B+2.5 12.9+2.5 11.4+2.6 12.2+4.6 12.7+5.5 18.1+4.8 
high 5.4+1.4 6.6+2.3 6.0+1.7 11.6+5.5 - 13.9+5.8 
all patients 8.0+1.7 10.3+2.4 9.2+1.9 11.9+3.5 10.4+4.1 16.3+3.7* 
Total sperm 
count (106/ml) 
low 37.5 + 13.4 47 + 12.3 42.2 + 9.9 37.9 + 20 44.8 + 13.4 69.2 + 13.1* 
high 27.1 + 10.0 38.0 + 18.0 32.6 + 13.8 38.5 + 15.3 57.1 + 17.8 
all patients 33.3+9.0 43.3+10.0 38.3+8.3 38.2+21 41.5+11.7 64.1+10.8* 
percentage low 
abnormal forms {%) 
high 
64 + 4 
68 + 7 
all patients 66 + 4 
68 + 4 
65 + 6 
67 + 3 
66 + 4 
67 + 6 
66 + 3 
72 + 4 
68 + 8 
70 + 4 
65 + 3 
68 + 4 
66 + 6 
69 + 6 
67 + 4 
*P < 0.05 V3 before tamoxifen 
E f f e c t o f t h e l o w e r and h i g h e r dose of tamoxifen on basal and LH-RH 
s t i m u l a t e d g o n a d o t r o p i n and s t e r o i d l e v e l s and sperm parameters ( f i g . 
2 , t a b l e I and I I ) 
No s t a t i s t i c a l l y s i g n i f i c a n t d i f f e r e n c e was found in the mean basal 
serum LH, FSH, Τ or E2 l e v e l s one months a f t e r s t a r t i n g tamoxifen 
t r e a t m e n t between t h e l o w e r and h i g h e r dose groups. The mean E2/T r a t i o 
was a l s o s i m i l a r ( t a b l e I ) . LH-RH a d m i n i s t r a t i o n one month af ter s t a r t ­
i n g t h e l o w e r o r h i g h e r dose t a m o x i f e n treatment s i m i l a r l y increased LH 
and FSH l e v e l s i n b o t h g r o u p s ( f i g . 2 ) . 
At no t i m e p o i n t o f t h e c u r v e s a s t a t i s t i c a l l y s ign i f icant difference 
c o u l d be d e m o n s t r a t e d i n t h e LH or FSH increments above baseline ( f i g . 
2) o r i n t h e mean maximum LH and FSH increments and the areas under the 
c u r v e s ( t a b l e I ) . The LH-RH i n d u c e d mean Τ increases and also did not 
d i f f e r s i g n i f i c a n t l y between t h e two groups at any point of the curves 
n o r d i d t h e maximum Τ i n c r e m e n t s ( t a b l e I ) . 
The o n l y s t a t i s t i c a l l y s i g n i f i c a n t d i f f e r e n c e observed between the 
l o w e r and h i g h e r dose g r o u p was i n the LH-RH induced E2 increments 
w h i c h were s i g n i f i c a n t l y h i g h e r i n the higher dose group ( f i g . 2) at 
s e v e r a l t i m e i n t e r v a l s a f t e r s t a r t i n g the in fus ion (P* < 0.05). 
B e f o r e s t a r t i n g t a m o x i f e n therapy no s t a t i s t i c a l l y s i g n i f i c a n t 
d i f f e r e n c e was f o u n d i n t h e sperm i n d i c e s between the lower and higher 
dose t a m o x i f e n g r o u p s ( t a b l e I I ) . Tamoxifen administration for a mean 
d u r a t i o n o f 5.5 +_ 0 . 4 months increased sperm density by 6.8 + 2.6 χ 
1 0 6 / m l i n t h e l o w e r dose and by 7.8 + 6.4 χ 106/ml (P* < 0.10 versus 
l o w e r dose) i n t h e h i g h e r dose g r o u p . Normal sperm density ( > 40 χ 10°) 
was a c h i e v e d i n o n l y one p a t i e n t of e i t h e r group. Sperm m o t i l i t y and 
t h e p e r c e n t a g e abnormal f o r m s were unchanged i n both groups. In 6 out 
o f 7 p a t i e n t s o f t h e l o w e r dose and 4 out of 5 of the higher dose group 
t o t a l sperm c o u n t s i n c r e a s e d , whereas leve ls above 100 χ 10^ were 
a c h i e v e d i n r e s p e c t i v e l y 2 and 1 of them. I t has to be emphasized that 
b o t h s u b s e t s w i t h i n t h e l o w e r tamoxi fen group behaved quite s i m i l a r l y 
i n t h e i r g o n a d o t r o p i n and s t e r o i d response to LH-RH administration and 
t h e i r changes i n sperm p a r a m e t e r s . 
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F i g u r e 2: Mean (+ SEM) L H , F S H , Τ a n d E2 i n c r e m e n t s i n r e s p o n s e t o 
c o n s t a n t LH-RH i n f u s i o n ( 1 M g / m i n u t e f o r 1 8 0 m i n u t e s ) i n 
p a t i e n t s w i t h i d i o p a t h i c o l i g o z o o s p e r m i a a f t e r 1 m o n t h o f 
t a m o x i f e n t h e r a p y , 7 o n t h e l o w e r d o s e o f 5 o r 1 0 mg ( о — о ) 
and 5 on t h e h i g h e r d o s e o f 2 0 mg ( · — · ) . T h e a s t e r i s k s 
i n d i c a t e s t a t i s t i c a l l y s i g n i f i c a n t d i f f e r e n c e s b e t w e e n b o t h 
g r o u p s , *P < 0 . 0 5 . 
DISCUSSION 
The p r e s e n t s t u d y i s i n a g r e e m e n t w i t h t h o s e o f m o s t a u t h o r s r e p o r t ­
i n g some b e n e f i c i a l e f f e c t o f t a m o x i f e n o n m e a n s p e r m d e n s i t y a n d m e a n 
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t o t a l sperm c o u n t , b u t n o t on t h e progressive moti l i ty or sperm morpho-
logy i n p a t i e n t s w i t h i d i o p a t h i c Oligozoospermie (Comhaire 1976; 
Vermeulen and Comhaire 1978; F ra jese et a l . 1983). Although the 
i n c r e a s e was poor i n a b s o l u t e t e r m s , the mean sperm density and total 
sperm c o u n t i n t h e p a t i e n t s from the present study improved by about 
70% a f t e r a mean t r e a t m e n t p e r i o d of about 1/2 year (range 3 to 9 
m o n t h s ) , w h e r e a s i n 2 r e s p e c t i v e l y 3 oF the pa t ients these indices 
n o r m a l i z e d . S i m i l a r i n c r e m e n t s i n sperm density (66-182%) were reported 
by o t h e r a u t h o r s (Comhaire 1976; S c h i l l and Landthaler 1981; Traub and 
Thompson 1 9 8 1 ; B u v a t , e t a l . 1982; Frajese, et a l . 1983) using the 
h i g h e r dose of 20 or even 30 mg of tamoxifen daily for the same period 
of t i m e . 
In c o n t r a s t t o W i l l i s e t a l . (1977), who fai led to demonstrate 
s t a t i s t i c a l l y s i g n i f i c a n t e f f e c t of the lower dose of 10 mg tamoxifen 
on sperm d e n s i t y in 9 p a t i e n t s w i th id iopathic Oligozoospermie treated 
fo r 6 m o n t h s , 6 o u t of 7 p a t i e n t s from the present study treated with 
t h e same o r even lower dose of 5 mg tamoxifen showed an increase of 
t h e sperm d e n s i t y a n d / o r t o t a l sperm count s imilar to that found in the 
p a t i e n t s t r e a t e d w i t h t h e h i g h e r dose. Although a placebo effect can 
n o t be e x c l u d e d ( W i l l i s , e t a l . 1977) the data in the present study 
f a v o u r t h e c o n c l u s i o n t h a t lower doses of tamoxifen (5 and 10 mg) are 
e q u a l l y , a l t h o u g h m o d e s t l y , e f f e c t i v e in ra i s ing sperm densities and 
sperm c o u n t s a s t h e commonly u sed higher doses. 
Tak ing i n t o a c c o u n t t h e e a r l i e r mentioned pharmacokinetics of tamo-
x i f e n r e s u l t i n g i n s t e a d y - s t a t e blood leve ls from one month of therapy 
on, t h e c o n c o r d a n c e i n t h e r a p e u t i c effect was predictable in the light 
of t h e s i m i l a r i t y i n b a s a l and LH-RH stimulated gonadotropin and 
s t e r o i d r e s p o n s e s i n t h e lower and higher dose therapy group. Only 
serum E2 l e v e l s were s l i g h t l y s i g n i f i c a n t l y higher during LH-RH infu-
s i o n i n t h e l a t t e r g r o u p . As h igh E2 levels have been reported to 
i n h i b i t s p e r m a t o g e n e s i s d i r e c t l y (Steinberger 1975; Kalla, et a l . 1980) 
o r i n d i r e c t l y (Nozu, e t a l . 1982 ; Smals, et a l . 1980), the higher E2 
l e v e l s i n t h i s group would r a t h e r mi l i t a t e against the use of the 
h i g h e r d o s e . As men t ioned above the changes in the semen parameters 
d u r i n g t a m o x i f e n t h e r a p y i n t h e p resen t study were not associated with 
s t a t i s t i c a l l y s i g n i f i c a n t c h a n g e s in basal gonadotropin levels confirm-
i n g r e c e n t d a t a of Buvat e t a l . (1982) and Frajese et a l . (1983), but 
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in contrast with reports of other authors (Willis, et al. 1977; Buvat, 
et al. 1982). 
Enhanced sensitivity of LH, and FSH to LH-RH administration and 
during tamoxifen treatment (Willis, et al. 1977; Vermeulen and Comhaire 
1978; Gooren 1981) arise in basal serum Τ levels (Willis, et al. 1977; 
Vermeulen and Comhaire 1978; Buvat, et al. 1982; Frajese, et al. 1983; 
Gooren 1981) both may account for the improvement in sperm density. It 
has to be emphasized that this improvement during antiestrogen 
treatment occurred despite lack of statistically significant changes in 
the E2/T ratio (present study) or even despite increases in this ratio 
(Vermeulen and Comhaire 1978). Although the precise mechanism by which 
tamoxifen improves spermatogenesis still remains to be elucidated, the 
present study demonstrates that the lower and higher doses - all 
probably were on the plateau of the dose response curve - were equally 
effective in increasing mean sperm density and total sperm counts in 
patients with idiopathic Oligozoospermie. 
Nevertheless, the relatively small percentage of patients showing -
quantitative - normalization of their sperm output (16% in the present 
study and about 25-30л in literature) pleads for further search for 
more effective selection of patients and more effective treatment 
modalities in these patients e.g. use of more specific antiestrogens 
(Vigersky, et al. 1981). Studies are now in progress on the effect of 
the aromatase enzyme inhibitor testolactone on sperm indices in 
patients with idiopathic Oligozoospermie. 
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CHAPTER I V 
EFFECT OF AROMATASE I N H I B I T I O N BY A I - T E S T O L A C T O N E ON BASAL AND 
LUTEINIZING HORMONE-RELEASING HORMONE STIMULATED P I T U I T A R Y AND GONADAL 
HORMONAL FUNCTION IN OLIGOSPERMIC MEN 
J . M . J . Dony, A.G.H. S m a l s , R. R o l l a n d , В . C O . M . F a u s e r , С . M . G . T h o m a s 
(accepted f o r p u b l i c a t i o n i n F é r t i l S t e r i l , 1 9 8 5 ) 
ABSTRACT 
Aromatase i n h i b i t i o n by Δ ΐ - t e s t o l a c t o n e ( T L ) , 5 0 0 mg t w i c e d a i l y f o r 
4 weeks, i n 9 p a t i e n t s w i t h i d i o p a t h i c o l i g o s p e r m i a l o w e r e d c i r c u l a t i n g 
e s t r a d i o l (£2) l e v e l s by a b o u t 3 0 % , e n h a n c e d t h e s e c r e t i o n o f f o l l i c l e 
s t i m u l a t i n g hormone (FSH) ( + З О Й ) , 1 7 - h y d r o x y p r o g e s t e r o n e ( 1 7 - 0 H P ) ( + 
40SD) and t e s t o s t e r o n e (T) ( + 3 0 % ) , b u t d i d n o t a f f e c t s e r u m l u t e i n i z i n g 
hormone (LH) l e v e l s . D e s p i t e E2 l o w e r i n g , t h e r e w a s a n a c c u m u l a t i o n o f 
17-OHP over Τ s u g g e s t i n g 1 7 , 2 0 - l y a s e i n h i b i t i o n . U n e x p e c t e d l y , a d m i n i s ­
t r a t i o n of TL a lmost c o m p l e t e l y d e l e t e d t h e Τ r e s p o n s e t o c o n t i n u o u s 
l u t e i n i z i n g h o r m o n e - r e l e a s i n g h o r m o n e ( L H - R H ) i n f u s i o n p r e s e n t b e f o r e 
TL t h e r a p y , d e s p i t e s i m i l a r g o n a d o t r o p i n r e l e a s e . B e c a u s e t h e 17-OHP 
response t o the LH-RH i n f u s i o n was e v e n h i g h e r d u r i n g t h e r a p y , t h e 
17,20-Іуазе l e s i o n seemed a g g r a v a t e d d e s p i t e s u b s t a n t i a l r e d u c t i o n o f 
E2 l e v e l s . 
Although the p r e s e n t d a t a s u g g e s t t h a t e s t r o g e n s p l a y a l e s s 
dominant r o l e i n t h e o r i g i n o f t h e l a t e s t e r o i d o g e n e t i c l e s i o n t h a n 
p r e v i o u s l y assumed, t h e s u g g e s t i o n a l s o a r i s e s t h a t TL p e r s e , i n 
a d d i t i o n t o i t s a n t i e s t r o g e n i c a c t i o n , e x e r t s a n i n h i b i t i n g e f f e c t o n 
the 1 7 ,2 0 - Іув зе l o c u s , w h i c h may o b s c u r e t h e b e n e f i c i a l e f f e c t o f 
reducing L . 
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INTRODUCTION 
Δ 1 - T e s t o l a c t o n e ( T L ) , 17oi-oxa-D-homo-l,4 androstadiene-3,17-dione, a 
t e s t o s t e r o n e ( Τ ) d e r i v a t i v e w i t h o u t major i n t r i n s i c androgenic a c t i v i ­
t y , i s a p o t e n t c o m p e t i t i v e i n h i b i t o r of aromábase ac t i v i t y and blocks 
t h e p e r i p h e r a l a r o m a t i z a t i o n o f androgens to estrogens (1-5), at least 
i n men ( 6 ) . 
I n p a t i e n t s w i t h i d i o p a t h i c ol igospermia an increase in tes t icu la r 
i n t r a t u b u l a r e s t r o g e n c o n c e n t r a t i o n and/or an inordinate sens i t i v i t y of 
t h e g e r m i n a l e p i t h e l i u m t o i t s i n h i b i t o r y ef fect has been postulated 
( 3 ) . V i g e r s k y and G lass (3 ) adduced prel iminary evidence that decreas-
i n g e s t r a d i o l (E2) f o r m a t i o n by the administrat ion of TL may indeed 
i m p r o v e sperm c o u n t s and f e r t i l i t y i n these pat ients, although the data 
have been c h a l l e n g e d by o t h e r s ( 7 ) . Apart from an altered estrogen 
h a n d l i n g , i n v i t r o and i n v i v o evidence point to the presence of a 
1 7 , 2 0 — l y a s e b l o c k i n i d i o p a t h i c o l igospermia (8-10). 
R e c e n t l y we demons t ra ted an i n t r i n s i c di f ference in the acute Leydig 
c e l l r e s p o n s e between euspenn ic and Oligospermie men because the l a t t e r 
f a i l e d t o show t h e i n i t i a l r i s e i n plasma Τ during continuous l u t e i n i z ­
i n g h o r m o n e - r e l e a s i n g hormone (LH-RH) infusion present in healthy 
c o n t r o l s ( 1 0 ) . F u r t h e r m o r e t h e y e x h i b i t e d a blunted and late r ise of Τ 
b u t , i n c o n t r a s t , a n o r m a l i n c r e a s e i n 17-hydroxyproge3terone (17-OHP), 
w h i c h i s c o m p a t i b l e w i t h t h e presence of a block l a t e in the steroid 
b i o s y n t h e s i s a t t h e l o c u s o f t h e 17,20-Іуазе enzyme. In rats and also 
i n h e a l t h y men a p e r m i s s i v e r o l e of estrogens - exogenous or endoge­
n o u s , as p r o v o k e d by human c h o r i o n i c gonadotropin (hCG) administration 
- h a s b e e n d e m o n s t r a t e d i n t h e genesis of such lesion (11-13). This 
b l o c k c o u l d be a b o l i s h e d by t h e concomitant administration of a n t i -
e s t r o g e n s ( 1 1 , 1 4 , 1 5 ) . 
The p r e s e n t s t u d y t h e r e f o r e was designed to investigate whether 
s u s t a i n e d l o w e r i n g o f endogenous estrogen levels by chronic administra­
t i o n o f TL m i g h t i n f l u e n c e t h e anomalous Leydig c e l l response to LH-RH 
i n p a t i e n t s w i t h i d i o p a t h i c o l i g o s p e r m i a . 
MATERIALS AND METHODS 
N i n e n o r m o g o n a d o t r o p i c O l i g o s p e r m i e men, [30.6 +_ 3.9 years of age 
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(standard deviat ion)] , w i t h proven i n f e r t i l i t y of at l e a s t one y e a r ' s 
duration were intensively studied dur ing the f i r s t f o u r weeks o f t h e i r 
long-term treatment with TL a f t e r informed consent was o b t a i n e d . T h e i r 
sperm density was less than 20 χ lO^/ml, the mean sperm count was Θ.1 •+ 
1.3 χ 106/ml, abnormal forms were 6655 +_ Ъ%, the mean sperm m o t i l i t y 3 
( m o t i l i t y graded 5 for rapid progression and 1 f o r immobile sperm) and 
a l l had normal t e s t i c u l a r volumes (19 +_ 2 m l ) . I n t o x i c a t i o n s (by h i s t o ­
ry) and the presence of a var icocele (by c l i n i c a l e x a m i n a t i o n ) were 
ruled out. Their wives underwent a complete f e r t i l i t y i n v e s t i g a t i o n 
revealing no impediment to conception. 
© A l l patients were given TL (Teslac , Squibb B.V. , R i j s w i j k , The 
Netherlands) 1 gram dai ly i n 2 d i v i d e d doses and blood f o r l u t e i n i z i n g 
hormone (LH), f o l l i c l e s t i m u l a t i n g hormone (FSH), p r o l a c t i n e (PRL), T, 
ΐ.2 and 17-OHP was col lected before and at weekly i n t e r v a l s up t o 4 
weeks a f t e r s t a r t i n g therapy. 
Before and at the end of the i n i t i a l 4 week t reatment p e r i o d , LH-RH 
(Relefact®, Hoechst Holland, Amsterdam, The Nether lands) 1 p g / m i n u t e 
was administered by constant intravenous i n f u s i o n (Harvard pump; 
Harvard Apparatus Company, South Nat ick, MA) f o r 180 minutes t o a l l men 
(10,16). 
Blood for LH, FSH, Τ, E2 and 17-OHP and PRL measurement was c o l l e c t ­
ed at 15-minute i n t e r v a l s by i n t e g r a t e d blood sampling t h r o u g h a 
heparin-coated catheter (Kowarski c a t h e t e r ; Cormed, M i d d l e p o r t , NY) 
with a constant withdrawal pump (16). The procedure s t a r t e d a t t = - 3 0 
minutes at 4:00 P.M. Serum LH and FSH were measured by a s p e c i f i c homo­
logous double-antibody solid-phase (DASP) radioimmunoassay u s i n g a n t i -
sera against highly p u r i f i e d hCG and FSH w i t h o u t any s i g n i f i c a n t m u t u a l 
cross react ion. The intraassay (RIA) v a r i a b i l i t y f o r d u p l i c a t e measure­
ments was 8.63Í for LH and 8.15» fo r FSH. Normal ranges i n euspermic men 
are respectively 4 to 15 and 0.9 to 4.5 IL)/1 (17) . Serum E2 l e v e l s were 
measured by speci f ic RIA wi th an antiserum ra ised aga ins t E 2 - 6 - ( 0 - c a r -
boxymethyl) oxime bovine serum albumin ( in t raassay c o e f f i c i e n t o f 
var iat ion 6.25S) ( IB) . Serum 17-OHP and Τ c o n c e n t r a t i o n s were measured 
by specif ic dextran-coated charcoal RIA a f t e r e x t r a c t i o n w i t h d i e t h y l -
ether and subsequent i s o l a t i o n of the 17-OHP and Τ f r a c t i o n s by 
Sephadex LH-20 (Pharmacia Fine Chemicals AB, Uppsala Sweden) column 
chromatography, using ant isera ra ised i n r a b b i t s and d i r e c t e d a g a i n s t 
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17-OHP - 7-carboxyethy l th ioether - BSA (Radioimmunoassay Systems 
L a b o r a t o r i e s , Carson, CA) and against Τ - 3-(0-carboxymethyl) oxime -
BSA, r e s p e c t i v e l y . T r i t i a t e d (1,2,6,7-Зн) 17-OHP (Amersham Interna­
t i o n a a l ; Amersham, U.K.) and (1,2,6,7,16,17-5H) Τ (New England Nuclear, 
Boston, MA) were used on the radioact ive labels and 17-OHP (range, From 
0.025 t o 3.0 pmol/tube) and Τ (sigma Chemical Company, St Louis, MO) 
( r a n g e , 0.01 t o 15 pmol/tube) as the standard preparations. Cross-
r e a c t i v i t i e s of a v a r i e t y of Cia. C19 and C21 steroids were always less 
than 0.01л (17-OHP), whi le progesterone and 17a-hydroxypregnenolone 
showed 0.4 and 1.155 с г о э з - r e a c t i v i t y . In the case of T, cross-react iv i­
t i e s of progestagens and estrogens were always less than 0.05%, whereas 
5«- and 5 8-dihydrotestosterone showed values of 485» and 14% respect­
i v e l y . Method blanks were below the minimum detectable doses, 0.02 pmol 
(17-OHP) and 0.007 pmol Τ per tube at B/BQ = 0.9. The intraassay and 
i n t e r a s s a y v a r i a b i l i t i e s f o r means of duplicate measurements were 7.5% 
and 8.55» f o r 17-OHP, and 5.5% and 6.5% for T, respectively. Serum 
c o n c e n t r a t i o n s of PRL were measured by s p e c i f i c , homologous, DASP 
radioimmunoassay. The intraassay c o e f f i c i e n t of var ia t ion was 6.3%. To 
a v o i d in terassay v a r i a t i o n s a l l samples from one individual were 
measured i n the same assay. S t a t i s t i c a l analysis was performed using 
S t u d e n t ' s p a i r e d (denoted by P) and unpaired (P*) t - t e s t s , and 
Freedman's nonparametric analysis of variance (P**). 
Unless otherwise s t a t e d , the mean values + 1 standard error of the 
mean are g i v e n . 
RESULTS 
E f f e c t of TL therapy on basal p i tu i tary-qonadal function 
The mean basal LH (10.0 + 0.7 IU/1) level i n the Oligospermie men 
was s i g n i f i c a n t l y higher than i n an e a r l i e r published group of nine 
h e a l t h y c o n t r o l s (7.0 + 0.8 I U / 1 , P* < 0 . 0 2 ) , whereas the mean serum 
FSH l e v e l tended t o be higher (2.5 + 0.4 IU/1 versus 2.0 + 0.2 IU/1, 
0.05 < P* < 0.10) ( 1 0 ) . I n a l l pat ients however, serum LH and FSH 
l e v e l s were w e l l w i t h i n the normal range. 
TL therapy w i t h i n 1 week lowered the mean serum E2 level (P < 0.001 
versus b a s e l i n e ) t o a minimal value of -33 + 6% below baseline. Whereas 
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the mean serum LH level remained v i r t u a l l y unchanged d u r i n g t h e r a p y , 
the mean FSH level increased (P** < 0.005) w i t h i n 1 week and t h e r e a f t e r 
plateaued (fig. 1). 
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Fig. 1: Effect of 4 weeks TL adminis trat ion (2 χ 500 mg d a i l y ) on t h e 
mean serum and on the percentage changes v s week О o f LH, FSH, 
estradiol (£2)? 17-hydroxyprogesterone (17-0HP) and t e s t o s t e ­
rone (T) levels and the r a t i o s 17-OHP/T and T/E2 i n 9 p a t i e n t s 
with idiopathic ol igospermia. The v e r t i c a l b a r s r e p r e s e n t SEM, 
the asterisks the s t a t i s t i c a l s i g n i f i c a n c e s : ( * ) Ρ < 0 . 1 0 v s 
week 0, * < 0.05. * ( * ) < 0 . 0 2 5 . ** < 0 . 0 1 . * * ( * ) < 0 . 0 0 5 . * * * < 
0.001. 
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A l t h o u g h t h e r e was a tendency f o r the absolute testosterone (T) 
l e v e l s t o r i s e d u r i n g TL t r e a t m e n t (0.05 < P** < 0.10), at no time 
i n t e r v a l d i d t h e i n c r e a s e reach s t a t i s t i c a l s igni f icance. M 3 and 4 
w e e k s t h e p e r c e n t a g e i n c r e a s e s (25 +_ 10% and 34 + 14л) were, however, 
s t a t i s t i c a l l y s i g n i f i c a n t . The T/E2 r a t i o almost doubled af ter 1 week 
o f t h e r a p y (P < 0 . 0 1 v e r s u s b a s e l i n e ) and remained elevated thereafter. 
Serum 17-OHP r a p i d l y i n c r e a s e d w i t h i n 1 week (P < 0.05 versus base­
l i n e ) t o a maximum v a l u e ( 1 . 5 + 0.2 times baseline, (P < 0.025) af ter 4 
w e e k s . Because t h e 17-OHP r i s e was more pronounced than that of T, the 
17—OHP/T r a t i o s i g n i f i c a n t l y i n c r e a s e d during TL therapy. 
Serum PRL l e v e l s d i d not change throughout the treatnent period 
( d a t a n o t s h o w n ) . 
E f f e c t o f TL m e d i c a t i o n on LH-RH st imulated pituitary-qonadal hormonal 
f u n c t i o n 
B e f o r e TL t h e r a p y LH-RH i n f u s i o n f o r 180 minutes e l i c i t e d a biphasic 
LH r e s p o n s e w i t h an i n i t i a l peak at 45 to 60 minutes, a nadir there­
a f t e r a n d a second r i s e f r o m 120 minutes on (P** < 0.05) ( f i g . 2 ) . The 
mean s e r u m FSH l e v e l s i n c r e a s e d w i t h i n 30 minutes, the maximum being 
a c h i e v e d a f t e r 125 m i n u t e s . T h e r e a f t e r , the levels plateaued. Serum 
17-OHP l e v e l s showed an i n i t i a l f a l l at 15 and 30 minutes (P < 0.005 
v e r s u s t = 0 ) a f t e r s t a r t i n g t h e i n f u s i o n , but thereafter the levels 
s i g n i f i c a n t l y i n c r e a s e d t o a mean value of 1.5 +_ 0.2 times baseline at 
180 m i n u t e s (P < 0 . 0 2 v e r s u s t = 0 ) . The mean serum Τ levels also showed 
a n i n i t i a l f a l l a t t=30 m i n u t e s (P < 0.005), but from 75 minutes on Τ 
i n c r e a s e d t o a maximum v a l u e at t= l80 minutes. The 17-0HP/T r a t i o 
v i r t u a l l y r e m a i n e d unchanged u n t i l 45 minutes. Thereafter i t showed a 
t e n d e n c y t o i n c r e a s e u n t i l 90 minutes (0.05 < Ρ < 0.10 versus t=0) 
w h e r e a f t e r t h e l e v e l s p l a t e a u e d . Serum E2 levels essential ly remained 
u n c h a n g e d t h r o u g h o u t t h e i n f u s i o n p e r i o d . 
LH-RH i n f u s i o n a f t e r 4 weeks of TL therapy e l i c i t e d an LH and FSH 
r e s p o n s e s i m i l a r t o t h a t b e f o r e treatment, the areas under the curves 
(LH 223 ± 47 v e r s u s 214 * 4 9 , FSH 18 * 5 versus 21 ± 4 area units) 
b e i n g a l m o s t i d e n t i c a l . As b e f o r e treatment, there was a tendency to a 
b i p h a s i c LH r e s p o n s e . 
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Fig. 2: Effect of 4 week TL a d m i n i s t r a t i o n (2 χ 500 mg d a i l y ) on t h e 
mean LHRH (1 ug/minute f o r 1Θ0 minutes) induced changes v e r s u s 
T=0 i n serum LH, FSH, e s t r a d i o l (E2)» 1 7 - h y d r o x y p r o g e s t e r o n e 
(17-OHP) and t e s t o s t e r o n e (T) l e v e l s and the 17-OHP/T r a t i o i n 
9 pat ients w i t h i d i o p a t h i c o l i g o s p e r m i a . The v e r t i c a l b a r s 
represent SEM, the a s t e r i s k s the s t a t i s t i c a l s i g n i f i c a n c e s : 
(*) Ρ < 0.10 vs t=0 m i n , * < 0.05. * ( * ) < 0 . 0 2 5 . * * < 0 . 0 1 . 
**(*) < 0.005. *** < 0 . 0 0 1 . 
On therapy, serum 17-0HP l e v e l s d i d not show the i n i t i a l decrease a t 
15 and 30 minutes a f t e r s t a r t i n g the LH-RH i n f u s i o n observed b e f o r e 
treatment. Thereafter, a s t a t i s t i c a l l y s i g n i f i c a n t i n c r e a s e o c c u r r e d . 
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At no t ime point before or during therapy did the 17-OHP curves differ 
s i g n i f i c a n t l y from each o t h e r , and the areas under the curves (14.9 + 
6.7 ver sus 14.8 + 4.2 area u n i t s ) were also similar. In contrast to 
17-OHP, serum Τ l e v e l s did not show any significant change throughout 
the whole LH-RH infus ion p e r i o d . Comparing both Τ curves before and 
dur ing TL therapy, at almost a l l time intervals from 75 minutes on, the 
Τ increments in response t o LHRH during TL therapy were significantly 
lower than before TL (Ρ < 0.05 - < 0.025), whereas the areas under the 
Τ curves (9.2 + 4.9 versus 21.4 + 5.6 area units , Ρ < 0.02) also 
d i f f e r e d s i g n i f i c a n t l y . 
During TL t r e a t m e n t , the 17-0HP/T r a t i o readily increased in 
response t o LH-RH and va lues s i g n i f i c a n t l y higher than baseline were 
achieved a t a l l time i n t e r v a l s from 60 minutes on. The maximum 17-OHP/T 
i n c r e a s e in response t o LH-RH during TL therapy was significantly high­
e r (0.1Θ + 0.02 versus 0.13 + 0.02, Ρ < 0.05) than without medication. 
The serum E2 l e v e l s on therapy v i r t u a l l y remained the same through­
out t h e LH-RH infusion per iod as before TL administration. 
DISCUSSION 
TL medicat ion for 4 weeks lowered the mean serum E2 levels in 
p a t i e n t s with i d i o p a t h i c oligospermia and increased the mean serum FSH 
s i g n i f i c a n t l y , but l e f t serum LH leve l s v ir tual ly unchanged, confirming 
t h e d a t a of Leinonen e t a l . (19), who gave the same dose for only 1 
week t o p a t i e n t s with p r o s t a t i c carcinoma. Gooren et a l . (5), who admi­
n i s t e r e d 1.5 gram of TL d a i l y for 2 weeks reported an LH and FSH 
response in heal thy v o l u n t e e r s s imi lar to that in the present study, 
whereas Vigersky and Glass ( 3 ) , using 1 gram daily for 6 to 12 months 
i n p a t i e n t s with i d i o p a t h i c oligospermia, did not find any change at 
a l l , e i t h e r in FSH or in LH. Other invest igators, however, administer­
ing h i g h e r doses (2 grams d a i l y ) for 7 to 10 days to normal male sub­
j e c t s r e p o r t e d a s t a t i s t i c a l l y s i g n i f i c a n t increase of both gonadotro­
p i n s ( 2 , 4 ) . The increase in serum FSH levels, but not in LH, in 
response t o the lower doses of TL i s probably due to the preferential 
s u p p r e s s i v e e f fect of endogenous E2 on pi tu i tary FSH secretion rather 
than LH (20-22). 
D e s p i t e the fact t h a t serum LH levels remained unchanged the major 
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precursor of Τ, 17-OHP r e a d i l y i n c r e a s e d w i t h i n one week a f t e r s t a r t i n g 
TL therapy at the same time when serum E2 l e v e l s became s i g n i f i c a n t l y 
decreased. Peak levels of 50% above b a s e l i n e were a c h i e v e d a f t e r 4 
weeks. 
In contrast to 17-OHP, serum Τ l e v e l s showed a r a t h e r s l u g g i s h r i s e . 
L i terature data on the e f f e c t o f TL on serum Τ a r e c o n f l i c t i n g . 
Marynick et a l . (2) reported a c l e a r i n c r e a s e a l r e a d y w i t h i n 10 d a y s i n 
healthy men treated w i t h a h i g h e r dose o f 2 g r a m , w h e r e a s o t h e r s d i d 
not f ind any increase at a l l ( 4 , 5 , 1 9 ) . V i g e r s k y and G l a s s ( 3 ) , h o w e v e r , 
administering TL for s i x t o t w e l v e months t o O l i g o s p e r m i e men, r e p o r t e d 
a 50% increase of Τ at the end o f t h e t r e a t m e n t p e r i o d . N e v e r t h e l e s s 
most investigators reported an i n c r e a s e o f t h e T/E2 r a t i o ( 2 - 5 ) . 
In the present study the r i s e i n 17-OHP exceeded t h e s e r u m Τ 
increase and therefore the 17-OHP/T r a t i o s i g n i f i c a n t l y i n c r e a s e d 
during treatment w i t h the aromatase i n h i b i t o r . T h i s a c c u m u l a t i o n o f 
17-OHP over T, which may i n t e r p r e t e d t o mean i n h i b i t i o n o f t h e 1 7 , 2 0 -
lyase enzyme system was r a t h e r u n e x p e c t e d i n t h e l i g h t o f t h e s u p p r e s s ­
ive ef fect of exogenous and p r o b a b l y a l s o endogenous e s t r o g e n s o n t h i s 
conversion (11,13,15) and t h e r e c e n t d e m o n s t r a t i o n o f a l l e v i a t i o n o f 
the block af ter a d m i n i s t r a t i o n o f t h e c o m p e t i t i v e e s t r o g e n r e c e p t o r 
antagonist tamoxifen ( 1 4 ) . 
A s imi lar r e l i e f a lso was a n t i c i p a t e d when serum e s t r o g e n l e v e l s 
were lowered by TL, but such r e l i e f d i d n o t o c c u r . I t i s h a r d l y i n t e l ­
l i g i b l e how aromatase i n h i b i t i o n on t h e one hand enhances 17-OHP a n d t o 
a lesser degree Τ s e c r e t i o n by t h e L e y d i g c e l l and on t h e o t h e r h a n d 
blocks the conversion of 17-OHP t o T. An o v e r a l l s t i m u l a t i n g e f f e c t o n 
test icu lar stero id b i o s y n t h e s i s by t h e d e c r e a s e o f i n t r a t e s t i c u l a r 
estrogens could be expected, even i n t h e absence o f any c h a n g e s i n 
serum LH levels. Furthermore, i t can be a r g u e d t h a t t h e i n c r e a s e o f FSH 
by modulating LH receptor a v a i l a b i l i t y may s t i m u l a t e L e y d i g c e l l 
steroidogenesis. In both c o n c e p t s however t h e r e i s no p l a c e f o r a n 
enzyme block. 
Another rather unexpected f i n d i n g was t h e d i f f e r e n c e i n s t e r o i d 
responsiveness to constant LH-RH i n f u s i o n b e f o r e and d u r i n g a r o m a t a s e 
blockade in the present s t u d y . The l a c k o f any d i f f e r e n c e i n g o n a d o t r o ­
pin responsiveness i n t h i s and two o t h e r s t u d i e s ( 3 , 4 ) was r a t h e r 
remarkable in the l i g h t of t h e n e g a t i v e f e e d b a c k e f f e c t s o f e s t r o g e n s 
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a t t h e h y p o t h a l a m o - p i t u i t a r y l e v e l (4,20-22). Nevertheless, despite 
s i m i l a r i n c r e m e n t s i n serum LH and FSH, the Τ response to constant 
LH-RH i n f u s i o n s w i t h an i n i t i a l f a l l and subsequent r i s e , typical for 
o l i g o s p e r m i a ( 1 0 ) was d e l e t e d d u r i n g TL therapy. In contrast, the 
17-OHP r e s p o n s e t o LH-RH i n f u s i o n was s i m i l a r before and during aroma-
t a s e i n h i b i t i o n . So, a g a i n , t h e r e was an accumulation of 17-OHP over T, 
w h i c h was even more pronounced than before TL treatment. The data 
i l l u s t r a t e t h a t i n c o n t r a s t t o e x p e c t a t i o n , TL, despite lowering E2 
l e v e l s , d i d n o t c o r r e c t t h e anomalous Leydig c e l l response to LH-RH 
c h a r a c t e r i s t i c o f o l i g o s p e r m i a but rather worsened i t with a complete 
d e l e t i o n o f t h e Τ r e s p o n s e and aggravation of the 17,20-lyase block. 
A l t h o u g h t h e s e d a t a s u g g e s t t h a t E2 does not play a p ivota l role in the 
g e n e s i s o f t h e L e y d i g c e l l d e f e c t i n oligospermia, a direct inh ib i tory 
e f f e c t o f TL p e r se on L e y d i g c e l l steroidogenesis cannot be excluded. 
E a r l i e r s t u d i e s s u g g e s t e d t h a t TL had no i n t r i n s i c estrogenic or andro­
g e n i c a c t i v i t y ( 2 3 ) . V i g e r s k y e t a l . (24) recently demonstrated the 
s t e r o i d , i n a d d i t i o n t o i t s aromatase i n h i b i t i n g a c t i v i t y , had a n t i -
a n d r o g e n i c p r o p e r t i e s ( i n h i b i t i o n of the T-induced increase in prosta­
t i c w e i g h t ) by v i r t u e o f i t s c o m p e t i t i v e interact ions with dihydro-
t e s t o s t e r o n e f o r t h e androgen r e c e p t o r (not with the estrogen recep­
t o r ) . T h i s e f f e c t i s t i m e - and dose-dependent, but doses up to 10 gram 
d a i l y a d m i n i s t e r e d f o r one month would be needed to exhibi t such a n t i -
a n d r o g e n i c e f f e c t i n men. F u r t h e r m o r e , i t i s not easily understood how 
c o m p e t i t i v e a n d r o g e n r e c e p t o r b i n d i n g of TL would in ter fere with the 
c o n v e r s i o n o f 17-OHP t o T. Another explanation is therefore necessary. 
The a r o m a t a s e i n h i b i t i n g e f f e c t of TL has been at t r ibuted to i t s 
c o m p e t i t i v e b i n d i n g w i t h Τ and androstenedione for microsomal cyto­
chrome Ρ 450 ( 1 ) . Because 1 7 , 2 0 - l y a s e (and 17oi-hydroxylase) are also 
m i c r o s o m a l c y t o c h r o m e Ρ 450 dependent enzymes (25), i t might be specu­
l a t e d t h a t TL w o u l d i n t e r a c t as a pseudosubstrate with the cytochrome Ρ 
4 5 0 l e a d i n g t o enzyme i n h i b i t i o n and accumulation of 17-0HP over Τ (and 
a l s o a n d r o s t e n e d i o n e ( 3 , 1 9 ) ) . 
I t must be s t r e s s e d , however, t h a t despite t h i s inh ib i tory action 
l a t e i n t e s t i c u l a r s t e r o i d o g e n e s i s , which obscures the ef fect of Eo 
l o w e r i n g , TL o v e r a l l enhances s t e r o i d biosynthesis and leads to almost 
d o u b l i n g o f t h e T/EI2 r a t i o . T h i s l a t t e r e f f e c t may be benef ic ia l in the 
t r e a t m e n t o f p a t i e n t s w i t h i d i o p a t h i c oligospermia in whom an altered 
6 1 
test icu lar estrogen handl ing has been p o s t u l a t e d . 
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CHAPTER V 
EFFECT OF CHRONIC AROMATASE I N H I B I T I O N BY Δ Ι - T E S T O L A C T O N E ON P I T U I T A R Y -
GONADAL FUNCTION IN OLIGOSPERMIC MEN 
J . M . J . Dony, A.G.H. Smals, R. R o l l a n d , B . C . D . M . F a u s e r , C . M . G . T h o m a s 
( s u b m i t t e d f o r p u b l i c a t i o n ) 
ABSTRACT 
Aromatase i n h i b i t i o n by Δ 1 - t e s t o l a c t o n e ( T e s l a c , 5 0 0 mg t w i c e 
d a i l y ) f o r 6 months i n 9 p a t i e n t s w i t h i d i o p a t h i c o l i g o s p e r m i a l o w e r e d 
the l e v e l s of serum e s t r a d i o l ( E 2 ) a n d t h e r e b y s e x h o r m o n e b i n d i n g 
g l o b u l i n (SHBG) ( r g = + 0 . 4 0 , Ρ < 0 . 0 2 5 ) t o v a l u e s - 3 5 a n d - 2 5 % , 
r e s p e c t i v e l y , below t h e p r e t r e a t m e n t v a l u e s (P < 0 . 0 0 1 a n d < 0 . 0 0 5 ) . 
The E2 decrease was a c c o m p a n i e d b y a t e m p o r a r y i n c r e a s e ( + 5 0 % ) i n 
t h e l e v e l s of f o l l i c l e s t i m u l a t i n g h o r m o n e ( F S H ) , n o t o f l u t e i n i z i n g 
hormone (LH), and o f 1 7 a - h y d r o x y p r o g e s t e r o n e ( 1 7 - O H P ) , b u t l e s s o f 
t e s t o s t e r o n e (T) ( + 3 0 Й ) , w h i c h l e d t o a t r a n s i e n t r i s e i n t h e 1 7 - O H P / T 
r a t i o . The T/E2 r a t i o and " f r e e T" i n d e x (T/SHBG) a l m o s t d o u b l e d u n t i l 
t h e end of t h e t r e a t m e n t p e r i o d . 
During Δ ΐ - t e s t o l a c t o n e t r e a t m e n t t h e mean s p e r m d e n s i t y g r a d u a l l y 
rose from Θ.1 + 1.3 (SEM) b e f o r e t o 2 1 . 3 + 6 . 7 χ 1 0 6 / m l a f t e r 6 m o n t h s 
(P < 0 . 0 1 ) , whereas t h e t o t a l s p e r m c o u n t a l m o s t t h r e e f o l d i n c r e a s e d (P 
< 0 . 0 5 ) . Sperm c o n c e n t r a t i o n s e x c e e d i n g 2 0 χ 1 0 ^ / m l w e r e a c h i e v e d i n 4 
of the 9 p a t i e n t s . Two o f t h e s e p a t i e n t s ' w i v e s b e c a m e p r e g n a n t . 
Although the d a t a p o i n t t o a p i v o t a l r o l e o f e s t r o g e n s i n t h e p a t h o ­
genesis of t h e s p e r m a t o g e n i c l e s i o n i n some p a t i e n t s w i t h i d i o p a t h i c 
o l i g o s p e r m i a , the l a c k o f a b e n i f i c i a l e f f e c t o f e s t r o g e n l o w e r i n g i n 
o t h e r s p o i n t s t o a m u l t i c a u s a l n a t u r e o f t h e d i s e a s e e n t i t y . 
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INTRODUCTION 
I n c r e a s e d i n t r a t u b u l a r e s t r o g e n s or an inordinate s e n s i t i v i t y of the 
g e r m i n a l e p i t h e l i u m t o t h e i r i n h i b i t i n g e f f e c t have been postulated as 
t h e cause o f t h e d e f e c t i v e spermatogenesis i n patients with idiopathic 
o l i g o s p e r m i a ( 1 , 2 ) . T h i s i n h i b i t o r y e f f e c t of estrogens on the germinal 
e p i t h e l i u m may be d i r e c t ( 3 ) or i n d i r e c t by inducing an enzymatic block 
a t t h e 1 7 a - h y d r o x y l a s e a n d / o r 17,20-Іуазе locus, thereby i n t e r f e r i n g 
w i t h normal L e y d i g c e l l s t e r o i d o g e n e s i s (4-9) . Preliminary evidence for 
a p i v o t a l r o l e o f e s t r o g e n s i n the suppression of spermatogenesis was 
adduced by V i g e r s k y and G l a s s ( 1 ) , demonstrating that lowering estra­
d i o l l e v e l s by a d m i n i s t r a t i o n o f the aromatase i n h i b i t o r Δ^-testolac-
t o n e (TL) ( 1 7 - o x a - o - h o m o - l , 4 - a n d r o s t a d i e n e - 3 , 1 7 - d i o n e ) indeed improves 
sperm d e n s i t y and f e r t i l i t y i n p a t i e n t s w i t h idiopathic oligospermia, 
w i t h o u t a f f e c t i n g serum g o n a d o t r o p i n l e v e l s . In another preliminary 
s t u d y , however, C l a r k and S h e r i n s (10) f a i l e d to demonstrate any ef fect 
a t a l l o f TL t r e a t m e n t i n t h e i r p a t i e n t s w i t h idiopathic oligospermia. 
These c o n f l i c t i n g d a t a p r o m p t e d us t o c a r e f u l l y monitor the ef fect of 
s u s t a i n e d l o w e r i n g o f endogenous estrogens by TL administration on 
p i t u i t a r y - L e y d i g c e l l f u n c t i o n and sperm parameters in patients with 
i d i o p a t h i c o l i g o s p e r m i a . 
MATERIALS AND METHODS 
Nine n o r m o g o n a d o t r o p i c O l i g o s p e r m i e men (age 30.6 + 3.9 years 
s t a n d a r d d e v i a t i o n ( S D ) , r a n g e 23-37 year) w i t h longstanding i n f e r t i l i ­
t y o f a t l e a s t 1 y e a r d u a r a t i o n (2,0 + 0.7 (SD) years) were studied 
a f t e r o b t a i n i n g a p p r o v a l o f t h e p r o t o c o l by the hospital e t h i c a l 
c o m m i t t e e and i n f o r m e d c o n s e n t . 
The sperm d e n s i t y i n semen samples f r e s h l y obtained by masturbation 
a f t e r s e x u a l a b s t i n e n c e f o r 4 t o 5 day was less than 20 χ lO^/ml on at 
l e a s t 3 o c c a s i o n s . The mean sperm concentrat ion was 8.1 + 1.3 χ 10°/ml 
r a n g e 2.6 t o 1 7 . 0 χ l O ^ / m l ) , t h e percentage abnormal forms 66 + Зй and 
t h e mean sperm m o t i l i t y 3 .3 +_ 0 . 5 (SD) (graded 5 for rapidly progress­
i v e and 1 f o r s l u g g i s h l y p r o g r e s s i v e spermatozoa). Testicular volume 19 
+_ 2 ml (SD) was n o r m a l i n a l l p a t i e n t s . Intox icat ions and t e s t i c u l a r 
i n f l a m m a t o r y d i s e a s e s (by h i s t o r y ) and the presence of varicocele were 
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ruled out in a l l of them. T h e i r w i v e s u n d e r w e n t a c o m p l e t e f e r t i l i t y 
invest igat ion r e v e a l i n g no impediment f o r c o n c e p t i o n . 
A l l pat ients were g i v e n Δ 1 - t e s t o l a c t o n e ( T e s l a c , S q u i b b BV, R i j s ­
wi jk , The Netherlands) 1 gram d a i l y i n 2 d i v i d e d d o s e s f o r a t l e a s t 6 
months. Blood samples f o r l u t e i n i z i n g hormone ( L H ) , f o l l i c l e s t i m u l a t ­
ing hormone (FSH), p r o l a c t i n ( P R L ) , t e s t o s t e r o n e ( T ) , e s t r a d i o l ( £ 2 ) » 
17oi-hydroxyprogesterone (17-OHP), sex hormone b i n d i n g g l o b u l i n (SHBG) 
and Cort isol measurement were c o l l e c t e d b e t w e e n 3 . 0 0 — 5 . 0 0 P . M . b e f o r e 
and at monthly i n t e r v a l s up t o 6 months a f t e r s t a r t i n g t h e r a p y . I n a n 
ear l ier study blood samples were a l s o c o l l e c t e d a t w e e k l y i n t e r v a l s u p 
to 4 weeks and LH-RH r e s p o n s i v e n e s s was a s s e s s e d b e f o r e a n d a f t e r 4 
weeks of Δ ΐ - testo lactone (TL) t r e a t m e n t . The r e s u l t s o f t h i s s t u d y w i l l 
be published elsewhere ( 1 1 ) . At m o n t h l y i n t e r v a l s a f t e r s t a r t i n g T L , 
semen analyses were o b t a i n e d as m e n t i o n e d a b o v e . 
Serum LH and FSH l e v e l s were measured by s p e c i f i c h o m o l o g o u s d o u b l e -
antibody solid-phase (DASP) r a d i o i m m u n o a s s a y s u s i n g a n t i s e r a a g a i n s t 
respectively h ighly p u r i f i e d hCG and FSH w i t h o u t any s i g n i f i c a n t m u t u a l 
cross react ion. The i n t r a a s s a y v a r i a b i l i t y f o r d u p l i c a t e m e a s u r e m e n t s 
was 8.6Й for LH and .1Ж f o r FSH. Normal r a n g e s i n e u s p e r m i c men a r e 
4-13 and 0.9 - 4.5 I D / l r e s p e c t i v e l y ( 1 1 ) . Serum E2 l e v e l s w e r e m e a s u r ­
ed by s p e c i f i c radioimmunoassay ( 1 1 ) u s i n g an a n t i s e r u m r a i s e d a g a i n s t 
E2-6 (O-carboxylmethyl) oxime b o v i n e serum a l b u m i n ( i n t r a a s s a y c o e f f i ­
cient of v a r i a t i o n , 6.2%) ( 1 2 ) . Serum 17-OHP and Τ c o n c e n t r a t i o n s w e r e 
measured by s p e c i f i c DCC r a d i o i m m u n o a s s a y a f t e r e x t r a c t i o n w i t h 
diethylether and subsequent i s o l a t i o n o f 17-OHP a n d Τ f r a c t i o n s by 
Sephadex LH-20 column c h r o m a t o g r a p h y , u s i n g a n t i s e r a r a i s e d i n r a b b i t s 
and directed against 1 7 - 0 H P - 7 - c a r b o x y e t h y l t h i o e t h e r - B S A a n d a g a i n s t 
T-3-(0-carboxymethyl)oxime-B5A r e s p e c t i v e l y ( 1 2 ) . The i n t r a - a n d i n t e r -
assay v a r i a b i l i t i e s f o r means o f d u p l i c a t e m e a s u r e m e n t s w e r e 7 . 5 % a n d 
8.5% for 17-OHP and 5.5 and 6.5% f o r T, r e s p e c t i v e l y . 
Serum concentrat ions o f PRL were measured by s p e c i f i c h o m o l o g o u s , 
DASP radioimmunoassay (13) ( i n t r a a s s a y c o e f f i c i e n t o f v a r i a t i o n 6 . 3 % ) . 
Serum sex hormone b i n d i n g g l o b u l i n (SHBG) l e v e l s ( n m o l / 1 ) w e r e 
determined using the SHBG i m m u n o r a d i o m e t r i c a s s a y ( I R M A ) t e s t k i t m a n u ­
factured by Farmos D i a g n o s t i c a ( O u l u n s a l o , F i n l a n d ) . T h i s l i q u i d - p h a s e 
one-step procedure sandwiches t h e SHBG a n a l y t e b e t w e e n a p o l y c l o n a l 
anti-SHBG-antibody r a i s e d i n r a b b i t s , and a m o n o c l o n a l SHBG a n t i b o d y 
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l a b e l e d w i t h 1 2 5 i . д s o l i d - p h a s e a n t i - r a b b i t IgG antiserum is added to 
p r e c i p i t a t e by c e n t r i f u g a t i o n t h e r a d i o l a b e l e d solid-phase matrix 
c o n t a i n i n g t h e SHBG a n a l y t e . The amount of r a d i o a c t i v i t y in the sedi-
m e n t e d s o l i d — p h a s e p e l l e t i s d i r e c t l y p r o p o r t i o n a l to the SHBG content 
i n t h e s a m p l e s w h i c h a r e i n t e r p o l a t e d from a standard curve with doses 
r a n g i n g b e t w e e n 6 . 2 5 and 200 n m o l / 1 . The s e n s i t i v i t y of the method i s 
6 . 2 5 n m o l / 1 , w h i l e i t s s p e c i f i c i t y i s h i g h . Since no human serum 
p r o t e i n i s known t o c r o s s - r e a c t w i t h the sandwich-type antibody 
c o m b i n a t i o n e m p l o y e d i n t h i s a s s a y . The p r e c i s i o n of the procedure as 
t e s t e d w i t h t h r e e d i f f e r e n t serum p o o l s (mean values: 11.4, 78.4, and 
110 n m o l / 1 ) i n e i g h t c o n s e c u t i v e t e s t s showed an intraassay v a r i a b i l i t y 
o f 4 . 7 % a n d a n i n t e r a s s a y p r e c i s i o n f o r means of duplicate measurements 
b e t w e e n 4 . 4 % a n d b.7%. Serum C o r t i s o l l e v e l s were measured by the 125£_ 
C o r t i s o l r a d i o i m m u n o a s s a y - k i t purchased from c l i n i c a l Assays/Travenol-
G r e n e n t e c h D i a g n o s t i c s (Cambr idge , MA, USA). 
To a v o i d i n t e r a s s a y v a r i a t i o n s a l l samples from one indiv idual were 
m e a s u r e d i n t h e same a s s a y . S t a t i s t i c a l analys is of the hormonal data 
was p e r f o r m e d u s i n g S t u d e n t ' s p a i r e d (denoted by P) and unpaired (P*) 
t - t e s t s . The r e l a t i o n between serum E2 en SHBG levels at the various 
t i m e i n t e r v a l s was s t a t i s t i c a l l y analysed by tes t ing the means of 
S p e a r m a n ' s r a n k c o r r e l a t i o n c o e f f i c i e n t s ( P * * ) . As the sperm counts did 
n o t show a n o r m a l d i s t r i b u t i o n t h e Wilcoxon signed rank test was used 
f o r s t a t i s t i c a l a n a l y s i s ( P * * * ) . 
U n l e s s o t h e r w i s e s t a t e d t he mean values +^  1 standard error of the 
mean (SEM) a r e g i v e n . 
RESULTS 
E f f e c t o f c h r o n i c t e s t o l a c t o n e t rea tmen t on the p i t u i t a ry Leydiq c e l l 
f u n c t i o n ( f i g s . 1 -3 ) 
The mean b a s a l LH l e v e l i n t h e Oligospermie men (10.0 + 0,7 IU/1) 
was s i g n i f i c a n t l y h i g h e r t h a n the mean concentration in an ear l ie r 
p u b l i s h e d ( 1 4 ) g r o u p o f h e a l t h y c o n t r o l s (7.0 + 0.8 I U / 1 , P* < 0.02), 
w h e r e a s t h e mean FSH l e v e l t ended t o be higher (2.6 + 0.4 vs 2.0 + 02 
I U / 1 , 0 . 0 5 < P* < 0 . 1 0 . I n a l l p a t i e n t s however, serum LH (7.2 - 13 
I U / 1 ) a n d FSH ( 0 . 9 - 4 . 2 I U / 1 ) l e v e l s were w i t h i n the normal range. The 
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mean basal serum Τ (14.6 + 1.Θ versus 1 1 . 1 +_ 1.1 n m o l / 1 and E2 ( 1 5 9 +^  
20 versuss 129 + 10 pmol/ l ) d i d not d i f f e r s i g n i f i c a n t l y b e t w e e n t h e 
two groups. 
TL treatment lowered serum E2 l e v e l s s i g n i f i c a n t l y (P 
wi th in 1 month to lowest values 34 ^ 10% below b a s e l i n e a t 
( f i g . 1) . 
testolactone 1 gr/day 
0 . 0 0 1 ) 
























Figure 1: Effect of A-'-'Testolactone a d m i n i s t r a t i o n ( T e s l a c , S q u i b b , 
R i jswi jk , The N e t h e r l a n d s , 500 mg t w i c e d a i l y ) f o r 6 m o n t h s 
on the mean percentage changes o f serum E2, l-H and FSH l e v e l s 
in 9 pat ients w i t h i d i o p a t h i c o l i g o s p s r m i a . The a s t e r i s k s 
indicate the s t a t i s t i c a l s i g n i f i c a n c e o f t h e c h a n g e s as 
compared to the b a s e l i n e v a l u e . * Ρ < 0 . 0 5 . * ( * ) Ρ < 0 . 0 2 5 . 
** Ρ < 0.01. *** Ρ < 0 . 0 0 1 . 
Afterwards the levels remained a t t h i s l e v e l (-33 t o -35%) d u r i n g t h e 
next 3 months (P < 0.01 - < 0.001 v e r s u s b a s e l i n e ) . The mean s e r u m LH 
levels did not change dur ing t h e 6 months t r e a t m e n t p e r i o d , e x c e p t f o r 
an unexplained s l i g h t but s i g n i f i c a n t decrease a t 3 months (P < 0 . 0 2 
versus t=0) . The mean serum FSH l e v e l s i n c r e a s e d s i g n i f i c a n t l y f r o m 1 
month on (P < 0.01 versus t=0) t o peak v a l u e s 1.5 +_ 0 . 2 t i m e s t h e b a s e ­
l i n e af ter 2 and 3 months (P < 0 . 0 5 ) . A f t e r w a r d s t h e mean FSH l e v e l s 
f e l l to values not s i g n i f i c a n t l y d i f f e r e n t f r o m b a s e l i n e . 
The mean t o t a l serum Τ l e v e l s s i g n i f i c a n t l y i n c r e a s e d t o peak v a l u e s 
1.34 + 0.1 times the base l ine (P < 0.05 v e r s u s t = 0 ) 1 month a f t e r 
s t a r t i n g therapy and t h e r e a f t e r g r a d u a l l y d e c l i n e d t o l e v e l s ( 1 . 1 - 1.2 
times the baseline) not s i g n i f i c a n t l y d i f f e r e n t f r o m t h e p r e t r e a t m e n t 
value. 
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F i g u r e 2 : E f f e c t of Δ l - t e s t o l a c t o n e administration (2 χ 500 mg daily) 
for 6 months on the mean percentage changes of serum E2» sex 
hormone b i n d i n g g lobul in (SHBG), T, the T/E2 rat io and the 
" f r e e " Τ index in 9 Oligospermie men. The asterisks indicate 
t h e s t a t i s t i c a l s i g n i f i c a n c e s of the changes as compared to 
t h e b a s e l i n e v a l u e . (*) 0.05< Ρ < 0.10. * Ρ < 0.05. *(*) Ρ < 
0 . 2 5 . * * Ρ < 0 . 0 1 . *** Ρ < 0.001. 
When t h e Τ v a l u e s however were corrected for the significantly 
d e c r e a s i n g SHBG l e v e l s ( n a d i r value -22 + 4S below baseline at 4 
m o n t h s , Ρ < 0 .005) t h e " f r e e " Τ index (T/SHBG) rose to values 1.4 to 
2 . 0 t i m e s t h e b a s e l i n e (P < 0.025 - < 0.005) throughout the treatment 
p e r i o d . 
The T/E2 r a t i o a l s o s i g n i f i c a n t l y increased within one month (P < 
0 . 0 2 ) and remained s i g n i f i c a n t l y elevated at a level 1.6 to 2.2 times 
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the pretreatment value (Ρ < 0.05 - < 0.005) u n t i l t h e end o f t h e t r e a t ­
ment period. Except f o r a s t a t i s t i c a l l y s i g n i f i c a n t f a l l o f one m o n t h 
(P < 0.01 versus baseline) the E2/SHBG r a t i o r e m a i n e d u n c h a n g e d 
throughout the treatment p e r i o d . Serum E2 and SHBG l e v e l s w e r e s i g n i f i ­
cantly correlated wi th each other ( r s = 0.040, p** < 0 . 0 0 5 ) . 
The mean serum 17-0HP l e v e l s i g n i f i c a n t l y i n c r e a s e d w i t h i n one m o n t h 
to a value 1.5 + 0.2 times the b a s e l i n e (Ρ < 0 . 0 2 5 ) , t h e r e a f t e r 
plateaued u n t i l 3 months and then g r a d u a l l y f e l l t o v a l u e s n o t 
s i i n i f i c a n t l y d i f f e r e n t from b a s e l i n e ( f i g . 3 ) . 
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Figure 3: Effect of A^-testo lactone a d m i n i s t r a t i o n (2 χ 500 mg d a i l y ) 
for 6 months on the mean percentage changes i n s e r u m E 2 , 
17-OHP, Τ and the 17-0HP/T r a t i o i n 9 O l i g o s p e r m i e m e n . The 
asterisks i n d i c a t e the s t a t i s t i c a l s i g n i f i c a n c e o f t h e 
changes as compared t o the b a s e l i n e v a l u e . ( * ) 0 . 0 5 < Ρ < 
0.10. * Ρ < U . 0 5 . * ( * ) Ρ < 0.025. * * Ρ < 0 . 0 1 . * * * Ρ < 0 . 0 0 1 
As the 17-OHP increase exceeded the r i s e of T, t h e 17-OHP r a t i o t o Τ 
transient ly s i g n i f i c a n t l y increased t o 1.2 and 1.3 t i m e s t h e 
pretreatment value 1 and 2 months a f t e r s t a r t i n g t h e r a p y (P < 0 . 0 5 a n d 
<
 0.005 respect ively) . Thereafter the 17-0HP/T r a t i o g r a d u a l l y d e c l i n e d 
to baseline values. 
7 0 
T h e mean serum p r o l a c t i n and C o r t i s o l l e v e l s d i d not change s i g n i f i -
c a n t l y t h r o u g h o u t t h e t r e a t m e n t p e r i o d (data not shown). There were no 
s y s t e m a t i c changes i n h e m a t o l o g i c a l , l i v e r or rena l f u n c t i o n parameters 
d u r i n g TL t h e r a p y n o r d i d t h e p a t i e n t s mention any compla in ts . 
E f f e c t o f c h r o n i c A ^ - t e s t o l a c t o n e t r ea tmen t on sperm parameters ( f i g . 4 ) 
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F i g u r e 4 : E f f e c t o f ¿ ¿ - T e s t o l a c t o n e a d m i n i s t r a t i o n (2 χ 500 mg d a i l y ) 
f o r 6 months on t h e mean sperm d e n s i t y , t o t a l sperm c o u n t , 
p e r c e n t a g e a b n o r m a l f o r m s and m o t i l i t y i n 9 p a t i e n t s w i t h 
i d i o p a t h i c o l i g o s p e r m i a . The a s t e r i s k s i n d i c a t e the s t a t i s ­
t i c a l s i g n i f i c a n c e o f t h e changes as compared t o the p r e ­
t r e a t m e n t v a l u e s . * Ρ < 0 . 0 5 . * ( * ) Ρ < 0.025. ** Ρ < 0.01 
T h e mean s p e r m d e n s i t y d i d n o t i n c r e a s e s i g n i f i c a n t l y d u r i n g t he 
f i r s t 3 m o n t h s o f TL t r e a t m e n t (Θ.1 + 0.8 t o 11.9 + 2.8 χ 1 0 б / т 1 ) · 
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T h e r e a f t e r the mean c o n c e n t r a t i o n g r a d u a l l y i n c r e a s e d b u t a s t a t i s t i ­
c a l l y s i g n i f i c a n t r i s e d i d n o t o c c u r u n t i l 6 m o n t h s a f t e r s t a r t i n g 
therapy (21.3 + 6.7 ж l O ^ / m l , P*** < 0 . 0 1 v e r s u s p r e t r e a t m e n t v a l u e ) . 
I n 5 of the pat ients sperm d e n s i t y i n c r e a s e d by more t h a n 2 SD a b o v e 
t h e basel ine values, whereas sperm c o u n t s e x c e e d i n g 20 χ 10^/ml w e r e 
achieved i n 4 of the p a t i e n t s . Two o f t h e s e p a t i e n t s ' w i v e s c o n c e i v e d . 
The t o t a l sperm count a l s o remained unchanged d u r i n g t h e f i r s t 3 
months of treatment. T h e r e a f t e r , t h e mean v a l u e s g r a d u a l l y r o s e t o 
s i g n i f i c a n t l y higher t o t a l sperm c o u n t s ( 9 5 . 9 + 3 8 . 6 χ 1θ6 v e r s u s 3 2 . 8 
+_ 5.3 χ lO^/ml, Ρ < 0.05) a t s i x months. I n 5 p a t i e n t s t o t a l s p e r m 
counts increased by more t h a n 2 SD above t h e b a s e l i n e v a l u e . The 
percentage abnormal forms s l i g h t l y b u t s i g n i f i c a n t l y d e c r e a s e d i n 7 o f 
9 p a t i e n t s from 2 months on u n t i l t h e end o f t h e t r e a t m e n t p e r i o d (P < 
0.025 - < 0.005 versus t = 0 ) . There was no s i g n i f i c a n t c h a n g e i n s p e r m 
m o t i l i t y . 
DISCUSSION 
The administrat ion of TL f o r s i x months t o 9 O l i g o s p e r m i e men 
produced a sustained decrease o f serum E2 and t h e r e b y SHBG c o n c e n t r a ­
t i o n s t o values about 35 and 25% r e s p e c t i v e l y b e l o w t h e p r e t r e a t m e n t 
l e v e l , increased the f r e e Τ i n d e x and T/E2 r a t i o by a b o u t 100% a n d 
almost doubled the mean sperm d e n s i t y . The d e c r e a s e i n s e r u m E2 l e v e l s 
induced by the aromatase i n h i b i t o r y e f f e c t o f TL was a c c o m p a n i e d by a 
t r a n s i e n t increase in serum FSH l e v e l s - n o t however LH - w h i c h r e a c h e d 
a maximum af ter 2 and 3 months and t h e n f a d e d o u t d e s p i t e p e r s i s t e n c e 
o f the E2 lowering. Such temporary r i s e i n FSH was n o t m e n t i o n e d i n t h e 
l o n g term TL study of Vigersky and Glass ( 1 ) , who i n c o n t r a s t s t r e s s e d 
t h e lack of any change i n FSH as w e l l as LH i n t h e i r p a t i e n t s t r e a t e d 
f o r 6 t o 12 months. The i n c r e a s e i n FSH l e v e l s , b u t n o t L H , i n t h e 
p r e s e n t study may be due t o p r e f e r e n t i a l s u p p r e s s i o n o f t h e t o n i c 
i n h i b i t o r y ef fect of endogenous e s t r o g e n s on p i t u i t a r y FSH s e c r e t i o n b y 
t h e aromatase i n h i b i t o r ( 1 4 ) . 
The f a l l of FSH a f t e r the i n i t i a l i n c r e a s e i s , h o w e v e r , more d i f f i ­
c u l t t o expla in. Other authors ( 1 6 , 1 7 ) , t r e a t i n g p a t i e n t s w i t h i d i o p a ­
t h i c oligospermia w i t h clomiphene o r t a m o x i f e n e , o b s e r v e d a s i m i l a r 
d e c l i n e in serum FSH 3 months a f t e r s t a r t i n g t h e r a p y , w h i c h t h e y 
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a s c r i b e d t o t h e c o n c o m i t a n t a c t i v a t i o n of the spermatogenic a c t i v i t y 
a n d p r o b a b l e c o n c o m i t a n t feedback i n h i b i t i o n by i n h i b i n . In t h e p r e s e n t 
s t u d y s p e r m d e n s i t y a d m i t t e d l y increased from 3 months o n , b u t a 
s t a t i s t i c a l l y s i g n i f i c a n t i n c r e a s e was not obseved u n t i l 6 months. 
The l o w e r i n g o f serum E2 l e v e l s was accompanied by a s i g n i f i c a n t 
r i s e o f t o t a l Τ and i t s major p r e c u r s o r 17-OHP. I t i s not q u i t e i n t e l ­
l i g i b l e how TL i n c r e a s e s t e s t i c u l a r s t e r o i d biosynthesis i n t h e absence 
o f an e n h a n c i n g e f f e c t on serum LH l e v e l s . An o v e r a l l s t i m u l a t i n g 
e f f e c t on L e y d i g c e l l s t e r o i d o g e n e s i s might, however, be e x p l a i n e d by a 
d e c r e a s e i n i n t r a t e s t i c u l a r e s t r o g e n s which have a t o n i c s u p p r e s s i v e 
e f f e c t on t h e s t e r o i d o g e n i c key enzymes, 17a-hydroxylase and 1 7 , 2 0 - l y a -
se and t h e r e b y i n t e r f e r e w i t h Τ synthes is (4-9). Remarkably however i s 
t h e f a c t t h a t t h e i n c r e a s e i n serum 17-OHP exceeded the r i s e i n Τ and 
t h e r e f o r e a t r a n s i e n t i n c r e a s e i n the 17-OHP over Τ r a t i o was o b s e r v e d 
1 a n d 2 m o n t h s a f t e r s t a r t i n g TL therapy. This accumulation o f 17-OHP 
o v e r Τ w h i c h rnay r e f l e c t a temporary blockage at the 1 7 , 2 0 - l y a s e l o c u s 
we e a r l i e r t e n t a t i v e l y a s c r i b e d t o be caused by an i n t r i n s i c i n h i b i t o r y 
e f f e c t o f TL i t s e l f on t h i s enzyme ( 1 1 ) . The rel ieve of t h i s e n z y m a t i c 
b l o c k t h e r e a f t e r may be due t o the preponderance of the f a c i l i t a t i n g 
e f f e c t o f E2 l o w e r i n g per se over the i n h i b i t o r y e f f e c t of TL. 
I t h a s t o be n o t e d t h a t b o t h the 17-OHP and Τ i n c r e m e n t s were 
a p p a r e n t l y e v a n e s c e n t , d e s p i t e pers is tence of the E2 l o w e r i n g . As f a r 
as Τ і з c o n c e r n e d t h e subsequent dec l ine can readi ly be e x p l a i n e d by 
t h e n o t e a r l i e r r e p o r t e d c o n c o m i t a n t f a l l i n SHBG l e v e l s which c l o s e l y 
c o r r e l a t e d w i t h E2· A f t e r c o r r e c t i o n f o r t h i s decrease t h e " f r e e " Τ 
i n d e x r e m a i n e d s i g n i f i c a n t l y e l e v a t e d which was f u r t h e r c o r r o b o r a t e d by 
t h e r i s e i n s a l i v a r y t e s t o s t e r o n e ( t o be published). The d e c l i n e i n 
17-OHP l e v e l s may a l s o be due t o an estrogen mediated decrease i n i t s 
m a j o r b i n d i n g g l o b u l i n , C o r t i s o l b i n d i n g globul in (CBG), but t h i s seems 
u n l i k e l y as serum C o r t i s o l l e v e l s d i d not s i g n i f i c a n t l y f a l l d u r i n g TL 
t h e r a p y . As s u g g e s t e d e a r l i e r the decrease in 17-OHP can a l s o be 
e x p l a i n e d by t h e e n h a n c i n g e f f e c t of sustained estrogen l o w e r i n g on t h e 
enzymes i n v o l v e d i n t e s t o s t e r o n e b iosynthes is . 
N e v e r t h e l e s s aromatase i n h i b i t i o n by TL and E^ l o w e r i n g l e d t o a n 
i n c r e a s e i n t h e T/E2 r a t i o and " f r e e " Τ index which - t o g e t h e r w i t h t h e 
t e m p o r a r y r i s e i n serum FSH - may have been responsib le f o r t h e 
i m p r o v e m e n t i n s p e r m a t o g e n e s i s and possible f e r t i l i t y i n t h e p r e s e n t 
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s t u d y . 
Estrogens inhibit d i rect ly spermatogenesis in r a t s (3) and probably 
a l s o in men (2,18). Elevated spermatic vein and p e r i p h e r a l E2 l e v e l s 
have been found in p a t i e n t s with germinal c e l l a r r e s t ( 2 ) , and i n 
i n f e r t i l e men with elevated l e v e l s of FSH ( 1 8 ) . F u r t h e r m o r e , S h e r i n s 
and Clark (19) demonstrated that excess ive E2 l e v e l s p r e v e n t e d comple­
t i o n of spermatogenesis in hypogonadotropic p a t i e n t s t r e a t e d with human 
c h o r i o n i c gonadotropin alone and t h a t n o r m a l i z a t i o n of e s t r a d i o l by t h e 
aromatase inhibitor TL restored s p e r m a t o g e n e s i s . As i n t r a t e s t i c u l a r Τ 
l e v e l s have been reported to be lowered in i d i o p a t h i c o l i g o s p e r m i a (20) 
t h e increase in Τ and the T/E2 r a t i o a l s o may have c o n t r i b u t e d t o t h e 
improvement of spermatogenesis in the p r e s e n t and Vigersky and G l a s s ' 
s tudy ( 1 ) . In both s tudies mean sperm d e n s i t y a lmost doubled and 
pregnancy occurred in 3 respect ive ly 2 of the p a t i e n t s ' wives . 
A s l i g h t but s ignif icant decrease in t h e p e r c e n t a g e abnormal forms 
was found in the present study whereas no changes were seen i n m o t i l i -
t y . 
In contrast to both these encouraging r e p o r t s , a very r e c e n t p r e ­
l iminary study of Clark and Sherina (10) f a i l e d t o demonst ra te any 
e f f e c t a t a l l of TL on t o t a l sperm c o u n t s , m o t i l i t y , or morphology i n a 
p lacebo controlled randomized double-bl ind c r o s s - o v e r s t u d y . During 8 
months of therapy the mean t o t a l sperm c o u n t s remained unchanged i n 
both groups of pat ients t r e a t e d with e i t h e r p lacebo or 2 gram of TL 
d a i l y . Unfortunately no hormonal data a r e given on t h e e f f e c t of both 
drug regimens throughout the t reatment p e r i o d . 
Comparing the effect of the compet i t i ve E2 r e c e p t o r a n t a g o n i s t 
tamoxifen with that of the aromatase i n h i b i t o r TL on sperm d e n s i t y in 
p a t i e n t s with idiopathic oligospermia the d i f f e r e n c e s in hormonal 
e f f e c t s have to be taken i n t o account . In c o n t r a s t t o TL tamoxifen 
produces a r ise in both serum LH and FSH l e v e l s and e q u a l l y i n c r e a s e s Τ 
and E2» leaving the T/E2 r a t i o unchanged ( 1 7 , 2 1 - 2 3 ) . N e v e r t h e l e s s b o t h 
a g e n t s are equally effective in improving s p e r m a t o g e n e s i s and f e r t i l i t y 
i n Oligospermie pat ients , as doubling of the sperm d e n s i t y was a l s o 
achieved in most reports deal ing with t h e e f f e c t of tamoxifen (17, 
21-23) . In an attempt to combine the b e n e f i c i a l e f f e c t s of both d r u g s , 
Vigersky and Glass (24) fa i led t o n o t i c e any f u r t h e r improvement of 
sperm density above that achieved with TL a l o n e . 
» 
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The r e s u l t s ob ta ined w i t h E2 lowering through aromábase i n h i b i t i o n 
are encourag ing and are i n favour of a p ivo ta l ro le of es t rogens i n t h e 
genes is o f the spermatogenic les ion in idiopathic o l i g o s p e r m i a . How-
eve r , the lack o f such b e n e f i c i a l e f fect in s t i l l a s u b s t a n t i a l 
percentage of these p a t i e n t s (about 40% in ours and Vigersky and G l a s s ' 
s t udy ) p o i n t s t o a mu l t i causa l o r i g i n of the les ion and p l e a d s f o r 
b e t t e r s e l e c t i o n c r i t e r i a and '.earch for more e f f e c t i v e t r e a t m e n t 
m o d a l i t i e s i n these p a t i e n t s . 
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CHAPTER VI 
DISCUSSION AND CONSIDERATIONS 
I n t h e p r e c e d i n g c h a p t e r s a t t e n t i o n i s pa i d to d iagnos t i c and t h e r a -
p e u t i c a s p e c t s o f i d i o p a t h i c o l i g o s p e r m i a . In chapter VI the data and 
c o n c l u s i o n s o f t h e p r e c e d i n g c h a p t e r s w i l l be i n t eg ra ted and fo l l owed 
by a g e n e r a l d i s c u s s i o n on t e s t i c u l a r f u n c t i o n . Suggestions which may 
c o n t r i b u t e t o f u r t h e r p r o g r e s s i n t h e development of more e f f e c t i v e 
d i a g n o s t i c and t h e r a p e u t i c m o d a l i t i e s i n p a t i e n t s w i t h i d i o p a t h i c 
o l i g o s p e r m i a a r e a l s o p r e s e n t e d . 
From t h e d a t a i n c h a p t e r I I i t appears t h a t i n men w i t h i d i o p a t h i c 
o l i g o s p e r m i a t h e r e i a a s t a t e o f compensated Leydig c e l l f a i l u r e as 
b a s a l p l a s m a t e s t o s t e r o n e l e v e l s a r e normal bu t on ly at the cost of 
s u p r a n o r m a l s e r u m g o n a d o t r o p i n l e v e l s , which conf i rms data of o ther 
a u t h o r s 4 1 - 9 ) . U n d e r b a s a l c i r c u m s t a n c e s no accumulat ion of the major 
p r e c u r s o r o f t e s t o s t e r o n e , 17a-hydroxyproges te rone (17o-0HP) was 
o b s e r v e d i n t h e O l i g o s p e r m i e p a t i e n t s , wh ich c o n t r a s t s w i t h i n v i v o and 
i n v i t r o d a t a o f S t e i n b e r g e r e t a l . (10) and Rodriguez-Rigau and 
c o w o r k e r s ( 1 1 ) . T h e i r d a t a d e m o n s t r a t e d evidence of a 17 ,20- lyase b lock 
i n O l i g o s p e r m i e men. P l y m a t e e t a l . ( 12 ) a l s o repor ted e leva ted 17a-0HP 
and l o w e r e d t e s t o s t e r o n e l e v e l s i n p a t i e n t s w i t h i d i o p a t h i c 
o l i g o s p e r m i a as c o m p a r e d t o e u g o n a d a l men. 
I n t h e p r e s e n t s t u d y , h o w e v e r , o n l y a f t e r LH-RH s t i m u l a t i o n i n d i r e c t 
e v i d e n c e o f a 1 7 , 2 0 - l y a s e b l o c k was o b t a i n e d which agrees w i t h the 
d a t a o f Ando e t a l . ( 1 3 , 1 4 ) i n O l i g o s p e r m i e p a t i e n t s w i t h v a r i c o c e l e . 
E a r l i e r we r e p o r t e d t h e p r e s e n c e o f such a b lock i n gonadotropin s t i m u -
l a t e d p a t i e n t s w i t h K l i n e f e l t e r ' s syndrome (15 ) . In a d d i t i o n t o the 
o c c u r r e n c e o f t h i s k e y e n z y m a t i c b l o c k l a t e i n s te ro idogenes i s , LH-RH 
i n f u s i o n r e v e a l e d t h e a b s e n c e o f t h e i n i t i a l t es tos te rone r i s e present 
i n e u s p e r m i c men 15 t o 30 m i n u t e s a f t e r s t a r t i n g the i n f u s i o n . F u r t h e r -
m o r e , t h e l a t e r i s e i n t e s t o s t e r o n e was on l y h a l f t h a t i n the c o n t r o l s 
( 1 6 ) . 
I t h a s been known f o r some y e a r s t h a t bo th i n r a t s and man est rogens 
p l a y a p e r m i s s i v e r o l e i n t h e o c c u r r e n c e o f the l a t e s te ro idogen ic 
b l o c k ( C h a p t e r I ) . I n t h e O l i g o s p e r m i e p a t i e n t s from the present s tudy , 
se rum e s t r a d i o l (E2 ) l e v e l s we re h i g h e r than i n the eugonadal men (42 
77 
versus 35 pg /ml ) , but t h i s d i f f e r e n c e l a c k e d s t a t i s t i c a l s i g n i f i c a n c e . 
In p a t i e n t s w i th severe t u b u l a r damage an i n c r e a s e i n p e r i p h e r a l and 
spermat ic e s t r a d i o l l e v e l s has been r e p o r t e d ( 1 7 - 1 9 ) . I n p a t i e n t s w i t h 
i d i o p a t h i c o l igospermia r a i s e d i n t r a t e s t i c u l a r e s t r o g e n l e v e l s have 
been pos tu la ted as the cause o f t h e g o n a d a l d y s f u n c t i o n ( 2 0 ) . We t h e r e -
f o r e hypothesized tha t these i n c r e a s e d E2 l e v e l s may b e t h e c a u s e o f 
the anomalous Leydig c e l l r e s p o n s e t o LH-RH i n f u s i o n i n t h e s e p a t i e n t s . 
Therefore lower ing o f t h i s endogenous e s t r o g e n i n c r e a s e by c h r o n i c 
a d m i n i s t r a t i o n of the a romatase i n h i b i t o r û l - t e s t o l a c t o n e ( T e s l a c ) 
cou ld c o r r e c t the anomaly. Our r e s u l t s , h o w e v e r , w e r e r a t h e r d i s a p -
p o i n t i n g i n t h i s respec t . I n d e e d A l - t e s t o l a c t o n e a d m i n i s t r a t i o n f o r 1 
month and longer led t o a 30% d e c r e a s e i n c i r c u l a t i n g s e r u m E2 l e v e l s 
w i t h enhancement of the FSH, 17-0HP and Τ s e c r e t i o n . B o t h u n d e r b a s a l 
and s t i m u l a t e d c o n d i t i o n s , h o w e v e r , a n a g g r a v a t i o n o f t h e 1 7 , 2 0 - l y a s e 
b l o c k o c c u r r e d , i n s t e a d of t h e e x p e c t e d r e l i e v e . F u r t h e r m o r e , a d m i n i s ­
t r a t i o n of Δ ΐ - t e s t o l a c t o n e c o m p l e t e l y d e l e t e d t h e l a t e t e s t o s t e r o n e 
response t o LH-RH i n f u s i o n , w h e r e a s t h e l a c k o f t h e i n i t i a l t e s t o s t e ­
rone response p e r s i s t e d . T o g e t h e r t h e s e d a t a t h e r e f o r e s u g g e s t t h a t 
e s t r o g e n s do not p lay a s i g n i f i c a n t r o l e i n t h e g e n e s i s o f t h e L e y d i g 
c e l l d e f e c t i n o l i g o s p e r m i a . R e m a r k a b l e h o w e v e r , i s t h e f a c t t h a t i n 
eugonadal men Δ ΐ - t e s t o l a c t o n e a d m i n i s t r a t i o n f o r 1 week a l s o l e d t o an 
a g g r a v a t i o n of the 1 7 , 2 0 - l y a s e b l o c k , b o t h u n d e r b a s a l a n d g o n a d o t r o p i n 
(hCG) s t i m u l a t e d c o n d i t i o n s w i t h a s i m i l a r b l u n t i n g o f t h e t e s t o s t e r o n e 
response t o hCG and a c c u m u l a t i o n o f 17α—OHP ( 2 1 ) . I n a n e a r l i e r s t u d y , 
a d m i n i s t r a t i o n of the c o m p e t i t i v e e s t r o g e n r e c e p t o r a n t a g o n i s t t a m o x i ­
f e n appeared t o completely a b o l i s h t h e hCG i n d u c e d 1 7 , 2 0 - l y a s e b l o c k i n 
normal men ( 2 2 ) . The data on 1 - t e s t o l a c t o n e i n t h e O l i g o s p e r m i e men 
t h e r e f o r e do not f a v o u r , nor e x c l u d e a p e r m i s s i v e r o l e o f e s t r o g e n s i n 
t h e genesis of the L e y d i g c e l l a b n o r m a l i t y i n s e v e r e t u b u l a r damage. 
They o n l y p o i n t out t o an h i t h e r t o u n k n o w n i n t r i n s i c a c t i o n o f 
Δ ΐ - t e s t o l a c t o n e per se - a p a r t f r o m i t s a r o m a t a s e i n h i b i t i n g a c t i o n — 
on probably the microsomal enzymes l a t e i n s t e r o i d o g e n e s i s ( c h a p t e r 
I V ) . T h i s i n t r i n s i c e f f e c t may h a v e o b s c u r e d t h e e x p e c t e d b e n e f i c i a l 
e f f e c t o f reducing F^. 
U n f o r t u n a t e l y , i n the t a m o x i f e n s t u d y i n t h e O l i g o s p e r m i e p a t i e n t s 
no 17 ct-OHP l e v e l s c o u l d be m e a s u r e d . T h e r e f o r e t h e q u e s t i o n o f t h e 
e s t r o g e n dependency of t h e 1 7 , 2 0 - l y a s e b l o c k i n d u c e d b y LH-RH u n d e r 
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b a s a l c o n d i t i o n s r e m a i n s u n a n s w e r e d . S c r u t i n i z i n g t h e data on t e s t o ­
s t e r o n e o n e m o n t h a f t e r s t a r t i n g the E2 receptor a n t a g o n i s t ( c h a p t e r 
I V ) t h e e a r l y Τ i n c r e a s e i n response t o LH-RH i n f u s i o n was s t i l l 
a b s e n t , w h e r e a s t h e l a t e r e s p o n s e was s i m i l a r to t h a t b e f o r e t a m o x i f e n 
a d m i n i s t r a t i o n . T h e s e d a t a s u g g e s t t h a t the ear ly d e f e c t i s not e s t r o ­
g e n d e p e n d e n t o r a t l e a s t i s n o t mediated by the Leydig c e l l e s t r a d i o l 
r e c e p t o r . We, t h e r e f o r e , h a v e t o hypothes ize t h a t the lack of an e a r l y 
t e s t o s t e r o n e r e s p o n s e t o LH-RH i n i d i o p a t h i c o l igospermia i s due t o t h e 
a b s e n c e o f a r a p i d l y r e l e a s a b l e p o o l of precursor s t e r o i d s or t e s t o s t e ­
r o n e i n t h e L e y d i g c e l l s o f t h e s e p a t i e n t s . I t has t o be demonstrated 
w h e t h e r l o n g s t a n d i n g h y p e r g o n a d o t r o p i s m per se or t h e i n d u c t i o n by 
l o c a l f a c t o r s p r o d u c e d by t h e S e r t o l i c e l l s and i n t e r a c t i n g w i t h LH t o 
m o d u l a t e L e y d i g c e l l f u n c t i o n , i s respons ib le f o r the l a c k of the 
i n i t i a l t e s t o s t e r o n e r e s p o n s e i n i d i o p a t h i c o l igospermia ( 2 3 - 3 3 ) . 
I n t h e i n t r o d u c t i o n t o t h i s t h e s i s we a l luded t o the p o s s i b l e dose 
d e p e n d e n c y o f t a m o x i f e n t h e r a p y on the f i n a l outcome of sperm p a r a ­
m e t e r s i n i d i o p a t h i c o l i g o s p e r m i a . 
F r o m t h e d a t a i n c h a p t e r I I I i t i s c l e a r t h a t lower and h i g h e r doses o f 
t a m o x i f e n a r e e q u a l l y ( a l t h o u g h o n l y modestly) e f f e c t i v e i n i m p r o v i n g 
s p e r m d e n s i t y a n d t o t a l s p e r m o u t p u t w i t h o u t a f f e c t i n g m o t i l i t y or 
m o r p h o l o g y . T h i s c o n c o r d a n c e i n s t i m u l a t i n g e f f e c t of b o t h lower and 
h i g h e r d o s e s o f t a m o x i f e n c o u l d a l r e a d y be presaged f r o m the s i m i l a r i t y 
i n b a s a l a n d LH—RH s t i m u l a t e d gonadotropin and s t e r o i d responses 
p r e s e n t o n e m o n t h a f t e r s t a r t i n g t a m o x i f e n . These data t h e r e f o r e 
s u g g e s t t h a t i f t a m o x i f e n p e r se has any e f f e c t on spermatogenesis -
F r a j e s e ( 3 4 ) i n d e e d f o u n d g o o d e v i d e n c e f o r such e f f e c t i n a placebo 
c o n t r o l l e d d o u b l e b l i n d c r o s s - o v e r study - t h i s e f f e c t i s not dose 
d e p e n d e n t o r i t h a s t o be assumed t h a t the lower dose of 5 mg or 10 mg 
i s a l r e a d y a t t h e p l a t e a u o f t h e dose response curve of t h i s d r u g . I f 
t h i s i s t r u e , we c a n n o t e x p l a i n t h e f a i l u r e of W i l l i s e t a l . (35) t o 
o b s e r v e a n y b e n e f i c i a l e f f e c t o f 10 mg tamoxifen on sperm parameters 
i n t h e i r p a t i e n t s w i t h i d i o p a t h i c o l igospermia or i t must be due t o 
s e l e c t i o n o f p a t i e n t s w i t h a more severe degree of o l i g o s p e r m i a . 
S c r u t i n i z i n g t h e h o r m o n a l c h a n g e s induced by tamoxi fen i n the O l i g o ­
s p e r m i e p a t i e n t s f r o m t h e p r e s e n t study no changes i n the t e s t o s t e r o n e 
o v e r e s t r a d i o l r a t i o w e r e o b s e r v e d as both s t e r o i d s showed a s i m i l a r 
i n c r e a s e . I n v i e w o f t h e h y p o t h e s i z e d increased i n t r a t u b u l a r e s t r o g e n 
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concentrations and/or inordinate sensitivity of the germinal epithelium 
to their inhibiting effect, theoretically an increase in testosterone 
and lowering of estradiol would be a more desirable effect when treat­
ing patients with oligospermia. Six months of estradiol lowering by 
administration of the eromatase inhibitor A^-testolactone (chapter V) 
significantly decreased serum sex hormone binding globulin levels and 
almost doubled the free testosterone index and T/E2 ratio. This was 
accompanied by a temporary rise in FSH and an increase in both sperm 
density and sperm counts. This improvement started after four months of 
treatment at the time when FSH levels fell, but only became statis­
tically significant after six months. In the first three months no 
effect of Δΐ-testolactone treatment on sperm indices was observed. This 
was to be expected in view of the time needed for sperm maturation and 
the transit time through the epididymis. The results obtained in the 
present study are similar of those of Vigersky and Glass (20) but 
contrast to those of Clark and Sherins (36) who did not observe any 
change in sperm parameters neither with placebo nor with - the higher 
dose of 2 gram daily - Δΐ-testolactone. 
Although the results obtained with both the E2 receptor antagonist 
tamoxifen and the aromatase inhibitor testolactone are encouraging and 
favour a role of estrogens in the genesis of the spermatogenic lesion 
in some patients with idiopathic oligospermia, the lack of a beneficial 
effect in others, points to a multicausal nature of the disease entity. 
The data therefore plead for better selection of patients with idio­
pathic oligospermia. 
As shown in this study the determination of basal hormone concentra­
tions and stimulated hormone concentrations in peripheral venous blood 
alone has not proved an appropriate method for optimal selection. More­
over several authors reported an extraordinary high intratesticular Τ 
levels in Oligospermie patients despite low peripheral Τ concentrations 
(37,38,39,40). As 75S> of the peripheral estradiol concentration is due 
to extratesticular conversion of testosterone into estradiol (41) only 
determination of the spermatic vein or intratesticular concentration of 
this steroid will give valid information. There is therefore a need to 
measure intratesticular hormone levels to obtain more insight in human 
spermatogenic (patho)fysiology. An exhaustive knowledge of the physio­
logical interactions beteen Leydig cells, Sertoli cell and germ cells 
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i s necessary. Up t i l l now t h i s knowledge is almost only a v a i l a b l e f r o m 
experience i n r o d e n t s . Recent studies in the rat suggested t h a t t h e 
s e m i n i f e r o u s t u b u l e s and orobably the S e r t o l i c e l l s s e c r e t e f a c t o r ( s ) 
which l o c a l l y r e g u l a t e Leydig c e l l s a c t i v i t y . In 197Θ Aoki and F a w c e t t 
showed t h a t f o c a l t u b u l a r damage, caused by implantat ion of a s i l a s t i c 
tube w i t h a n t i - a n d r o g e n i n the r a t t e s t i s , results i n h y p e r p l a s i a o f 
the Leydig c e l l s i n the v i c i n i t y of the implant ( 4 2 ) . L e y d i g c e l l s 
l o c a t e d i n immediate v i c i n i t y of the tubular wal l were l a r g e r i n s i z e 
than p e r i v a s c u l a r Leydig c e l l which are closest to c i r c u l a t o r y LH ( 4 3 ) . 
This was e s p e c i a l l y t r u e f o r stage VI I and V I I I of the r a t s p e r m a t o g e -
n i c c y c l e ( m e i o s i s ) , when endogenous testosterone c o n c e n t r a t i o n and 
s e c r e t i o n of androgen b i n d i n g p r o t e i n (ABP) are close t o maximal v a l u e . 
Therefore i t seems t h a t i n r a t s the tubules have a s t i m u l a t o r y i n f l u ­
ence on the Leydig c e l l which among others is dependent on the s t a g e o f 
the spermatogenic c y c l e . The nature of t h i s paracrine i n f l u e n c e i s 
unknown. I n abdominal t e s t e s , tubular damage abol ishes t h i s s t a g e 
dependent v a r i a t i o n i n the s i z e of the paratubular Leydig c e l l s whereas 
the s e n s i t i v i t y t o human c h o r i o n i c gonadotropin i s reduced ( 4 4 , 4 5 ) . 
There are c o m p e l l i n g reasons f o r bel iev ing that S e r t o l i c e l l - L e y d i g 
c e l l communications are an i n t e g r a l part of normal t e s t i c u l a r f u n c t i o n . 
As yet t h e r e i s l i t t l e i n f o r m a t i o n on the nature of the f a c t o r ( s ) w h i c h 
f a c i l i t a t e i s ) s e m i n i f e r o u s tubule-Leydiq c e l l i n t e r a c t i o n . One c a n d i ­
date i s t e s t i c u l a r LH-RH or LH-RH-like factors produced by the S e r t o l i 
c e l l and e x c l u s i v e l y a c t i n g on the Leydig c e l l (23-30) t h r o u g h i t s 
LH-RH ( l i k e ) r e c e p t o r . I n t h i s respect i t i s relevant t h a t L e y d i g c e l l s 
from t e s t e s w i t h damaged t u b u l e s show a greatly enhanced response t o 
LH-RH i n v i t r o , as do Leydig c e l l s deprived of gonadotropin s t i m u l a t i o n 
f o r longer p e r i o d s . In 1984 Sharpe et a l . (30) adduced evidence f o r t h e 
presence of a h i g h molecular weight factor in rat t e s t i c u l a r i n t e r s t i ­
t i a l f l u i d w i t h major s t i m u l a t o r y e f f e c t on Leydig c e l l s t e r o i d s e c r e ­
t i o n . Verhoeven and C a i l l e a u (31) using d i f f e r e n t approaches, came t o 
the same c o n c l u s i o n : S e r t o l i c e l l s secrete a f a c t o r s t i m u l a t i n g an 
e a r l y step i n the s t e r o i d o g e n i c pathway but i n h i b i t i n g the c o n v e r s i o n 
of С 2 Г i n t o C-, g - s t e r o i d s . These e f f e c t s resemble those observed w i t h 
exogenous LH-RH, but i n c o n t r a s t t o the l a t t e r , the a c t i v i t y o f t h e 
S e r t o l i c e l l f a c t o r was not i n h i b i t e d by an LH-RH a n t a g o n i s t . 
Parv inen et a l . (46) a l s o r e p o r t e d , that the stage dependent L e y d i g 
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ce l l st imulat ion observed oredominant ly i n s tage V I I and V I I I o f the 
rat seminiferous e p i t h e l i a l c y c l e , cou ld not be b locked by a LH-RH 
antagonist. In add i t ion t o a s t i m u l a t o r y e f f e c t o f t he S e r t o l i c e l l s 
the same invest igators adduced evidence f o r the s e c r e t i o n o f a f a c t o r 
part ly i n h i b i t i n g testosterone s e c r e t i o n by Leyd ig c e l l ( 4 7 ) . I n t h i s 
way Ser to l i ce l l s exercise a f i n e l o c a l t u n i n g c o n t r o l on t e s t i c u l a r 
testosterone leve ls , which i s more e f f i c i e n t than the feedback r e g u l a -
t ion via the hypo tha lamic -p i tu i ta ry a x i s . The i n t r a t e s t i c u l a r s e c r e t i o n 
of factors with major e f f e c t s on Leyd ig c e l l s t e r o i d o g e n e s i s , has o b v i -
ous implications in view of the abso lu te and q u a n t i t a t i v e dependence o f 
spermatogenesis on the e x t r a o r d i n a r y h igh i n t r a t e s t i c u l a r t e s t o s t e r o n e 
levels (48). 
Reflecting the a l te red Leydig c e l l f u n c t i o n d u r i n g the spermatogenic 
cycle in the r a t , enzymes present i n the p e r i t u b u l a r Leyd ig c e l l s and 
germ ce l l s also show c y c l i c changes. Thus i n the r a t h i g h e s t l e v e l s o f 
acid phophatase a c t i v i t y - gene ra l l y thought t o r e f l e c t uptake o f 
testosterone - i s found at the stage of mid-pachytene spermatocy tes . 
At th is stage testosterone dependency i s h ighes t and p r o d u c t i o n o f i t s 
carr ier androgen binding p r o t e i n (ABP) i s maximal ( 4 9 , 5 0 ) . S i m i l a r l y 
levels of the microsomal enzyme 3ß-hydroxy3tero id -dehydrogenase 
(3B-HSD) in the pe r i t ubu la r Leyd ig c e l l s , which conve r t s Δ-* t o Δ * 
steroids, are highest i n t h i s stage ( 4 9 , 5 0 ) . 
Although the human male s e m i n i f e r o u s t u b u l e s have an a t y p i c a l 
arrangement of the spermatogenic e p i t h e l i u m , a c i d phosphatase a c t i v i t y 
shows a s imi lar behaviour as i n t h e r a t . I n t h e human t h i s a c t i v i t y 
also arises at the mid pachytene spermatocyte s tage ( 5 0 , 5 1 ) . I n cases 
of spermatogenic damage (spermatogenic a r r e s t , S e r t o l i c e l l o n l y 
syndrome), levels of ac id phosphatase are decreased c o n c o m i t a n t l y w i t h 
diminished levels of t e s t o s t e r o n e and the enzyme 33-HSD ( 5 1 ) . The 
i n f e r t i l e men wi th low 3 3-HSD a c t i v i t y i n v i t r o may be b e n e f i c i a l l y 
treated with exogenous gonadotrop ins t o s t i m u l a t e t e s t o s t e r o n e 
steroidogenesis, thereby p r o v i d i n g the h i g h i n t r a t e s t i c u l a r c o n c e n t r a ­
t ion of testosterone e s s e n t i a l f o r normal spermatogenesis ( 5 2 - 5 4 ) . 
These data i l l u s t r a t e t h a t a l s o i n man t h e r e i s ev idence f o r a s t a g e 
dependent cycle of the Leydig c e l l f u n c t i o n and p r o b a b l y a l s o o f t h e 
Serto l i c e l l . 
In the r a t diminished s e c r e t o r y c a p a c i t y of t h e S e r t o l i c e l l has 
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been found i n a l l s t a t e s o f spermatogenic damage (cryptorchidism, f e t a l 
i r r a d i a t i o n , v i t a m i n A d e f i c i e n c y , hydroxyurea treatment) (55,56). 
Impairment of S e r t o l i c e l l f u n c t i o n has also been shown in natural ly 
o c c u r r i n g models of d im in i shed spermatogenesis. In the H r e rat with 
o l i g o s p e r m i a and e leva ted FSH l e v e l s , production of ABP by the Ser to l i 
c e l l i s d im in i shed (57 ) . 
Apar t f rom impai red S e r t o l i c e l l f unc t i on , Leydig ce l l function i s 
a l s o impa i red i n animal and human spermatogenic damage, as ref lected by 
lowered c i r c u l a t i n g t e s t o s t e r o n e l e v e l s , a diminished response to hCG 
and e l e v a t e d l e v e l s o f LH w i t h an exaggerated r ise fol lowing LH-RH 
( 1 6 , 5 6 , 5 8 - 6 5 ) . Th is i n t e r f e r e n c e w i t h Leydig c e l l function occurs in 
r a t s , rams, and i n men, i n d i c a t i n g a common response to spermatogenic 
damage ( 5 5 , 5 6 ) . The cause of t h i s change in Leydig c e l l function asso-
c i a t e d w i t h spermatogenic i n j u r y i s not understood. I t i s necessary to 
p o s t u l a t e t ha t the semin i fe rous tubules exert a cont ro l l ing influence 
on Leyd ig c e l l s which i s d i s r u p t e d fo l l ow ing spermatogenic damage. The 
na tu re o f t h i s i n t e r a c t i o n i s unknown, but again substances with 
LH-RH- l i ke a c t i v i t y have been thought to be involved as in te rce l lu la r 
messengers between the t u b u l e s and the in te r tubu lar t issue (23-31,46). 
I n man a l s o the presence of LH-RH-l ike a c t i v i t y has been demonstrated 
i n semina l plasma ( 3 2 , 3 3 ) . I t i s remarkable however, that in some 
c l i n i c a l c o n d i t i o n ( K l i n e f e l t e r ' s syndrome (66), Ser to l i ce l l only 
syndrome) the spermatogenic damage i s associated with hypertrophy of 
the Leyd ig c e l l s . I n a d u l t r a t s a s i m i l a r hypertrophy of Leydig ce l l s 
has been demonstrated a f t e r any type of spermatogenic disrupt ion. Yet 
d e s p i t e t h i s hyper t rophy , the tes tosterone response to hCG stimulat ion 
i s subnormal a t l e a s t i n v i v o . In v i t r o the biosynthetic capacity of 
the Leyd ig c e l l t e s t e d by hCG was diminished at lower doses but 
s u r p r i s i n g l y increased a t h igher doses (56,57). 
From the f o r e g o i n g , i t appears that there i s a close interact ion 
between S e r t o l i c e l l s and Leyd ig c e l l s i n ra ts and probably also in 
man. Receptors f o r t e s t o s t e r o n e have been shown in Ser to l i ce l ls (67) 
which toge the r w i t h FSH has been reported to increase the secretion of 
ABP amongst o t h e r s . ABP thereby provides the high in t ra tes t icu la r 
t e s t o s t e r o n e microenvironment necessary fo r spermatogenesis (48). 
I n a d d i t i o n t o the c l ose r e l a t i o n s h i p between Leydig ce l l s and 
S e r t o l i c e l l s ( 6 7 - 6 9 ) , t h e r e i s a lso a close interact ion between 
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S e r t o l i c e l l s and germ c e l l s and v i s a v e r s a ( 6 9 , 7 0 ) . F i r s t the S e r t o l i 
c e l l s provide pyruvate and l a c t a t e as energy s u b s t r a t e t o the germ 
c e l l s (71,72). The product ion of which i s markedly i n c r e a s e d by FSH, 
t e s t o s t e r o n e and also i n s u l i n . F u r t h e r m o r e , a t l e a s t i n r a t s the 
S e r t o l i c e l l s have the capaci ty t o m e t a b o l i z e l i p i d s and t h i s may 
r e p r e s e n t the primary source of energy f o r t h e S e r t o l i c e l l and a d d i ­
t i o n a l energy substrate to the germ c e l l s ( 7 3 ) . B e s i d e s ABP and LH-RH-
l i l c e f a c t o r s (74,75), a number of o t h e r t e s t i s s p e c i f i c p r o t e i n s 
s u p p o r t i n g spermatogenesis i s produced by S e r t o l i c e l l s , p r o v i d i n g t h e 
o p t i m a l microenvironment f o r t h e f u l f i l l m e n t o f t h e v a r i o u s stages of 
spermatogenesis such as plasminogen a c t i v a t o r , t r a n s f e r r i n , m e i o s i s 
i n d u c i n g (MIS) and prevent ing substances (MPS) w h i c h a l s o have been 
demonstrated in the human male ( 7 6 , 7 7 ) . 
I t has been mentioned e a r l i e r t h a t s p e r m a t o g e n i c c e l l s i n f l u e n c e 
S e r t o l i c e l l f u n c t i o n , since S e r t o l i c e l l s a d j a c e n t t o d i f f e r e n t stages 
of spermatogenic epi thel ium d i s p l a y d i f f e r e n t p r o p e r t i e s w i t h r e s p e c t 
t o product ion of plasminogen a c t i v a t o r , ABP ( 7 Θ ) , MIS and MPS ( 7 7 ) , 
enzymatic a c t i v i t y (acid phosphatase) ( 7 9 ) , and b i n d i n g of FSH ( 8 0 ) . 
From a l l these foregoing arguments i t i s c l e a r t h a t t h e r e i s a c l o s e 
i n t e r r e l a t i o n s h i p between S e r t o l i c e l l s on one hand and L e y d i g and germ 
c e l l s on the other. This r e l a t i o n s h i p emphasizes t h a t t h e t e s t i s s h o u l d 
be considered as a f u n c t i o n a l u n i t and not as 3 i n d e p e n d e n t l y f u n c t i o n ­
i n g compartments. Every proces i n t e r f e r i n g w i t h one o f these t h r e e 
compartments therefore must have d e l e t e r i o u s i m p l i c a t i o n s f o r the 
o t h e r s and lead to d i s r u p t i o n of L e y d i g - and S e r t o l i - c e l l f u n c t i o n and 
impairment of spermatogenesis. 
Unfortunately h i t h e r t o knowledge on t h e i n t e r a c t i o n between t h e 
t h r e e compartments i n man i s only f r a g m e n t a r y as compared t o t h a t i n 
r a t s . Admittedly there i s ample evidence i n man f o r a d e f e c t i n L e y d i g 
c e l l f u n c t i o n i n p a t i e n t s w i t h spermatogenic damage ( 5 6 , 5 8 - 6 5 ) , 
a l t h o u g h i t i s s t i l l unknown whether t h e p r i m a r y d e f e c t r e s i d e s i n t h e 
Leydig c e l l or i n the semini ferous t u b u l e . 
A simple comparison of t e s t i c u l a r f u n c t i o n between man and r a t i s 
not poss ib le despite the resemblence i n many a s p e c t s . 
Human Leydig c e l l s as compared t o r a t L e y d i g c e l l s have a low amount 
o f LH receptors. They contain l e s s than 10% o f t h e same r e c e p t o r i n t h e 
r a t Leydig c e l l (81). Gonadotropin s t i m u l a t i o n i n c r e a s e s human t e s t i c u -
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l a r s t e r o i d b i o s y n t h e s i s only marginally ( less than 50%), in c o n t r a s t 
t o the t e n f o l d i n c r e a s e in the r a t . This may be due to the i n s u f f i c i e n t 
supply or f u r t h e r metabolism of mitochondrial cholesterol in man (Θ1). 
The most s t r i k i n g d i f f e r e n c e between r a t and human t e s t i s i s t h e Leydig 
c e l l d e n s i t y . Only 1% of the t e s t i c u l a r volume of the r a t c o n s i s t s of 
Leydig c e l l s whereas in man t h i s i s as high as 12%. The d i f f e r e n c e i n 
Leydig c e l l d e n s i t y i s compensated by the large functional a c t i v i t y i n 
the r a t . Fur thermore d i f f e r e n c e s in steroid synthesis e x i s t between 
r a t s and men. In men in c o n t r a s t to rodents and some subhuman p r i m a t e s 
(orangutan and r h e s u s monkey) the ^ pathway is preferred for t h e syn­
t h e s i s of t e s t o s t e r o n e with a somewhat lower conversion of t e s t o s t e r o n e 
o c c u r r i n g through t h e Δ* pathway (82). Whereas the presence of LH-RH 
r e c e p t o r s on t h e Leydig c e l l in r a t s has been firmly demonstrated, i t s 
presence on human Leydig c e l l s i s s t i l l a matter of controversy ( 8 3 ) . 
With r e s p e c t t o spermatogenesis overt differences between r a t s and 
man a r e p r e s e n t . In r a t the complete cycle la s t s 12 days and compr i ses 
a t l e a s t 14 s t a g e s , each s t a g e being composed of a s p e c i f i c c e l l u l a r 
c o n s t e l l a t i o n r e p r e s e n t i n g a p a r t i c u l a r degree of m a t u r a t i o n . In man 
t h e spermatogenic c y c l e comprises only 6 stages and l a s t s 74 + . 4 . 5 
days ( 8 4 ) . In r a t s and most mammalian species there i s a wave l i k e 
arrangement of t h e semini ferous epithelium which can be v i s u a l i z e d by 
t r a n s i l l u m i n a t i o n of f r e s h l y i so la ted unstamed seminiferous t u b u l e s . 
The human male i s a r a r e exception to t h i s rule, as, t h e r e i s a h i g h l y 
d i s o r g a n i z e d p a t t e r n of d i s t r i b u t i o n of the various s tages of s p e r m a t o ­
g e n e s i s . The arrangement i s patchy and moaaic-like, two or more s t a g e s 
of s p e r m a t o g e n e s i s o c c u r r i n g together in a single c r o s s - s e c t i o n of t h e 
t u b u l e . N e v e r t h e l e s s a l s o in man stage dependent changes in Leydig c e l l 
and S e r t o l i c e l l enzymatic a c t i v i t i e s have been observed. 
In r a t s , a s p e c i e s without sex hormone binding globulin (SHBG), t h e 
presence of ABP, t h e i n t r a c e l l u l a r c a r r i e r of testosterone and d i h y d r o -
t e s t o s t e r o n e has been convincingly demonstrated. In man the p r e s e n c e of 
t h i s macromolecule has not been conclusively reported: ABP and SHBG 
being s t r u c t u r a l l y and immunologically similar (85-88). 
From t h e forego ing i t i s c l e a r that there are major d i f f e r e n c e s i n 
t e s t i c u l a r s t e r o i d o g e n e s i s and spermatogenesis between man and r a t . 
Simply e x t r a - p o l a t i n g d a t a obtained in r a t s to the human t h e r e f o r e may 
be h a z a r d o u s , d e s p i t e the fact t h a t Rodriguez-Rigau e t a l in 1980 
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stated that "current concepts of hormonal regulation of mammalian 
spermatogenesis derived primarily in the rat, also apply to the human 
testis" (89). 
However, even if a laboratory animal model exists with a spermato-
genesis more comparable to man, still the problem of oligospermia would 
not have been solved. This is due mainly to two factors: Firstly the 
definition of oligospermia is too unspecific and allows great variabi-
lity and secondly, the etiology of idiopathic oligospermia is far from 
homogenous. The definition of oligospermia in most of the studies is 
based on sperm density, whereas the total sperm count of an ejaculate 
is a more reliable parameter. The total sperm count eliminates the 
pseudo-oligospermia which can be due to a large ejaculate volume. As 
nearly all sperms are present in the first fraction of an ejaculate 
collected in two equal volume fractions there is the possibility that 
incomplete collection of semen can influence the calculated sperm 
density (90). This has not only serious consequences for a proper 
diagnosis of oligospermia, but also for a proper interpretation of the 
results of therapeutical regimens. 
A different problem is the question how often a semen analysis must 
be obtained before a proper diagnosis of oligospermia can be made. 
Six semen analyses over a period of 3 months lower considerably the 
risk of a faulty diagnosis of oligospermia due to, for an example, a 
temporary depression of spermatogenesis caused by a viral infection. 
The diversity in the etiology of idiopathic oligospermia constitutes 
however the most important problem. Kjessler (91) showed for instance, 
that in men with oligospermia, despite a normal karyotype in cultured 
lymfocytes from peripheral blood, an aberrant karyotype could be 
discovered in studies on meiotic division in material obtained from 
testicular biopsies. Rabin et al. (92) found in a group of 24 patients 
with oligospermia in 75% of them immune deposits in their testis 
biopsies. However the significance of these immunologic findings is 
uncertain. Recently, Yoshida et al. (39) reported on the significance 
of paying as much attention to the tubualr compartment as to intersti-
tial compartment of testis biopsies underlining the need to see these 
compartments as a functional unit: They combined and integrated the 
hormonal, histological and biochemical findings in Oligospermie men. 
This made it possible to divide men with the same degree of oligosper-
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mia, tubular derangement and serum FSH levels in two categories. One 
category was characterized by dense clusters of proliferative Leydig 
cells, normal serum testosterone levels, but elevated serum LH levels 
and higher intratesticular testosterone concentrations and steroidoge­
nic enzyme activities. The other category showed sparse Leydig cells in 
combination with lower serum testosterone and LH levels, in combination 
with lower intratesticular testosterone concentrations and steroidoge­
nic enzyme activities. It was concluded that only the last category 
could benefit from Leydig cell stimulating therapy. 
From the foregoing, it seems obvious that progress in the knowledge 
of the pathofysiology of idiopathic oligospermia asks for intensive 
investigation in the individual patient. The current detaile'l knowledge 
on the pathofysiology of female reproductive impairment and the great 
progress in therapeutic modalities has been achieved due to timely 
investments in patients and volunteers. As nearly fifty oer cent of 
marital infertility is due - at least in part - to impaired rrale 
fertility, there is a strong need to invest more research in this згеа 
of impaired male infertility. 
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I i n p a i r m e n t o f male f e r t i l i t y i s a common cause o f b a r r e n m a r r i a g e . 
O l i g o s p e r m i a i s q u i t e o f t e n t h e r e a s o n o f s u b f e r t i l i t y i n man. In the 
m a j o r i t y o f t h e m o d e r a t e l y O l i g o s p e r m i e p a t i e n t s no d e f i n i t e cause of 
t h e o l i g o s p e r m i a can be d e t e c t e d and t h e f i n a l d i a g n o s i s i s " i d i o p a t h i c 
o l i g o s p e r m i a " . The s t u d i e s p r e s e n t e d i n t h i s t h e s i s concern p a t i e n t s 
w i t h i d i o p a t h i c o l i g o s p e r m i a . 
I n c h a p t e r I o l i g o s p e r m i a i s d e f i n e d a c c o r d i n g t o MacLeod and Gold: 
a r b i t r a r i l y t h e sperm d e n s i t y o f 20 χ 106/mi was chosen t o d i f f e r e n ­
t i a t e b e t w e e n f e r t i l e and s u b f e r t i l e men. I n a l l p a t i e n t s , i n a d d i t i o n 
t o t h e o l i g o s p e r m i a , t h e r e a r e a l s o decreased sperm m o t i l i t y (astheno-
z o o s p e r m i a ) and an a b n o r m a l m o r p h o l o g y ( t e r a t o z o o s p e r m i a ) . 
I n t h i s c h a p t e r t h e m u l t i c a u s a l n a t u r e o f o l i g o s p e r m i a has been 
s t r e s s e d a n d t h e c r i t e r i a f o r t h e d i a g n o s i s i d i o p a t h i c o l i g o s p e r m i a 
h a v e b e e n a s s e s s e d . I t a p p e a r s t h a t i d i o p a t h i c o l i g o s p e r m i a i s not a 
d i s t i n c t n o s o l o g i c a l e n t i t y b u t r a t h e r a m i x t u r e o f h y p o t h a l a m i c , 
p i t u i t a r y and g o n a d a l a b n o r m a l i t i e s l e a d i n g t o spermatogenic damage. 
F u r t h e r m o r e , i t a p p e a r s t h a t s e m i n i f e r o u s t u b u l e and L e y d i g c e l l f u n c ­
t i o n s a r e e q u a l l y a f f e c t e d i n t h i s syndrome. 
Ample t h e r a p e u t i c m o d a l i t i e s have been used i n i d i o p a t h i c o l i g o ­
s p e r m i a . D a t a a r e p r e s e n t e d r e g a r d i n g t h e success r a t e o f t reatment 
w i t h t h e a n t i e s t r o g e n s c l o m i p h e n e c i t r a t e ( C l o m i d ) and t a m o x i f e n 
( N o l v a d e x ) o f p a t i e n t s w i t h i d i o p a t h i c o l i g o s p e r m i a . I n t e r p r e t a t i o n of 
t h e r e s u l t s i s o f t e n hampered by l a c k o f agreement as t o what c o n s t i ­
t u t e s a p o s i t i v e r e s p o n s e t o t h e r a p y . F u r t h e r m o r e , s e l e c t i o n c r i t e r i a 
o f p a t i e n t s a r e n o t a l w a y s c o n s i s t e n t . 
I n c h a p t e r I t h e a im o f t h e s t u d i e s i n t h e p r e s e n t t h e s i s has been 
d e l i n e a t e d . 
From t h e d a t a i n c h a p t e r I I i t appears t h a t i n men w i t h i d i o p a t h i c 
o l i g o s p e r m i a t h e r e i s a s t a t e o f compensated L e y d i g c e l l f a i l u r e as 
p l a s m a t e s t o s t e r o n e l e v e l s a r e n o r m a l b u t o n l y a t t h e c o s t of supra-
n o r m a l g o n a d o t r o p i n c o n c e n t r a t i o n s . Under b a s a l c i r c u m s t a n c e s no accu­
m u l a t i o n o f t h e m a j o r p r e c u r s o r o f t e s t o s t e r o n e , 17oi-hydroxyprogeste-
r o n e (17-OHP) o c c u r r e d . D u r i n g LH-RH s t i m u l a t i o n , however, the 17-OHP/ 
t e s t o s t e r o n e r a t i o s i g n i f i c a n t l y i n c r e a s e d , r e f l e c t i n g the presence of 
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a 17,20-lyase block. In the Oligospermie p a t i e n t s t he r i s e in plasma 
testosterone 60 to 180 minutes a f t e r the s t a r t of the i n fus ion was only 
half the increase observed in the con t ro l s u b j e c t s , who did not show a 
17,20-lyase block. Furthermore, in the Oligospermie men t h e e a r l y 
testosterone r ise was completely absent , in c o n t r a s t to t h e f i n d i n g i n 
the euspermic men who showed a c l ea r t e s t o s t e r o n e response 15 minu tes 
after the s t a r t of exogenous LH-RH s t i m u l a t i o n . 
The data i l l u s t r a t e that in id iopa th ic ol igospermia Leydig c e l l f u n c -
tion is anomalous. Chronic d e s e n s i t i z a t i o n by supranormal g o n a d o t r o p i n s 
and/or locally secreted LH-RH-like pep t i de s , due to s emin i f e rous t u b u l e 
damage, leading to depletion of rapid ly r e l e a s a b l e t e s t o s t e r o n e s t o r e s 
and enzymatic impairment, may be one of the causes of the Leydig c e l l 
dysfunction. 
In chapter I I I the e f fec t s of lower (5 and 10 mg once d a i l y ) and 
higher doses (10 mg twice da i ly) of the compet i t ive e s t r o g e n r e c e p t o r 
antagonist tamoxifen on c i r cu l a to ry hormone l e v e l s and sperm p a r a m e t e r s 
in idiopathic oligospermia are compared. The study was f u r t h e r des igned 
to assess the predictary value - i f any - of basa l and LH-RH s t i m u l a t e d 
gonadotropin and s te ro id l eve l s on spermatogenesis one month a f t e r 
start ing tamoxifen therapy. From the data in chapter I I I i t i s c l e a r 
that lower and higher doses of tamoxifen adminis tered for about h a l f a 
year are equally effect ive in improving t o t a l sperm counts and sperm 
density, without affect ing mot i l i ty or morphology. Sperm d e n s i t y 
normalized in one pa t ien t of e i t h e r group. The concordance in s t i m u l a -
ting effect of both the lower and higher doses of tamoxifen cou ld 
already be presaged from the s i m i l a r i t y in basa l and LH-RH s t i m u l a t e d 
serum gonadotropin and s t e ro id responses and in the t e s t o s t e r o n e / e s t r a -
diol (T/E2) ra t io one month a f t e r the s t a r t of t r e a t m e n t . 
The relat ively small percentage of p a t i e n t s ach iev ing n o r m a l i z a t i o n 
of the total sperm counts and densi ty pleads for f u r t h e r s e a r c h fo r 
more effective se lect ion of p a t i e n t s and more e f f e c t i v e t r e a t m e n t 
modalities. 
In patients with id iopa th ic oligospermia r a i s e d i n t r a t e s t i c u l a r 
estrogen levels have been pos tu la ted as the cause of the gonadal d y s -
function. I t was hypothesized tha t these increased e s t r o g e n l e v e l s may 
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be t h e cause of the anomalous Leydig c e l l response to LH-RH infusion 
d e s c r i b e d in chapter I I and that lowering endogenous estrogens by 
c h r o n i c a d m i n i s t r a t i o n of the aromatase inhibi tor A^-testolactone could 
c o r r e c t the anomaly. The r e s u l t s were rather disappointing. Indeed ДІ-
t e s t o l a c t o n e a d m i n i s t r a t i o n (500 mg twice daily) for 1 iionth led to a 
30% d e c r e a s e in c i r c u l a t i n g e s t r a d i o l (E2) levels with enhancement of 
t h e FSH, 17-OHP and l e s s Τ s e c r e t i o n and almost doubling of the T/E2 
r a t i o . However, both under basal and stimulated conditions, an aggrava­
t i o n of t h e LH-RH induced 17,20-lyase block occurred, in stead of the 
expected r e l i e v e . Furthermore, Δΐ-Testolactone completely deleted the 
l a t e t e s t o s t e r o n e response to LH-RH infusion, whereas the lack of the 
e a r l y t e s t o s t e r o n e response in the Oligospermie men persisted. Together 
t h e d a t a may suggest t h a t es trogens do not play a significant role in 
t h e g e n e s i s of the Leydig c e l l defect in oligospermia. However, the 
o c c u r r e n c e of a s i m i l a r aggravation of the 17,20-lyase block in gonado­
t r o p i n s t i m u l a t e d eugonadal men, administered Al-testolactone for 1 
week p o i n t s t o a dual a c t i o n of A^-testolactone i . e . inhibition of 
aromatase and s imultaneously of 17,20-lyase. This l a t te r effect may 
p a r t i a l l y obscure the b e n e f i c i a l effect of lowering E2 on test icular 
s t e r o i d o g e n e s i s (chapter IV). 
I n c r e a s e d i n t r a t u b u l a r estrogen leve l s and/or an inordinate sens i t i­
v i t y of t h e germinal epi the l ium to t h e i r inhibit ing effect have been 
p o s t u l a t e d as the cause of the defective spermatogenesis in patients 
wi th i d i o p a t h i c ol igospermia. Therefore, i t was considered important to 
i n v e s t i g a t e the e f fect of sus ta ined lowering of the endogenous estrogen 
l e v e l s by chronic a d m i n i s t r a t i o n (6 months) of the aromatase inhibitor 
A-^-testolactone (500 mg twice dai ly) on endocrinological and sperm 
p a r a m e t e r s in these p a t i e n t s . A^-Testolactone administration for 6 
months t o 9 p a t i e n t s with i d i o p a t h i c oligospermia lowered the levels of 
e s t r a d i o l and thereby sex hormone binding globuline by about 30%, 
t e m p o r a r i l y increased serum FSH leve l s and almost doubled the T/E2 
r a t i o ( i n c o n t r a s t with tamoxifen which l e f t the T/E2 rat io unchanged) 
and t h e f ree t e s t o s t e r o n e index. During A^-testolactone treatment the 
mean sperm dens i ty and t o t a l sperm count almost doubled and normosper-
mia was achieved in A p a t i e n t s . 
Although t h e data point t o a p i v o t a l ro le of estrogens in the patho-
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genesis of the spermatogenic l e s i o n in some p a t i e n t s w i t h i d i o p a t h i c 
oligospermia, the lack of a b e n e f i c i a l e f f e c t of e s t r o g e n l o w e r i n g in 
others points to a mult icausal n a t u r e of t he d i s e a s e e n t i t y ( c h a p t e r 
V). 
In chapter VI data from the p rev ious c h a p t e r s have been i n t e g r a t e d . 
The need for a more profound i n s i g h t in the r e l a t i o n s h i p between Leydig 
ce l l s , Sertoli ce l l s and germ c e l l s a l s o in man i s s t r e s s e d . H i t h e r t o 
such knowledge is almost only a v a i l a b l e from s t u d i e s i n r a t s i n which a 
close interaction between the t h r e e t e s t i c u l a r compar tments h a s been 
demonstrated. Merely ex t r apo l a t i ng t he se da t a t o man i s no t p o s s i b l e 
because there are many d i f fe rences between both s p e c i e s in s t e r o i d b i o -
synthesis and soermatogenesis. P rogres s in the knowledge of t h e p a t h o -
physiology of idiopathic o l igospermia w i l l u l t i m a t e l y l e a d t o more 
effective selection c r i t e r i a and to more e f f e c t i v e t r e a t m e n t m o d a l i -
t i e s . 
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SAMENVATTING 
Verminderde v r u c h t b a a r h e i d van de man i s een veel voorkomende oor-
zaak van ongewi lde k i n d e r l o o s h e i d . Wanneer het aantal spermatozoën 
onder de g e s t e l d e norm v a l t , wordt geconcludeerd dat er sprake is van 
O l i g o z o o s p e r m i e . Een a a n t a l oorzaken van Oligozoospermie is bekend en 
v a s t t e s t e l l e n . Vaak i s d i t echter n i e t mogelijk en wordt de verlegen-
h e i d s d i a g n o s e i d i o p a t h i s c h e Oligozoospermie gesteld. 
De i n d i t p r o e f s c h r i f t gepresenteerde studies hebben a l le betrekking op 
p a t i ë n t e n met i d i o p a t h i s c h e Oligozoospermie. 
I n h o o f d s t u k I wordt Ol igozoospermie gedefinieerd volgens het c r i t e -
r i u m van MacLeods minder dan 20 χ 106 spermatozoën/ml. A l le in d i t 
p r o e f s c h r i f t bes tudeerde mannen voldoen aan deze d e f i n i t i e . Tevens is 
e r b i j hen sprake van verminderde beweeglijkheid van de spermatozoën 
(as thenozoospe rm ie ) en een verhoogd aantal abnormaal gevormde spermato-
zoën ( t e r a t o z o o s p e r m i e ) zoa l s meestal het geval i s b i j idiopathische 
O l i g o z o o s p e r m i e . 
De v e r s c h i l l e n d e oorzaken van Oligozoospermie en de c r i t e r i a voor het 
s t e l l e n van de d iagnose z i j n k o r t samengevat. Endocrinologische aspec-
t e n worden behandeld en argumenten worden aangevoerd welke de overtu i -
g i n g s teunen dat i d i o p a t h i s c h e Oligozoospermie zowel een aandoening van 
de t u b u l u s s e m i n i f e r u s a l s van de Leydig cel i s . In een ui tvoer ig l i t e -
r a t u u r o v e r z i c h t worden de r e s u l t a t e n van de behandeling van patiënten 
met i d i o p a t h i s c h e Ol igozoospermie met anti-oestrogenen samengevat. De 
i n t e r p r e t a t i e van de gepub l iceerde resul taten van behandeling met 
r e s p e c t i e v e l i j k c l o m i p h e e n - c i t r a a t (Clomid ) en tamoxifen (Nolvadex®) 
w o r d t b e m o e i l i j k t door he t ontbreken van un i fo rmi te i t in de gebezigde 
s e l e c t i e c r i t e r i a . Ook i s he t begr ip ' s ign i f i can te verbetering' niet 
a l t i j d nauwkeur ig g e d e f i n i e e r d . 
T e n s l o t t e worden de d o e l s t e l l i n g e n van de in d i t proefschr i f t gerappor-
t e e r d e s t u d i e s nader u i t e e n g e z e t . 
I n h o o f d s t u k I I word t nagegaan welke hormonale verschi l len er onder 
b a s a l e omstandigheden en t i j d e n s s t imu la t i e met lu te in iz ing hormone-
r e l e a s i n g hormone (LH-RH) bestaan tussen groepen van mannen met eu-
spe rm ie en i d i o p a t h i s c h e Oligozoospermie. De gevonden verschi l len 
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steunen de opvatting dat er sprake i s van een a fw i jkende f u n c t i e van de 
Leydigcel bi j patiënten met i d i o p a t h i s c h e O l i g o z o o s p e r m i e . Onder b a s a l e 
omstandigheden is het plasma t e s t o s t e r o n g e h a l t e w e l i s w a a r n o r m a a l , maar 
hiervoor i s een sterkere LH-s t imula t ie nodig ( ' c o m p e n s a t e d L e y d i g c e l l 
f a i l u r e ' ) . Tijdens toediening van LH-RH s t i j g t de serum t e s t o s t e r o n 
spiegel b i j deze oligozoosperme mannen s i g n i f i c a n t minde r dan b i j 
proefpersonen met euspermie. Bovendien v ind t a c c u m u l a t i e p l a a t s van 
z i jn belangrijkste voorloper, het 17 -hyd roxyproges t e ron (17-OHP) . D i t 
wi js t op een remming van het s leute lenzym 1 7 , 2 0 - l y a s e . O p m e r k e l i j k i s 
bovendien dat bi j de mannen met Oligozoospermie de i n i t i ë l e s t i j g i n g 
van de testosteronspiegel on tb reek t , welke wel wordt g e z i e n b i j mannen 
met euspermie. Dit afwijkende r e a c t i e p a t r o o n van de L e y d i g c e l b i j i d i o -
pathische Oligospermie kan een gevolg z i j n van c h r o n i s c h e d e s e n s i t i z e — 
ring van de Leydigcel door verhoogde gonado t ro f inen of doo r LH-RH-ach-
t i g e peptiden afkomstig u i t het afwijkend k i e m c e l e p i t h e e l t e r p l a a t s e . 
In hoofdstuk III wordt het e f f e c t be s tudee rd van l a n g d u r i g e t o e d i e -
ning van lagere (5 en 10 mg, 1 χ daags) en h o g e r e (10 mg, 2 χ d a a g s ) 
doseringen van de competitieve o e s t r o g e e n - r e c e p t o r a n t a g o n i s t t a m o x i f e n 
(Nolvadex ; op de serum s p i e g e l s van gonadotrof i n e n , t e s t o s t e r o n en 
o e s t r a d i o l en de kwantitatieve en k w a l i t a t i e v e s p e r m a p a r a m e t e r s . T e v e n s 
was een doel van de s tudie na t e gaan in h o e v e r r e een LH—RH—st imula t ie-
t e s t één maand na begin van de behande l ing , v o o r s p e l l e n d e w a a r d e h e e f t 
voor de beoogde verbetering van de Spermatogenese . D i t b l e e k n i e t h e t 
geval t e zi jn. Bovendien bleken genoemde dose r ingen van t a m o x i f e n na 4 
weken toediening een verge l i jkbaar e f f e c t t e hebben op de b a s a l e en 
door LH-RH gestimuleerde s p i e g e l s van gonadotrof inen en t e s t o s t e r o n e n 
de r a t i o tes tos te ron/oes t rad io l (T/E2) . De b a s a l e waa rden van gonado— 
t rof inen en oestradiol en de T/E2 r a t i o waren na 4 weken t a m o x i f e n n i e t 
s ign i f i can t veranderd. De LH respons op LH-RH en b a s a l e t e s t o s t e r o n 
waarde waren echter s ign i f i can t toegenomen. Ook l i e t e n de v e r s c h i l l e n d e 
tamoxifendoseringen geen v e r s c h i l in e f f e c t z i e n op de spermatozoën— 
dichtheid en het to ta le aan ta l spermatozoën per e j a c u l a a t . S l e c h t s b i j 
1 pa t ien t in beide behandelingsgroepen werd n o r m a l i s e r i n g van b e i d e 
parameters verkregen. Het percentage abnormale s p e r m a t o z o ë n en hun b e -
weeglijkheid veranderden n i e t . Deze t e l e u r s t e l l e n d e r e s u l t a t e n p l e i t e n 
voor betere s e l e c t i e c r i t e r i a voor behandel ing van p a t i ë n t e n met o l igo— 
9 8 
z o o s p e r m i e met a n t i o e s t r o g e n e n en meer nog voor het zoeken naar andere 
meer e f f e c t i e v e behandel ingsmethoden. 
B i j i d i o p a t h i s c h e Ol igozoospermie wordt verondersteld dat de gonada-
l e d y s f u n c t i e b e r u s t op een t e hoge oestrogeenconcentratie i n de t u b u l i 
s e m i n i f e r i . Tevens zou een t e hoge i n t e r s t i t i ë l e oestrogeenconcentrat ie 
h e t a f w i j k e n d e r e a c t i e p a t r o o n van de Leydiqcel op toediening van LH-RH 
k u n n e n v e r k l a r e n . Om deze hypothese te toetsen werd in hoofdstuk IV het 
e f f e c t van t o e d i e n i n g van de aromatase-remmer A^- testo lacton (Teslac ) 
op genoemd r e a c t i e p a t r o o n onderzocht . De resultaten waren verrassend. 
I n d e r d a a d v e r l a a g d e A ^ - t e s t o l a c t o n de serum oest rad io lsp ieqe l binnen 1 
maand met 30%. De serumspiege ls van FSH, 17-OHP en i n mindere mate 
t e s t o s t e r o n , s tegen en de T/E2 r a t i o verdubbelde. Echter tegen de 
v e r w a c h t i n g i n t r a d zowel onder basale omstandigheden a l s t i j d e n s toe -
d i e n i n g van LH-RH een v e r e r g e r i n g van de 17,20-lyase remming op. Boven-
d i e n deed t o e d i e n i n g van de aromatase-remmer de door LH-RH ges t imu leer -
de l a t e s t i j g i n g van t e s t o s t e r o n t e n i e t , t e r w i j l d i t n i e t het geval was 
met 17-OHP. Een i n i t i ë l e s t i j g i n g van testosteron zoals b i j eugonadale 
c o n t r o l e personen werd n i e t waargenomen. Tezamen suggereren deze 
gegevens d a t oes t rogenen n i e t z o ' η b e l a n g r i j k e r o l spelen b i j de genese 
v a n de g o n a d a l s d y s f u n c t i e a l s wel wordt aangenomen. Opmerkel i jk i s , 
d a t v e r g e l i j k b a r e b e v i n d i n g e n ook werden verkregen b i j eugonadale 
m a n n e n , d i e k o r t d u r e n d A ^ - t e s t o l a c t o n kregen toegediend. Aangenomen 
moet dan ook worden dat Δ ^ - t e s t o l a c t o n een tweeledig e f f e c t u i t o e f e n t . 
Het b e w e r k s t e l l i g t de beoogde remming van de omzetting van androgenen 
n a a r o e s t r o g e n e n door b e ï n v l o e d i n g van het enzym aromatase, maar tevens 
een ongewenste remming van het sleutelenzym 17,20-lyase. Deze l a a t s t e 
w e r k i n g doe t mins tens g e d e e l t e l i j k t en ie t het gunstige e f f e c t van ver -
l a g i n g van i n t r a t e s t i c u l a i r e oestrogeenconcentratie op de synthese van 
S t e r o i d e n door de L e y d i g c e l . 
Een verhoogde i n t r a t u b u l a i r e concentrat ie van oestrogenen of een 
v e r h o o g d e g e v o e l i g h e i d van het k iemepi theel voor oestrogenen zou een 
c a u s a l e f a c t o r kunnen z i j n b i j het ontstaan van Oligozoospermie. D i t 
was de reden om p a t i ë n t e n met id iopath ische Oligozoospermie gedurende 6 
maanden t e behandelen met de aromatase-remmer Δ ΐ - t e s t o l a c t o n . De r e s u l ­
t a t e n h i e v a n z i j n i n h o o f d s t u k V beschreven. Het voordeel van t o e d i e -
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ning van /¿--testolacton boven tamoxifen blijkt uit de blijvende daling 
van de spiegels van oestrogenen en het testosteron-bindend globuline 
tijdens Δΐ-testolacton en de daarme gepaard gaande tijdelijke stijging 
van de serum FSH-spiegel en verdubbeling van zowel de T/E2 ratio als 
vrije testosteron index. Bij 4 van de 9 met Δ ^ --testolacton behandelde 
patiënten vond tijdens deze behandeling normalisering plaats van de 
spermatozoëndichtheid. Ook daalde het percentage abnormale spermatozo-
ën. Omdat bij de overige patiënten slechts een geringe of geen verbete-
ring van deze parameters optrad, moet echter worden geconcludeerd, dat 
een verhoogde intratubulaire oestrogeenconcentratie of een verhoogde 
gevoeligheid van het Uiemepitheel minder vaak verantwoordelijk is voor 
de afwijkende Spermatogenese dan gemeenlijk wordt aangenomen. 
In hoofdstuk VI worden de gegevens uit de hoofdstukken I t/m V 
geïntegreerd. Bovendien wordt gewezen op de noodzaak om de kennis te 
vergroten van de interactie tussen Leydigcellen, Sertolicellen en kiem-
cellen bij de mens. Thans bestaat dergelijke kennis alleen uit experi-
menten verricht bij proefdieren, vooral de rat. Extrapolatie van deze 
kennis naar de mens is niet zonder meer mogelijk, gezien de vele 
verschillen welke bestaan tussen beide species wat betreft de synthese 
van Steroiden en de Spermatogenese. 
Tenslotte worden mogelijkheden aangegeven waardoor het inzicht in de 
Pathogenese van idiopathische Oligozoospermie kan worden verdiept. De 
hoop is dat dit resulteert in betere selectiecriteria en betere resul-
taten van behandeling. 
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ERKENTELIJKHEID 
Dit proefschrift is het resultaat van vruchtbare samenwerking in het 
onderzoekscluster 'Endocriene Regelmechanismen'. 
Degenen, die mij bij dit proefschrift hebben begeleid, ben ik zeer 
erkentelijk. Zij maakten van een clinicus en docent toch nog een onder-
zoeker. 
Aan mijn opleider Prof.dr J.L. Mastboom heb ik veel te danken. Ik prijs 
mij gelukkig zijn klinische signatuur te dragen. 'The seeds of first 
instruat-íons are dropped into the deepest furrows ' (Ticpper) 
Velen zijn mij behulpzaam geweest bij dit proefschrift. Een ieder ben 
ik daarvoor erkentelijk. Met naam wil ik noemen en extra bedanken 
- de verpleegkundige staf van de polikliniek voor Obstetrie en Gynaeco-
logie en in het bijzonder Mevr. J. Vader, die zich een ware Teslac-
hostess toonde. 
- het laboratorium van de kliniek voor Obstetrie en Gynaecologie 
(hoofd: Drs P.W.C. Houx) en in het bijzonder Dr C.M.G. Thomas en 
Ing. M.F.G. Segers voor de talloze hormoonbepalingen. 
- het laboratorium voor Experimentele en Chemische Endocrinologie 
(hoofd: Prof.dr Th.J. Benraad) voor de 17-OHP-bepalingen. 
- de afdeling Klinische Farmacie (hoofd: Prof.dr E. v.d. Kleijn) en in 
het bijzonder Mevr. dra 3. Benneker voor alle getrooste moeite om 
д 1-testolactone te bemachtigen en daarvan capsules te bereiden. 
- de afdeling Medische Illustratie (hoofd: de Hr M.M. Bollen) en 
Medische Fotografie (hoofd: de Hr A.Th.A. Reynen) voor alle illustra­
ties. 
- de staf van de Medische Bibliotheek en in het bijzonder het voormalig 
hoofd de Hr E. de Graaf f voor alle ondervonden medwerking. 
- ICI-Farma Holland B.V. voor de verstrekte subsidie. 
- de collegae Drs R.F.P.M. Kruitwagen en Drs R.W. de Haan voor hun 
participatie in de uitvoering van de LHRH-stimulatietesten. 
- Mevr. Th. Smals-Vermeulen, zo loyaal met "may I borrow your husband?" 
en zo royaal met gastvrijheid. 
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- Dr A. Soanauf voor z i j n c o r r e c t i e s van het Enge l s . 
- Drs B.C.3.M. Fauaer, wiens daadwerke l i j ke en morele s teun o n o n t b e e r -
l i j k was. 
- Mevr.dra E. Wolters-Everhardt, d i e ondermeer op een c r u c i a a l moment 
k l in ische werkzaamheden overnam. 
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B i j i d i opa th i sche O l i gozoospe rm ie i s de f u n c t i e v a n de L e y d i g c e l g e s t o o r d . 
I I 
De s e l e c t i e c r i t e r i a voor b e h a n d e l i n g v a n p a t i ë n t e n met i d i o p a t h i s c h e 
Oligozoospermie met t a m o x i f e n ( N o l v a d e x ) o f Δ 1 - t e s t o l a c t o n e ( T e s l a c ) 
z i j n voor v e r b e t e r i n g v a t b a a r . 
I l l 
De 17,20-lyase remming t i j d e n s LH-RH s t i m u l a t i e b i j mannen met i d i o p a t h i ­
sche Oligozoospermie wordt n i e t ongedaan qemaakt door inname van 1 g r a m 
Δ^-testolacton (Teslac ) gedurende 4 v o o r a f g a a n d e weken. 
IV 
De opvatt ing, dat de act ieve u i t d r i j v i n g s f a s e d i e n t t e b e g i n n e n z o d r a 
volledige o n t s l u i t i n g i s b e r e i k t , g e t u i g t van o b s t e t r i a c h e o n e r v a r e n h e i d . 
V 
De behandeling van vaginisme met p e l o t t e - t h e r a p i e f a a l t z e l d e n , i n d i e n 
anamnestisch i s gebleken dat er sprake i s van een p o s i t i e v e s e x u e l e 
at t i tude en van voldoende m o t i v a t i e . 
V I 
De kans op mislukken van een l a p a r o s c o p i s c h e s t e r i l i s a t i e d o o r ' d o c t o r ' s 
f a i l u r e ' wordt gereduceerd i n d i e n de u t e r u s met een h u l k a k l e m i n o p t i m a l e 
anteflexie wordt gebracht. 
V I I 
'Pul l up' operaties, die zowel t o t d o e l hebben de b l a a s h a l s omhoog t e 
brengen als g e l i j k t i j d i g een c y s t o c e l e t e c o r r i g e r e n , p r e d i s p o n e r e n t o t 
het ontstaan van een enterocele. 
V I I I 
Sacraal gerichte f i x a t i e van de b l i n d - e i n d i g e n d e v a g i n a t o p b i e d t m i n d e r 
kans op topprolaps dan v e n t r a l e f i x a t i e . 
IX 
De o p v a t t i n g , da t de concept iekana wordt vergroot door een extra lange 
a b s t i n e n t i e p e r i o d e , zo d iep mogel i jke intravaginale ejaculat ie en vo l l e -
d i g h e i d van de l a a t s t e s p e r m a f r a c t i e , i s o n j u i s t . 
X 
Semenplasma i s een s l e c h t medium voor spermatozoën. 
XI 
B i j een u t e r u s i n mob ie le r e t r o v e r s i e , die zich n iet zonder meer in ante-
f l e x i e l a a t b r e n g e n , d i e n t de mogel i jkheid van een myoom in de uterus-
a c h t e r w a n d overwogen t e worden. 
X I I 
De b i j s l u i t e r t e k s t van ve rpak te geneesmiddelen in z i j n huidige vorm geeft 
i n a d e q u a t e i n f o r m a t i e aan de gebru iker . 
X I I I 
De p r o f i e l s c h e t s van de u n i v e r s i t a i r e (hoofd)docent biedt geen waarborg 
v o o r de benoeming van ech te docenten. 
XIV 
Zowel i n de tandhee lkunde a l s i n de gynaecologie gaat sonderen met 
r i s i c o ' s gepaa rd . 
XV 
B i j de b e o o r d e l i n g van he t tes t isvo lume van een ander, neigt de minder 
e r v a r e n onderzoeker e r t o e z i j n eigen teatisvolume als 'modaal' te beschou-
wen en daaraan t e r e f e r e r e n . 
XVI 
De opges lagen a c h t e r s t e arm b i j de mediane episiotomie maakt een van 
b e i d e n ' m i s p l a a t s t ' . 
XVII 
Z e g s w i j z e n a l s 'doe n i e t zo gauche ' , 'twee l inker handen' en de betekenis 
van d e x t e r i t y z i j n d i s c r i m i n e r e n d voor minstens sommige linkshändigen. 
XVI I I 
Te w e i n i g gynaeco logen z i j n tevens androloog en te weinig andrologen z i j n 
t e v e n s gynaeco loog . 




